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Severe anemia is the primary outcome of childhood malaria in holoendemic malaria transmission regions 
such as western Kenya.  HIV-1 and bacteremia are equally important diseases in Kenyan children.  
Anemia is also the hallmark trait of pediatric HIV-1 infection, and despite our previous reports of 
exacerbated anemia in malaria/HIV-1 co-infected childrena, we also observed significantly lower 
parasitemias without worsening anemia in malaria/bacteremia co-infected children.  Abundant production 
of pro-inflammatory cytokines is known to adversely affect erythropoiesis and is common to malaria, HIV-
1, and bacteremia.  As such, we performed a comprehensive bead-based 25-plex Multiplex assay to 
identify cytokines patterns and profiles associated with negative and positive hematolgic outcomes in co-
infected children.   Children in Aims 1 and 2 infected with P. falciparum malaria (Pf[+], aged 3-36 mos., 
n=542) were stratified into three groups: HIV-1 negative (HIV-1[-]/Pf[+]); HIV-1 exposed (HIV-
1[exp]/Pf[+]); and HIV-1 infected (HIV-1[+]/Pf[+]).  In Aim 3, malaria and bacteremia co-infected 
children (n=192) were divided into three categories: malaria alone, Pf[+]; Gram negative 
bacteremia/malaria co-infected, G[-]/Pf[+]; and Gram positive bacteremia/malaria co-infected, 
G[+]/Pf[+].  Univariate, correlational, and hierarchical regression analyses were used to determine 
differences among the groups and to define predictors of worsening anemia.  Aim 1 analyses revealed 
HIV-1[+]/Pf[+] children had significantly more malarial pigment-containing neutrophils (PCN), 
monocytosis, increased severe anemia (Hb<6.0g/dL), and ~10-fold greater mortality.  Hierarchical 
multiple regression revealed that worsening anemia was associated with elevated pigment-containing 
monocytes, younger age, and increasing HIV-1 status (HIV-1[-]→HIV-1[exp]→HIV-1[+]).  Aim 2, 
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addressing the inflammatory milieu, demonstrated that exacerbated anemia was associated with 
inflammatory mediator (IM) dysregulation, but not parasitemic or erythropoietic indices.  A principal 
component analysis revealed that IL-12 was the most influential variable on Hb levels in HIV-1[+]/Pf[+] 
children, while the IL-1β:IL-10 ratio was most influenced by PCN.  In Aim 3, both bacteremia co-infected 
groups had lower parasitemia compared to the Pf[+] group.  A multiple mediation model examining IMs 
responsible for decreased parasitemia in the bacteremia co-infected groups identified IL-4, IL-10, IL-12, 
and IFN-γ as the key molecules in decreasing parasitemia.  Thus, malaria/HIV-1 co-infection is defined by 
significantly enhanced anemia that is associated with unique IM profiles known to exacerbate anemia, 
while enhanced immune activation in malaria/bacteremia co-infected children appears to promote 
reduced parasitemia without adversely affecting anemia outcomes.  By defining the inflammatory milieu 
associated with severe anemia, therapies can be developed to mitigate detrimental immune responses, 
thereby lessening the pediatric public health burden in western Kenya.  
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1.0  CHAPTER ONE:  INTRODUCTION 
 
 
 
 
Malaria, meaning ‘bad air’ in Italian, is an ancient protozoal pathogen that has ravaged 
the human population and shaped its genome for thousands of years.  Plasmodium 
entered the realm of known infectious agents in 1880 during the inspection of an 
Algerian malaria patient’s blood smear, when Alphonse Laveran noted a gametocyte 
amongst the red blood cells (RBCs) (Laveran 1880).  Ronald Ross provided the next 
milestone in 1897 when, during the dissection of mosquitoes fed on parasitemic avian 
hosts, he observed Plasmodial oocysts in the guts of the insects, thereby linking malaria 
transmission to mosquitoes (Ross 1899).  These findings were solidified by William 
George McCallum in 1897 when he verified that exflagellation was indeed the 
mechanism of Plasmodial sexual reproduction (McCallum 1897; McCallum 1898), and 
confirmation by Batistta Grassi et al. in 1900 (Grassi 1899) that anopheline mosquitoes 
transmitted human malaria. Currently there is an estimated one to two million deaths 
attributed to malaria annually worldwide, or 1.6% of the total global deaths, and 
Plasmodium infections constitute 2.3% of the global disease burden (Lewison and 
Srivastava 2008).  Human malarial disease is caused by infection with four of the 100 
species of Plasmodium, specifically Plasmodium falciparum, P. vivax, P. ovale, or P. 
malariae, as well as the recently recognized P. knowlesi (Cox-Singh, Davis et al. 2008; 
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Cox-Singh and Singh 2008).  Falciparum malaria is the most severe of these and 
responsible for more than 95% of the global malaria morbidity and mortality (Playfair 
1994).   This single-celled eukaryotic vector-borne disease is transmitted by various 
species of the female anopheline mosquitoes and is endemic to 109 countries, thereby 
placing three billion people at risk each year (WHO 2008). 
 
 
 
1.1  MALARIA LIFE CYCLE IN HUMANS 
 
Malaria is transmitted by the female Anopheles mosquito, of which there are 
approximately 60 species competent for transmission out of the 400 Anopheles species 
worldwide.  Sporozoites are contained in the mosquito’s saliva and less than 100 are 
transferred to the human host during a blood meal (Vanderberg 1977; Rosenberg, Wirtz 
et al. 1990).  These sporozoites then circulate through blood and lymph, with the 
majority arriving at the liver to infect hepatocytes.  Even with approximately 80% of 
sporozoites reaching the liver, erythrocytic productive infection is low (Frevert, 
Engelmann et al. 2005), and in human volunteers, at least five infective bites were 
needed to guarantee parasitemia (Rickman, Jones et al. 1990; Verhage, Telgt et al. 
2005).  Recognition and binding of sporozoites to hepatocytes involves thrombospondin 
domains on the sporozoite binding to hepatocyte heparan sulfate proteoglycans to 
effect invasion (Frevert, Sinnis et al. 1993).  After entry, the sporozoites begin asexual 
amplification, a stage known as exo-erythrocytic schizogeny, for 8 to 25 days to mature 
into schizonts, which then rupture releasing 1,000 to 30,000 merozoites per sporozoite 
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into the blood stream (Tuteja 2007).  The exception being P. vivax and P. ovale, which 
are capable of lying dormant in liver cells, in the form of hypnozoites, and reactivating 
to continue infection weeks to months after the initial inoculation (Krotoski, Collins et al. 
1982).  The liver merozoites are actually released as clusters contained in a host cell 
membrane, termed merosomes, rather than individually as from the erythrocytic stage 
(Baer, Klotz et al. 2007).  Merozoite invasion of the erythrocyte (Cowman and Crabb 
2006) is a four-step process that involves recognition and temporary binding to the 
RBC; reorientation and permanent attachment of the apical end of the merozoite to the 
RBC; engulfment of the merozoite by invagination of the RBC membrane; and finally, 
closing of the parasitophorous vacuole and the RBC membrane (Miller, Baruch et al. 
2002).  Initial recognition of the RBC by the merozoite involves merozoite surface 
proteins (MSP)-1 through -4, while permanent docking employs erythrocyte binding 
antigen (EBA)-175 to form a junction with glycophorin A (Miller, Baruch et al. 2002).  
The merozoite grows by nuclear division, while catabolizing host cell hemoglobin (Hb) 
and glucose, and transitioning from ring stage, to trophozoite, and finally maturing into 
schizonts approximately 48 hrs from erythrocyte invasion.  During intracellular growth, 
the infected erythrocytes display the parasite-encoded P. falciparum erythrocyte 
membrane protein-1 (PfEMP1), which is responsible for parasite recognition by host 
receptors as well as pathogenesis, such as capillary occlusion, due to recognition and 
binding within capillaries (Su, Heatwole et al. 1995; Newbold, Craig et al. 1999; Chen, 
Schlichtherle et al. 2000; Duffy, Craig et al. 2001; Horrocks, Pinches et al. 2004; 
Kraemer and Smith 2006).  The schizont-laden erythrocyte eventually ruptures, 
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releasing 6 to 40 merozoites into circulation to infect additional RBCs.  Occasionally, 
sexual forms of the parasite develop into the gametocytes, typically requiring 7 to 15 
days from liver merozoite release.  Although gametocytogenesis is essential to the cycle 
between human and vector hosts, it still remains poorly understood (Drakeley, 
Sutherland et al. 2006).  The male microgametocytes, and the female 
macrogametocytes, are ingested by the female Anopheles mosquito during subsequent 
blood meals, which initiates the sporogenic cyle in the mosquito and requires between 
ten and twelve days for P. falciparum.  In the stomach of the mosquito the 
microgametocyte penetrates the macrogametocyte and fuses to form a zygote.  As the 
zygotes mature, they become elongated and motile, which allows them to penetrate the 
midgut wall of the mosquito.  Attached to the outer midgut wall, these ookinetes 
mature into oocysts in 24 hrs, which then rupture and release sporozoites.  The 
sporozoites migrate through the hemocoel to the salivary glands of the mosquito 
(Vanderberg 1975), where they will be injected into the mammalian host during the 
next blood meal.   
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1.2  MALARIA BURDEN 
 
 
1.2.1  Worldwide malaria burden 
 
Approximately 247 million malaria infections are estimated annually, resulting in greater 
than one million deaths, primarily in African children under the age of five (WHO 2008).  
The 3.3 billion people at risk for malarial disease span the globe, but are focused in 
South and Central America, Africa, and South-East Asia (WHO 2008).  Outside of sub-
Saharan Africa, the greatest number of cases and deaths occur in India and Sudan.  
After accounting for infecting species, with P. falciparum responsible for the greatest 
mortality, it is transmission intensity of the region that dictates disease severity, clinical 
presentation, and age of presentation, and can be broadly grouped as either seasonal 
(unstable) or stable transmission.  In areas of seasonal transmission, children typically 
are exposed at a later age, and the disease manifests as cerebral malaria (CM).  
Conversely, in regions of stable transmission, children are chronically exposed to the 
malaria parasite at a very young age, and this chronicity of infection leads to severe 
malarial anemia (SMA).  Transmission intensity can be measured by a number of 
methods, but entomologic inoculation rate (EIR) and endemicity, which is derived from 
parasite rate (PR) (Gilles 1993), are the two most common.  EIR is a metric that 
considers the ratio of human bites by competent vectors per person per day and bites 
by infectious mosquitoes per person (Birley and Charlewood 1987).  For example, the 
average EIR estimation for the African continent is 121, and is expressed per annum, 
meaning 121 infective bites per person per year (Rogers, Randolph et al. 2002), 
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whereas the EIR of the rural research area presented herein, Siaya District, has been 
estimated at 60 to 300 (Beier, Oster et al. 1994).  PR is defined by the proportion of 
individuals sampled, typically between the ages of two and ten, which have positive 
blood smears for malaria.  The PR then translates into endemicity as follows: 
hypoendemic, <0.10 PR; mesoendemic, 0.11-0.50; hyperendemic, 0.51-0.75; and 
holoendemic, >0.75, in which only children one year of age are sampled (Metselaar 
1959).  Unfortunately, while substantial strides have been made in reducing or 
eliminating malaria in regions designated as epidemic (100% reduction), hypoendemic 
(66%), and mesoendemic (45%) from 1900 to 2002, the regions with the highest 
transmission rates, hyperendemic and holoendemic, had 16% and 0% reductions, 
respectively, during the same time period (Hay, Guerra et al. 2004).  While malaria 
accounts for approximately 2% of the deaths and infectious disease burden worldwide, 
only about 0.4% of the global biomedical research is focused on this disease (Lewison 
and Srivastava 2008). 
 
1.2.2  Malaria burden in sub-Saharan Africa 
 
In 2006, 91% of the estimated malaria cases were caused by P. falciparum and 86% 
were located in Africa (WHO 2008).   Additionally, 90% of deaths from malaria occurred 
in Africa, compared to just 4% in south-east Asia.  Within Africa, nineteen countries 
bear the burden of 90% of the estimated cases, while eighteen countries are 
responsible for 90% of the deaths, with Kenya being fifth and seventh on these lists, 
respectively (WHO 2008).  The at-risk population in sub-Saharan Africa has increased 
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ten-fold since 1900 due to population increase, and more than 80% of these individuals 
reside in hyper- or holoendemic areas (Hay, Guerra et al. 2004).  Interestingly, because 
of the dynamics of malaria immunity acquisition, the risk of disease is actually lower in 
areas of high transmission, and higher risks are found in low transmission areas 
(Mbogo, Snow et al. 1993; McElroy, Beier et al. 1994; Mbogo, Snow et al. 1995; 
McElroy, Beier et al. 1997; Snow, Omumbo et al. 1997) because clinical immunity is 
never acquired in regions with low or sporadic transmission. 
 
 
 
1.3  CLINICAL MANIFESTATIONS OF MALARIA 
 
Malaria is unique in that the transmission intensity of the region dictates the clinical 
presentation observed in the resident population.  Generally speaking, areas of low 
transmission have higher rates of hospital admission, primarily of older patients 
presenting with severe, acute disease manifesting as CM (Snow, Omumbo et al. 1997; 
Okiro, Al-Taiar et al. 2009).  Areas of high transmission have lower rates of admission, 
with these patients being younger and experiencing a more chronic illness in the form 
of severe anemia, which can quickly escalate to life-threatening disease (Snow, 
Omumbo et al. 1997; Okiro, Al-Taiar et al. 2009).  In the study conducted by Snow et 
al., the mean age of admission in the low transmission area of Bakau, Gambia was 49 
months, with 11% of children under one year of age admitted, versus Siaya, Kenya, 
where 52% of admissions were below the age of one and the mean age was 17 months 
(Snow, Omumbo et al. 1997; Okiro, Al-Taiar et al. 2009).  Interestingly, although low 
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endemicity regions have higher rates of hospital admissions, the percentage of children 
diagnosed with severe disease is lower, while the converse is true in highly endemic 
areas.  Okiro et al. reported this phenomenon with a meta-analysis of 17 regions of 
varying endemicity, where they noted a 4% diagnosis of CM in 10,642 children, 
compared to 17% of children reported with SMA (Okiro, Al-Taiar et al. 2009).  In 
addition to endemicity, age plays a significant role as well, as children are more 
susceptible to severe anemia and hypoglycemia, while non-resident malaria-naïve adults 
are more likely to present with jaundice and progress to renal failure and respiratory 
distress due to pulmonary edema (White 1998). 
 Approximately 11 days after an infective bite, parasites reach a detectable level 
of 20 to 50 parasites/µL in the blood, which may or may not elicit mild symptomatology.  
The patient begins to feel overt symptoms on the 13th day post-inoculation such as 
fever, headache, malaise, myalgia, and weakness, which typically correlates with 20 to 
20,000 parasites/µL.   At this point, patients follow one of three paths that depends on 
regional endemicity, previous exposure, genetics, and age; eventual resolution or 
chronic low level parasitemia, severe disease manifesting as CM, or severe disease 
manifesting as SMA.  In resident adults of endemic areas, it is possible for them to 
remain asymptomatic with parasite loads of 10,000/µL or more (Schellenberg, Smith et 
al. 1994; Smith, Genton et al. 1994). 
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1.3.1  Cerebral malaria and related sequelae 
 
 
The CM manifestation of P. falciparum occurs in both children and adults, unlike SMA, 
which is predominantly a childhood manifestation.  The diagnosis is one of exclusion, 
where all other potential diagnoses for altered consciousness in a patient with evidence 
of parasitemia have been ruled out (WHO 1990).  Children with CM typically present 
with seizures and coma (Molyneux, Taylor et al. 1989), while adults are less likely to 
present with seizures but often have accompanying multi-organ failure that includes 
acute renal failure and respiratory distress from pulmonary edema (Warrell 1987).  
Mortality is dependent on the age of the patient, previous exposure, regional 
endemicity, and sophistication of medical care, and occurs in 10 to 50% of the CM 
cases (Rey, Nouhouayi et al. 1966; Bernard and Combes 1973; Stace, Bilton et al. 1982; 
Warrell, Looareesuwan et al. 1982).  However, those who emerge from coma or altered 
consciousness, 90% of children and 98% of adults, typically recover with no long-term 
sequelae (WHO 1990).  These statistics cast doubt on the widely touted mechanism for 
CM first described in the 1800s (Marchiafava 1894), that oxygen deprivation in the brain 
is due to vascular blockage with parasitized RBCs (pRBCs) (Berendt, Ferguson et al. 
1994; Berendt, Tumer et al. 1994; Silamut, Phu et al. 1999; Beeson and Brown 2002).  
If vascular blockage, anoxia, and subsequent cell death were the cause of coma, one 
would expect outcomes similar to those seen in stroke, with little to no cognitive 
improvement following recovery (Clark, Alleva et al. 2008).  Since recovery in these 
patients is nearly complete, and parasite sequestration is not always present (Turner 
1997), it is more likely that soluble mediators, such as nitric oxide (NO), tumor necrosis 
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factor (TNF)-α, and macrophage migration inhibitory factor (MIF), may be affecting 
neurotransmission and consciousness (Clark, Awburn et al. 2003).  For instance, 
antibodies to TNF-α administered to mice have been shown to be protective from 
cerebral manifestations (Grau, Fajardo et al. 1987).  Similarly, another study in P. 
berghei-infected mice, which usually succumb to infection via neurological sequelae or 
severe anemia, found that administration of human recombinant interferon (IFN)-α 
reduced TNF-α, brain sequestration of pRBCs and white blood cells (WBCs), the 
expression of intercellular adhesion molecule (ICAM)-1, and circulating parasite 
numbers, which in turn reduced mortality from 87% in control mice to 6% in IFN-α-
treated mice (Vigario, Belnoue et al. 2007).  Studies such as those above, among 
others, suggest that cytokine modulation may be the key to pathogenesis, protection, 
and recovery from CM, and perhaps even the alleged mechanism of CM (Ringwald, 
Peyron et al. 1993; Prudhomme, Sherman et al. 1996), i.e., pRBC sequestration in the 
brain (Clark, Alleva et al. 2008). 
 
1.3.1.1  Renal insufficiency  Renal insufficiency and failure are primarily adult 
manifestations of severe disease, which are rarely seen in African children.  A study 
published from Vietnam (Trang, Phu et al. 1992) found that half of the adult patients 
with severe malaria in their study had renal insufficiency, and mortality was reduced 
from 75% to 25% with peritoneal dialysis.  Severe anemia, hemoglobinuria, and 
hypovolemia all contribute to the renal insufficiency caused by tubular necrosis (White 
1998).  Hypoxia and poor perfusion of the kidney are suspected to cause the necrosis,  
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which is precipitated by occlusion of the capillaries by pRBCs (Mishra and Das 2008) in 
addition to other immunologic mechanisms (Eiam-Ong 2002). 
 
1.3.1.2  Metabolic acidosis  Metabolic acidosis is a frequent result of severe malarial 
infection and cause of death, which is primarily caused by lactate accumulation (White 
1998).  Respiratory failure and salicylate intoxication can be other important 
contributors in malaria endemic regions (English, Marsh et al. 1996).  The degree of 
lactic acidosis is proportional to disease severity, and is thought to stem from the 
sequestration and blockage of microvasculature.  Pro-inflammatory cytokines, such as 
MIF (Calandra and Bucala 1995), increase metabolism, and combined with accelerated 
glycolysis, impairment of kidney and liver function, and restricted oxygen delivery, the 
anaerobic glycolysis produces more lactate than can be cleared by the impaired organs 
(Krishnan and Karnad 2003).  In addition to increasing metabolism, the pro-
inflammatory cytokine TNF-α, a molecule that plays a prominent role in the immune 
response to malaria, has been associated with hypoglycemia in African children with 
severe malaria (Grau, Taylor et al. 1989).  Parasites contribute to the lactate 
accumulation as well, since pRBCs metabolize approximately 70 times more glucose 
than uninfected erythrocytes, the majority of which is catabolized to lactate (Maitland 
and Newton 2005; Planche, Dzeing et al. 2005).  A similar process and consequence 
occurs in bacterial sepsis, with the exception being the septic metabolic acidosis is 
predominantly driven by hypermetabolism rather than anoxia (Jacobi 2002).   
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1.3.2  Severe malarial anemia 
  
 
SMA is a manifestation of falciparum malaria predominantly seen in children and 
pregnant women residing in holoendemic transmission areas (Bloland, Ruebush et al. 
1999; Ekvall 2003).  These holoendemic regions, such as western Kenya, carry the risk 
of receiving an infective bite nearly every day of the year (Beier, Oster et al. 1994), and 
with antimicrobial resistance high and no effective vaccine available, long-term survival 
depends on acquisition of protective immunity through repeated infections during 
childhood.  However, the repeated infections necessary to acquire this immunity takes a 
significant toll on children born and raised in these areas and manifests as severe 
anemia due to the chronicity.  SMA has also been found to contribute heavily to hospital 
admissions in low and moderate regions of malaria transmission (Brewster and 
Greenwood 1993), making SMA a potential outcome in any falciparum-endemic region, 
and even in epidemic outbreaks (Idro, Bitarakwate et al. 2005).  In Tanzania, 60% of 
the severe anemia cases in children were attributed to malaria [(Menendez, Kahigwa et 
al. 1997; Abdulla, Schellenberg et al. 2001), while malaria was responsible for only 18-
39% of anemic pregnant women in that region (Shulman, Dorman et al. 1999; Brabin, 
Premji et al. 2001; Guyatt and Snow 2001; Marchant, Schellenberg et al. 2002), so 
clearly younger age predisposes to SMA.  Studies in holoendemic regions of Kenya have 
found that the previous exposure and parasitemia levels were far more predictive of the 
current Hb level than the present infection’s degree of parasitemia (Ekvall, Premji et al. 
2001; McElroy, ter Kuile et al. 2001). 
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The primary manifestations of SMA are fatigue, prostration, rapid breathing, and 
pulmonary edema.  The direct cause of death, which is significantly more likely at Hb 
values less than 5.0g/dL, is believed to be a combination of tissue hypoxia and 
metabolic acidosis (English, Waruiru et al. 1996; English, Waruiru et al. 1996).  Since 
90% of the RBCs destroyed in a falciparum malaria infection are uninfected (Price, 
Simpson et al. 2001), due to nonspecific immune activation, treatment with anti-
malarial drugs can only have a limited effect on the anemia present.  Management of 
severe anemia currently is confined to blood transfusion, which still carries a 
considerable risk in areas where human immunodeficiency virus (HIV) and hepatitis 
prevalence is high [reviewed in (Jayaraman, Chalabi et al. 2010)].  
SMA is caused by a myriad of mechanicsms, including RBC lysis of infected and 
uninfected RBCs (Dondorp, Angus et al. 1999; Dondorp, Chotivanich et al. 1999; Price, 
Simpson et al. 2001; Egan, Fabucci et al. 2002), splenic sequestration of RBCs (Buffet, 
Safeukui et al. 2009), dyserythropoiesis and marrow suppression (Abdalla, Weatherall et 
al. 1980; Phillips, Looareesuwan et al. 1986) by cytokines and hemozoin (PfHz), 
nutritional deficiencies (Berkley, Bejon et al. 2009), co-infections (Berkley, Lowe et al. 
2005; Otieno, Ouma et al. 2006; Bassat, Guinovart et al. 2009; Davenport, Ouma et al. 
2010), and the chronic transmission in a holoendemic region, all contribute to 
chronically low Hb values in children residing in these endemic regions.  For this reason, 
degree of parasitemia is a poor indicator of disease severity in SMA, especially 
considering that it is a “snapshot” in time of a complex and continuously evolving 
disease state.  However, while a low parasitemia may not necessarily indicate a mild 
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infection, high parasitemias in children or non-immune individuals can certainly lead to 
massive lysis and clearance of RBCs, resulting in profound anemia (Phillips, 
Looareesuwan et al. 1986; Molyneux, Taylor et al. 1989). 
Since SMA only occurs in a subset of the population residing in a holoendemic 
region, genetic susceptibility plays a significant role in the development of, or protection 
from, severe disease [reviewed in (Verra, Mangano et al. 2009)].  For instance, the 
human leukocyte antigen (HLA) class I and class II alleles, HLA-B53 and HLA-
DRB1*1302, respectively, were associated with protection from SMA in children with 
severe malaria in The Gambia (Hill, Allsopp et al. 1991).  Two other studies from The 
Gambia found associations between single nucleotide polymorphisms (SNPs) in the 
TNF-α promoter region and CM (TNF-α -308) (McGuire, Hill et al. 1994) and SMA (TNF-
α -238) (McGuire, Knight et al. 1999).  Our group, working in a pediatric population 
located in western Kenyan, has identified multiple SNPs and haplotypes in cytokines 
associated with either SMA protection [interleukin (IL)-10 -1082G/ -819C/ -592C, odds 
ratio (OR) 0.68 (Ouma, Davenport et al. 2008)] or increased susceptibility [IL-1β -31C/ -
511A, OR 1.98 (Ouma, Davenport et al. 2008); MIF -794CATT7,8/ -173C, OR 2.46 
(Awandare, Martinson et al. 2009)].  These polymorphisms and haplotypes lead to 
dysregulation of cytokine pathways, which are believed to be an important underlying 
cause of SMA, i.e. dyserythropoiesis and erythropoietic suppression, since hemolysis 
cannot solely account for the severity of anemia. 
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1.4  ACQUIRED IMMUNITY TO MALARIA 
 
 
Robert Koch, in 1900, compared peoples from West Java, an area of low endemicity, 
and Central Java, which was highly endemic, illustrating that chronic exposure to 
malaria was able to induce clinical immunity over time (Koch 1900; Koch 1900; Koch 
1900; Koch 1900).  Those residing in West Java showed similar disease patterns 
regardless of age, while those in Central Java also had similar clinical signs, but which 
were only focused in the young and rarely observed in those who survived childhood. 
 
1.4.1  Semi-immune status 
 
While sterilizing immunity is virtually unachievable in humans naturally, clinical immunity 
or the ability to tolerate parasitemia without signs or symptoms, as  well as resistance 
to severe disease, is well documented [reviewed in (Doolan, Dobano et al. 2009)].  As 
early as 1920, the tenets of naturally acquired immunity were understood to be: 
present in adults that had endured a holoendemic environment since birth; specific to 
the Plasmodia species of that endemic region, and initially, to the strains in the 
immediate area; gained proportionally to the EIR of that region, i.e., acquired more 
quickly in a holoendemic region than in a mesoendemic region; and quickly lost upon 
leaving the endemic area (Sergente 1910; Schuffner 1919).  Falciparum malaria is not 
only the most severe form of the human malarias, but is also the slowest to confer 
clinical immunity as well.  The explanation for this phenomenon was put forth in a 
landmark paper in 1965 (Brown and Brown 1965) suggesting that the slow acquisition 
of immunity was due to the immense antigenic repertoire displayed by the parasite, 
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which necessitates many infections to develop adequate immunity.  PfEMP1 is believed 
to be the dominant antigen in host immunity to P. falciparum [reviewed in (Scherf, 
Lopez-Rubio et al. 2008)], and is one of the proteins termed variant surface antigens 
(VSA).  An immunoglobulin (Ig)G immune response to this group of VSA proteins has 
been shown to be associated with protection in various venues across sub-Saharan 
Africa (Giha, Staalsoe et al. 2000; Dodoo, Staalsoe et al. 2001; Staalsoe, Shulman et al. 
2004; Joergensen, Turner et al. 2006).   Unfortunately, studies using sera from children 
in The Gambia (Marsh and Howard 1986) and Papua New Guinea (Forsyth, Anders et 
al. 1989) previously infected with P. falciparum, as well as primate studies with rhesus 
macaques (Brown, Brown et al. 1968) and Aotus monkeys (James 1931), demonstrated 
that there was little to no cross-reactivity of antibodies between various strains, thereby 
confirming the need for multiple infections to develop a broad repertoire capable of 
recognizing the various strains present in the region.  However, evidence exists that 
repeated infection with a homologous strain eventually confers some resistance against 
other heterologous strains (Sinton 1935; Cadigan and Chaicumpa 1969; Powell 1972). 
Clinical immunity is acquired in two phases, with the first being ‘anti-disease 
immunity’ in young children, which eventually minimizes the likelihood of cerebral 
manifestations of disease and results in increasingly milder symptoms with subsequent 
infections.  While anti-disease immunity is a relatively rapid development, the ability to 
control and tolerate parasitemia with few to no symptoms is established much more 
slowly.  This ‘anti-parasite immunity’, achieved around puberty, not only controls 
parasitemia but protects from the more chronic manifestations of disease, such as SMA 
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(Marsh and Snow 1997).  The acquisition of these two forms of immunity is estimated 
to require approximately five infections per year for 10 to 15 consecutive years (Doolan, 
Dobano et al. 2009).  Once established, mathematical modeling has estimated the 
duration of these two ‘forms’ of immunity outside of the endemic region to be 
approximately five years for the anti-disease immunity and greater than 20 years for the 
anti-parasitic immunity (Filipe, Riley et al. 2007).  While parasitemia does not always 
predict the degree of disease (Meerman, Ord et al. 2005), high-density parasitemia 
(HDP) does increase the risk of hypoglycemia, metabolic acidosis, respiratory distress, 
CM, and SMA (WHO 2000), as well as having some predictive ability for mortality 
(McElroy, Beier et al. 1994; Beadle, McElroy et al. 1995).  Rather than a sterile immunity 
derived from the immune response, clinical immunity achieved in adulthood was 
originally termed “premunition" by Koch in 1900, and is believed to be parasite-driven, 
in that, the near-constant presence of parasitemia prevents re-infection (Sergent 1935).  
This was demonstrated in a holoendemic area of Northern Ghana where 97% of the 
adults were parasitemic during a 16-week follow-up during the wet season (Owusu-
Agyei, Koram et al. 2001).  In contrast, 32% of children less than 24 months had 
parasitemia >20,000/µL, while only 2% of the adults had this high level of parasitemia, 
and disease severity was nearly identical in both groups with high parasitemia. 
In a holoendemic environment, the likelihood of severe disease begins at birth 
and does not subside until approximately five years of age.  Initially the child is 
protected by the mother’s antibodies (Fouda, Leke et al. 2006), but then susceptibility 
to severe disease and death increases dramatically at approximately six months after 
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these antibodies have cleared the child’s system.  In areas of seasonal transmission, the 
child is at the greatest risk for CM between two and four years of age.  Depending on 
the endemicity of the region, resistance to severe disease can be observed from the 
ages of two to five years.  Generally speaking, the susceptibility to SMA decreases with 
age, while risk of CM increases with age (Baird, Masbar et al. 1998; Marsh and Snow 
1999).  As emphasized above, parasitemia is not indicative of disease severity or 
prognosis, partially due to the fact that sequestration can potentially constitute the bulk 
of the parasite burden.  By puberty, the risk of severe disease has fallen to almost nil, 
but debate exists concerning the significance of this milestone, that is, whether 
cumulative immunity merely coincides with puberty or pubescent changes solidify the 
immunity enjoyed by adults.   A study of non-immune immigrants to Indonesian New 
Guinea showed that parasitemia prevalence was similar across age groups after eight 
months, but after 20 months prevalence peaked at 10 years of age, with a 40% 
prevalence, and decreased every five years to a low of 10% in the over-forty age group 
(Baird 1998). 
 
1.4.2  Non-immune status 
 
 
Non-immune status, as the name suggests, describes an individual with no exposure to 
malaria, or one who has been removed from a region of endemicity long enough that 
immunity wanes, leaving them susceptible to severe disease.  While not corroborated in 
recent literature, reports from the 1800s of Europeans dying in Niger (McGregor 1993) 
and Senegal (Curtin 1994) from malaria-like illness suggests a fatality rate of 30%.  
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Although the African children are currently the hardest stricken by malaria, their 
estimated death rate is only 2% by comparison (Greenwood, Marsh et al. 1991).  This 
disparity of severe disease between adults and children was verified in the Indonesian 
New Guinea study cited above when three months into residence, an epidemic struck 
the transmigrants (Baird, Jones et al. 1991).  At the peak of the epidemic, 48 adults 
(60%) required emergency evacuation, compared to only seven children (40%), which 
translated into a relative risk of 2.7 for adults (Baird, Masbar et al. 1998).  Similar 
findings were discovered in a rat model of lipopolysaccharide (LPS) exposure, in which 
the adult rats were found to be more sensitive than younger rats, which also applied to 
P. berghei infection in these animals (Clark 1982).  So it would seem that the 
immunological advantage of adulthood is a double-edged sword, being protective if 
cultured in a holoendemic environment, while detrimental in a naïve host entering an 
endemic area. 
 
 
 
1.5  HOST IMMUNE RESPONSE TO MALARIA 
 
 
A successful type 1 response to malaria requires a well-timed and proportional release 
of IL-12, IFN-γ, and TNF-α to minimize parasitemia and preserve erythropoiesis 
(Crutcher, Stevenson et al. 1995; Stevenson, Tam et al. 1995).  The pro-inflammatory 
phase should be followed by an equally timely abrogation of this response by type 2 
cytokines such as IL-10, transforming growth factor (TGF)-β, and IL-4, to avoid 
inflammatory host damage (Clark, Budd et al. 2006). 
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1.5.1  Pro- and anti-inflammatory cytokines 
 
 
IL-12 is a heterodimeric protein composed of 35 and 40 kDa subunits and the 
prototypical cytokine of the type 1 immune response (Gately, Renzetti et al. 1998; 
Trinchieri 1998).  It is secreted from dendritic cells, monocytes, and B-cells in response 
to bacterial cell wall components, intracellular pathogens, and by CD40 ligation (Gately, 
Renzetti et al. 1998; Trinchieri 1998; Mosser and Karp 1999) and stimulates production 
of IFN-γ and TNF-α from T-cells and natural killer (NK) cells (Gately, Renzetti et al. 
1998; Trinchieri 1998), thereby driving type 1 responses.  Other cytokines and 
chemokines can either promote IL-12 [e.g., granulocyte macrophage-colony stimulating 
factor (GM-CSF) and IFN-γ] or hinder its production [e.g., IL-4, IL-10, IL-11, IL-13, 
monocyte chemotactic protein (MCP)-1/CCL2, and TGF-β] (Trinchieri 1998; Mosser and 
Karp 1999).  While IL-12 has myriad crucial immune functions during infection, its role 
as a hematopoietic growth factor is particularly important in malaria infection (Bellone 
and Trinchieri 1994; Dybedal, Larsen et al. 1995).  In concert with IL-3, IL-12 as well as 
IL-6, GM-CSF, and IL-11 can bolster colony formation in dormant hematopoietic 
progenitors during times of cytopenic crisis (Bellone and Trinchieri 1994; Dybedal, 
Larsen et al. 1995). 
IFN-γ is produced by natural killer and αβ-T cells, as well as the regulatory γδ-T 
cells, early in the immune response to a malaria infection (Hensmann and Kwiatkowski 
2001; Artavanis-Tsakonas and Riley 2002; D'Ombrain, Hansen et al. 2007).  This 
prototypical type 1 cytokine has been shown to be a key molecule in protecting children 
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(D'Ombrain, Robinson et al. 2008) and pregnant women (Moore, Nahlen et al. 1999) 
from severe disease, as well as non-immune volunteers experimentally infected with 
malaria (Pombo, Lawrence et al. 2002).  IFN-γ has recently been attributed to the Fulani 
tribe’s significant resistance to P. falciparum malaria as compared to other tribes in the 
Mali, Burkina Faso, and Sudan regions.  The authors found that, compared to the 
Dogon tribe, mononuclear cells exposed to asexual parasites in vitro produced more 
than ten times the amount of IFN-γ 2010(McCall, Hopman et al.). 
TNF-α, the molecule typically associated with pathology in malaria disease, but 
also critical for parasite clearance, was first describe in 1975 (Carswell, Old et al. 1975) 
and hypothesized to be involved in host response to malaria in 1978 (Clark 1978).  
Indeed, correlations have been found between greatly elevated TNF-α levels and 
morbidity and mortality (Grau, Taylor et al. 1989; Kwiatkowski, Hill et al. 1990), as well 
as TNF-α being necessary for parasite killing and holding parasite replication in check 
(Grau, Taylor et al. 1989; Kern, Hemmer et al. 1989; Kwiatkowski, Cannon et al. 1989; 
Clark, Cowden et al. 1990; Kwiatkowski, Hill et al. 1990).  In addition to its direct effects 
(Clark, Hunt et al. 1987; van Hensbroek, Palmer et al. 1996), TNF-α also mediates its 
effects by inducing production of MIF (Calandra and Bucala 1995; Lan, Yang et al. 
1997) and inducible nitric oxide synthase (iNOS) (Rockett, Awburn et al. 1992), which 
through generation of NO also has direct parasite killing effects (Rockett, Awburn et al. 
1991).  TNF-α can also exacerbate inflammation by induction of cyclooxygenase (COX)-
2 and hence prostaglandins, which is important in placental malaria (Perkins and Kniss 
1997).  In addition to promoting further pro-inflammatory mediator production, TNF-α 
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has also been shown to suppress IL-12 production as well, which is important for a 
strong erythropoietic response (Ma, Sun et al. 2000).  Many of the signs and symptoms 
of malaria, as well as other systemic disease such as sepsis, can also be linked to TNF-
α, such as fever, headache, nausea, vomiting, diarrhea, anorexia, myalgias, and 
thrombocytopenia (Schwartz, Scuderi et al. 1989).  This was definitively proven in 
human clinical trials using recombinant TNF-α to treat cancer (Creagan, Kovach et al. 
1988), as well as the inability to distinguish between those with malaria and/or sepsis 
by clinical signs alone in the field (Clark, Budd et al. 2006). 
IL-10 is a powerful type 2 anti-inflammatory cytokine necessary to prevent 
damage from over-production of pro-inflammatory responses, such as TNF-α, during 
infection (Ho, Schollaardt et al. 1998).  Unfortunately, an over-abundant type 2 
response is just as detrimental to the resolution of, and recovery from, malaria 
(Ferrante, Staugas et al. 1990; Day, Hien et al. 1999), and in the case of IL-12 (Aste-
Amezaga, Ma et al. 1998) and GM-CSF (Moore, de Waal Malefyt et al. 2001), can inhibit 
secretion necessary for erythropoiesis (Mohan and Stevenson 1998).  We have 
previously shown that IL-10 suppresses IL-12 production using both in vitro experiments 
with PfHz and in vivo findings (Keller, Yamo et al. 2006).  Studies conducted in 
Gabonese children with severe malaria by our group also showed low IL-12 levels in the 
presence of elevated circulating IL-10 and TNF-α concentrations (Luty, Perkins et al. 
2000; Perkins, Weinberg et al. 2000). 
MIF was the first soluble mediator described in malaria (Coleman, Bruce et al. 
1976), but was only recently fully explored in the context of malaria (Awandare, Hittner 
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et al. 2006; Awandare, Ouma et al. 2006; Awandare, Ouma et al. 2007; De Mast, 
Sweep et al. 2008; Awandare, Martinson et al. 2009; Jain, McClintock et al. 2009).  
While MIF has been found in high levels in patients with Gram negative (G[-]) sepsis 
(Roger, Glauser et al. 2001), it is decreased in children with increasing malaria severity 
(Awandare, Hittner et al. 2006).  MIF has also been shown to up-regulate toll-like 
receptor (TLR)-4 in response to endotoxin and G[-] bacteremia (Roger, David et al. 
2001).  In summary, severe malaria is a disease of inappropriate responses in 
magnitude, rather than inappropriate responses in type, much like bacterial sepsis. 
 
1.5.2  Chemokines 
 
 
Chemotactic cytokines, or chemokines, not only recruit leukocytes by chemotaxis, but 
also play a role in immune activation, hematopoiesis, angiogenesis, and have 
antimicrobial properties as well (Rollins 1997).  These molecules have been found to be 
important in placental malaria (Abrams, Brown et al. 2003; Suguitan, Leke et al. 2003), 
CM (Sarfo, Singh et al. 2004; John, Opika-Opoka et al. 2006; Armah, Wilson et al. 
2007; Jain, Armah et al. 2008), and SMA.  Burgmann et al. (Burgmann, Hollenstein et 
al. 1995) first investigated chemokines in 1995 by measuring the C-C chemokine 
macrophage inflammatory protein (MIP)-1α/CCL3 and C-X-C chemokine IL-8/CXCL8 in 
the serum of acutely infected P. falciparum adult patients, finding a positive linear 
association between parasitemia and IL-8/CXCL8.  Lyke et al. (Lyke, Burges et al. 2004) 
also found ten-fold higher concentrations of IL-8/CXCL8 in Malian children with severe 
malaria compared to either healthy controls or uncomplicated malaria.  PfHz, one of the 
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primary parasitic products responsible for immune dysregulation, has been found to 
increase messenger RNA (mRNA) levels of MIP-1α/CCL3, MIP-1β/CCL4, MIP-2/CXCL2, 
and MCP-1/CCL2 in murine models (Jaramillo, Godbout et al. 2005).  Similarly, our 
group reported elevated levels of MIP-1α/CCL3 and MIP-1β/CCL4 from children with 
mild and severe anemia, while regulated on activation normal T-cell expressed and 
secreted (RANTES)/CCL5 levels were inversely proportional to increasing disease 
severity (Ochiel, Awandare et al. 2005).  These findings were confirmed by measuring 
transcripts in peripheral blood mononuclear cells (PBMCs), which mimicked the levels 
found in plasma samples from these same children (Ochiel, Awandare et al. 2005).  In 
addition, RANTES/CCL5 levels were found to correlate with prior malaria disease 
severity, as children with a history of SMA had decreased circulating levels of 
RANTES/CCL5 compared to those with previous mild disease (Ochiel, Awandare et al. 
2005).  In a follow-up study, we found RANTES/CCL5 was associated with 
thrombocytopenia as well as suppression of erythropoiesis (Were, Hittner et al. 2006).   
The Duffy blood group antigen is also important in vivax malaria, since absence of this 
marker on RBCs confers resistance.  In addition, the Duffy antigen receptor for 
chemokines (DARC) also serves as a receptor for IL-8/CXCL8, MCP-1/CCL2, and 
RANTES/CCL5, so it is relevant in other Plasmodium infections and general immune 
activation as well (Horuk, Chitnis et al. 1993).  The population in western Kenya is 
mostly devoid of DARC [Davenport et al., 2009, American Society of Tropical Medicine & 
Hygiene annual conference], which helps explain the absence of P. vivax in this region.   
 
 
 
25 
 
Since there is no signal transduction from chemokines binding to DARC, it is thought to 
function as a chemokine “sink” to regulate blood levels of these molecules (Comerford 
and Nibbs 2005).   
 
1.5.3  Growth factors 
 
 
Growth factors, such as GM-CSF (Liehl, Hildebrandt et al. 1994) and stem cell growth 
factor (SCGF) (Hiraoka, Yano Ki et al. 2001; Elliott, Pham et al. 2008), are key to 
erythropoiesis, and therefore, recovery from malarial anemia.  Infections that influence 
the levels of these molecules can severely impact the generation of new RBCs that have 
been lysed, phagocytized, and cleared during malaria.  TGF-β is a growth factor that 
has recently been found to be instrumental in malaria pathogenesis (Gourley, Kurtis et 
al. 2002; Chaiyaroj, Rutta et al. 2004; Prakash, Fesel et al. 2006), and also attributed to 
both positive (Zermati, Varet et al. 2000) and negative (Hino, Tojo et al. 1988; Sing, 
Keller et al. 1988; Zermati, Fichelson et al. 2000) effects on erythropoiesis.  Similarly, 
granulocyte-colony stimulating factor (G-CSF) has been associated with complicated P. 
falciparum infections as well (Stoiser, Looareesuwan et al. 2000), which may stem from 
its negative impact on erythropoiesis (Van Zant and Goldwasser 1977; Kojima, Fukuda 
et al. 1991; Papaldo, Ferretti et al. 2006).  GM-CSF, in addition to its beneficial effects 
on erythropoiesis, has been demonstrated to synergize with TNF-α to increase the 
killing capabilities of neutrophils on blood-stage malaria parasites (Kumaratilake, 
Ferrante et al. 1996).  Lastly, we have previously shown that the circulating levels of the 
beneficial erythropoietic factor SCGF were proportional to Hb levels and the reticulocyte 
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production index (RPI).  However, SCGF was inversely proportional to the number of 
pigment-containing monocytes (PCM), suggesting a mechanism for the inhibited 
erythropoiesis seen in children with SMA (Keller, Ouma et al. 2009). 
 
1.5.4  Immune dysregulation by parasite products 
 
1.5.4.1  Hemozoin  Infection with malaria exerts its effects on the immune system 
through various mechanisms.  As the organism grows within the erythrocyte, Hb is 
metabolized for amino acids (Krugliak, Zhang et al. 2002; Liu, Istvan et al. 2006), 
leaving the iron-rich heme portion designated ferriprotoporphyrin IX (FP-IX).  The 
organism polymerizes these toxic free FP-IX molecules, using heme polymerase (Chou 
and Fitch 1992; Slater and Cerami 1992), into an insoluble product known as malarial 
pigment or PfHz (Slater, Swiggard et al. 1991; Egan 2002; Pandey, Babbarwal et al. 
2003).  Once the schizont has outgrown the host RBC, the erythrocyte ruptures 
(Omodeo-Sale, Motti et al. 2005), releasing PfHz along with merozoites, with newly-
formed merozoites infecting other RBC, while PfHz is phagocytized by 
monocytes/macrophages and neutrophils.   
The immune perturbances caused by monocytic and neutrophillic phagocytosis of 
PfHz have yet to be fully elucidated, although in vitro and ex vivo experiments have 
shown significant cytokine dysregulation in response to PfHz acquisition (Luty, Perkins 
et al. 2000; Casals-Pascual, Kai et al. 2006; Keller, Yamo et al. 2006; Awandare, Ouma 
et al. 2007; Ong'echa, Remo et al. 2008; Dostert, Guarda et al. 2009; Jaramillo, 
Bellemare et al. 2009; Were, Davenport et al. 2009; Cambos, Bazinet et al. 2010).  For 
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instance, our lab (Keller, Yamo et al. 2006) and others (Aste-Amezaga, Ma et al. 1998; 
Casals-Pascual, Kai et al. 2006) have previously demonstrated that IL-12 is significantly 
reduced in children with SMA, as well as in in vitro experiments with PfHz, by an IL-10-
dependent mechanism.  Similarly, IL-12 can also be antagonized by high levels of TNF-α 
(Ma, Sun et al. 2000), which is a hallmark of malaria infections, as well as G[-] sepsis 
(Giroir 1993).  In addition to the sub-therapeutic levels of IL-12 being produced, greatly 
elevated levels of TNF-α, IL-1, and IL-6 are associated with severe malaria (Grau, Taylor 
et al. 1989; Kwiatkowski, Hill et al. 1990; Kurtzhals, Adabayeri et al. 1998) and PfHz 
deposition (Sherry, Alava et al. 1995; Griffith, Sun et al. 2009) and are known to inhibit 
erythropoietin (EPO) secretion (Faquin, Schneider et al. 1992), erythropoiesis (Schooley, 
Kullgren et al. 1987; Means, Dessypris et al. 1992), and alter iron store regulation 
(Nemeth, Rivera et al. 2004), respectively.   
Hemozoin, in addition to inducing erythropoiesis-inhibiting cytokines, can also 
directly cause apoptosis of erythroid precursor cells via oxidative stress (Lamikanra, 
Theron et al. 2009).  Interestingly, while pigment-containing neutrophils (PCN) have 
been shown to be an indicator of disease severity, PCMs generally have the same 
amount of PfHz regardless of the degree of clinical manifestation (Amodu, Adeyemo et 
al. 1998).  In addition, activated macrophages also phagocytize infected RBCs (Turrini, 
Ginsburg et al. 1992), which results in PfHz residing within macrophage endosomes 
where, among other effects, TLR-9 interacts with the PfHz (Latz, Visintin et al. 2004; 
Takeshita, Gursel et al. 2004; Coban, Igari et al. 2010).  PfHz signaling via the TLR-9 
receptor has been shown to elicit production of IL-6, IL-12p40, TNF-α, and MCP-
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1/CCL2, which is nearly identical to the cytokines/chemokines produced in response to 
treatment with CpG oligodeoxynucleotide (ODN) (Coban, Ishii et al. 2005).  PfHz has 
also been shown to mediate the release of TNF-α, MIP-1α/CCL3, and MIP-1β/CCL4 
from both murine macrophages and human PBMCs (Sherry, Alava et al. 1995).  Recent 
studies have suggested the effect of PfHz to be mediated by TLR-9 ligation of the 
parasitic nucleic acids embedded in the surface of PfHz (Parroche, Lauw et al. 2007), or 
bound in protein-DNA complexes (Wu, Gowda et al. 2010).  The caveat to these 
findings is many of these studies were conducted in mouse myeloid (mDC) and 
plasmacytoid (pDC) dendritic cells, which display significantly different TLRs from 
human cells (Iwasaki and Medzhitov 2004).   
A significant body of data also exists for similar immune disturbances being 
caused by the synthetically produced polymer, synthetic hemozoin (sHz), which also 
contains the heme components found in PfHz, but no parasitic or host products 
(Taramelli, Monti et al. 2001; Keller, Hittner et al. 2004; Coban, Ishii et al. 2005; Nti, 
Slingluff et al. 2005; Ochiel, Awandare et al. 2005; Huy, Trang et al. 2006; Keller, Yamo 
et al. 2006; Ong'echa, Remo et al. 2007).  Newly published data have definitively 
shown, on a molecular and atomic level, that it is indeed the PfHz binding to, and 
causing conformational changes in, the TLR-9 receptor, identical to those induced by 
CpG-ODN, the classical TLR-9 ligand (Coban, Igari et al. 2010).   
 
1.5.4.2  Glycosylphosphatidylinositol  The other major category of malaria 
antigens that have been associated with altered immune responses are the 
glycosylphosphatidylinositols (GPIs) (Nebl, De Veer et al. 2005), which form the 
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connection between the parasite’s cellular membrane and its external antigens.  
Krishnegowda et al. (Krishnegowda, Hajjar et al. 2005) demonstrated that GPIs act as a 
ligand for the TLR-4 receptor, as well as the TLR-2 receptor in concert with either TLR-1 
or TLR-6.  Using IFN-γ-primed murine bone marrow-derived monocytes/macrophages 
(BMDM) the authors demonstrated that increasing concentrations of GPI elicited TNF-α 
in a dose-dependent manner and treatment of these mouse BMDMs with either anti-
TLR-2 or -4 reduced TNF-α production, as did TLR-2 and MyD88 gene knockouts.  The 
bacterial products peptidoglycan (PGN) and LPS also bind these receptors, respectively, 
and induce powerful immune responses (Beutler 2002; Dziarski and Gupta 2005).  Not 
surprisingly, ligation of TLR-2, -4, and -9 have also been implicated in HIV reactivation 
in latently infected mast cells (Sundstrom, Little et al. 2004), while Mycoplasma lipid 
extracts signaling through the same TLR as P. falciparum GPIs have also been found to 
activate the long terminal repeat (LTR) of HIV (Shimizu, Kida et al. 2004).  Jarrossay et 
al. found that mDCs down-regulated the C-C chemokine receptor CCR5 in response to 
the TLR-2 and -4 ligands PGN and LPS, while pDC only responded to CpG-ODN by 
upregulating CCR7 and downregulating CXCR3 (Jarrossay, Napolitani et al. 2001), which 
may also have HIV-susceptibility implications. 
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1.6  ANEMIA AND ERYTHROPOIESIS 
 
 
1.6.1  The erythropoietic response 
 
The generation of new RBCs begins with the sensing of low oxygen tension by cells in 
the kidneys using heme-like molecule receptors (Goldberg, Dunning et al. 1988).  The 
endothelial and interstitial cells of the kidneys then release EPO in response to the 
hypoxic conditions.  Extrarenal sources account for up to 15% of the secreted EPO, and 
is released from hepatocytes and Kupffer cells in the liver, as well as small amounts 
released by monocytes (Rich, Heit et al. 1982), human placenta (Conrad, Benyo et al. 
1996), and hair follicles (Bodo, Kromminga et al. 2007).  Synthesis of EPO has been 
found to be inhibited by IL-1 and TNF-α (Fandrey and Jelkmann 1991), with conflicting 
reports on the ability of IL-6 to block production (Faquin, Schneider et al. 1992).  EPO is 
a highly glycosylated heat- and pH-stable protein that exerts its effects by binding to 
specific receptors found on many cell types, including those unable to respond to EPO, 
presumably because of its extra-erythropoietic ability to reduce pro-inflammatory 
cytokines and oxidative damage (Kanzaki, Soda et al. 2005; Li, Takemura et al. 2006).  
EPO is primarily responsible for regulating differentiation and maturation of progenitor 
cells, which carry 300 – 3000 EPO receptor gene copies per cell, and synergizes with IL-
4.   The sensitivity of progenitor cells to EPO increases with maturation, and EPO may 
also play a role in their proliferation.  As progenitor cells mature into burst-forming 
units, erythroid (BFU-E), which are the earliest dedicated erythroid cells, they become 
increasingly more dependent on EPO as well as IL-3, IL-4, IL-6, and IL-11, while 
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expressing CD33, CD34, and HLA-DR surface markers.  IL-6 has the dubious distinction 
of both directly aiding in BFU-E maturation and progenitor cell proliferation (Pojda and 
Tsuboi 1990), while simultaneously causing hypoferremia by inducing hepcidin 
(Nemeth, Rivera et al. 2004).  Hepcidin, which is secreted in response to free iron and 
inflammation, and suppressed in hypoxic conditions, exerts its effect by preventing the 
release of iron from macrophages and hepatocytes through degradation of ferroportin, 
which is the sole iron export channel (Nicolas, Bennoun et al. 2002; Nicolas, Chauvet et 
al. 2002; Nicolas, Viatte et al. 2002; Nemeth, Rivera et al. 2004).  Similar to the 
contradictory roles of IL-6, IL-1 has the ability to promote the survival of BFU-E, while 
also inhibiting their growth (Smith, Knight et al. 1992).  The effect of IL-1 on BFU-E is 
believed to be mediated through IFN-γ (Means, Dessypris et al. 1992).  Similarly, while 
the survival and differentiation of BFU-E into hemoglobinized cells is dependent on EPO, 
in conjunction with IL-9, their growth is independent of this crucial protein.  Continued 
development of the BFU-E also relies heavily on stem cell factor (SCF), which can 
substitute for EPO in the presence of IL-3.  The chemokine MIP-1α/CCL3 (Su, Mukaida 
et al. 1997) also has the ability to inhibit colony formation of BFU-E, while TGF-β 
(Zermati, Fichelson et al. 2000), TNF-α (Roodman, Bird et al. 1987), TNF-β 
(lymphotoxin, LT) (Ratajczak and Ratajczak 1994), and MIF (Martiney, Sherry et al. 
2000; McDevitt, Xie et al. 2006) can inhibit BFU-E growth.  BFU-E give rise to the 
colony-forming unit erythroid (CFU-E), which have the densest expression of EPO 
receptors, while also expressing CD36.  Exposure of CFU-E to EPO results in several 
rounds of cell division leading to terminal differentiation and the inability to undergo 
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further cell division.  TNF-α may also inhibit colony formation of CFU-E (Allen, Breen et 
al. 1999), in addition to its effects on BFU-E and EPO (Pontikoglou, Liapakis et al. 
2006).  IFN-γ has been found to inhibit CFU-E indirectly (Means, Dessypris et al. 1992) 
through an IL-15-dependant mechanism (Mullarky, Szaba et al. 2007).  Maturation of 
the CFU-E results in formation of proerythroblasts, which mature through ambiguous 
phases to reach polychromatophilic normoblasts, the first cell stage to contain Hb.  
These cell types are still capable of cell division until the nucleus is extruded, at which 
point they become reticulocytes and exit the bone marrow.  Given the extensive 
beneficial and detrimental effects of cytokines, chemokines, and growth factors on 
erythropoiesis, with both effects occasionally being exhibited by the same molecule, 
exploring the inflammatory milieu elicited during co-infection will lead to insight into the 
origin of dyserythropoiesis associated with these co-infections. 
 
1.6.2  Anemia of inflammation 
 
 
The cytokines dysregulated and over-expressed in malaria are also those that pose the 
greatest impediment to erythropoiesis, which are not unique to malaria, but are a 
reoccurring theme in autoimmune-related anemia, as well as those diseases with 
infectious origins (Ferrucci, Guralnik et al. 2005).  For example, in patients with chronic 
idiopathic neutropenia there is significantly reduced BFU-E, which rebounds upon 
treatment with anti-TNF-α and/or anti-IFN-γ (Pontikoglou, Liapakis et al. 2006).   
However, a study in which mice were treated with CpG-ODN, a TLR-9 agonist, and the 
same TLR shown to be targeted by PfHz, only neutralization of IFN-γ ameliorated the 
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erythropoietic suppression, while neutralization of IL-12, TNF-α, IFN-α, IL-1α, and IL-1β 
had no effect (Thawani, Tam et al. 2006).  Similarly, addition of serum from patients 
with rheumatoid arthritis and anemia of chronic disease (ACD), as well as exogenous 
TNF-α and IFN-γ, inhibits EPO production from cobalt-induced human hepatic cancer 
cells and dose-dependently suppresses BFU-E and CFU-E in normal human bone 
marrow (Zhu, Ye et al. 2000).  In addition, studies indicate that 5 – 10% of those 
suffering from chronic kidney disease are either refractory or poor responders to 
exogenous EPO (Eschbach, Downing et al. 1989).  Cooper et al. found that poor 
responders to EPO therapy had at least twice the concentration of IFN-γ, TNF-α, IL-13, 
and IL-10 of either good responders or healthy controls (Cooper, Breen et al. 2003).  C-
reactive protein (CRP) has also been shown to be a predictor of response to EPO in 
anemia (Ortega, Rodriguez et al. 2002; Martone, Zanchi et al. 2003).  A study in renal 
disease patients demonstrated that 80% higher doses of EPO were needed in those 
with CRP levels >20 mg/L, versus patients with EPO deficiency simply due to renal 
disease (Barany 2001).  Similarly, MacDougall et al. (Macdougall and Cooper 2002; 
Macdougall and Cooper 2002) found that patients with CRP levels >50 mg/L failed to 
achieve the Hb concentrations of those with CRP levels <50 mg/L, despite receiving 
greater doses of EPO.  Patients with anemia of inflammation also have a greater 
proportion of zinc, rather than iron, substituted into FP during heme synthesis, and this 
cannot be corrected by iron supplementation, as the additional iron simply becomes 
trapped in the reticuloendothelial system (Hume, Currie et al. 1965; Cartwright 1966; 
Beamish, Davies et al. 1971; Hastka, Lasserre et al. 1993).  TNF-α is also known to 
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inhibit EPO production in addition to inducing NO, which has direct detrimental effects 
on stem cells (Shami and Weinberg 1996).  Many of the cytokines common to 
inflammation-derived anemia are also central to the immune response towards various 
infectious diseases as well, such as IFN-γ, TNF-α, and IL-10, which are recurring themes 
in malaria cytokine dysregulation (Kwiatkowski, Hill et al. 1990; Sherry, Alava et al. 
1995; Chaisavaneeyakorn, Moore et al. 2002; Deshpande and Shastry 2004; Lyke, 
Burges et al. 2004; Prato, Giribaldi et al. 2005; Keller, Yamo et al. 2006; Ong'echa, 
Remo et al. 2007). 
 
1.6.3  Infectious disease-derived anemia 
 
 
Malarial anemia stems from three distinct mechanisms:  RBC destruction caused by the 
rupture of infected RBC, erythrophagocytosis of infected and uninfected RBC by 
activated macrophages (Clark and Chaudhri 1988; Waitumbi, Opollo et al. 2000; Evans, 
Hansen et al. 2006), and inhibition of erythropoiesis by a pro-inflammatory environment 
(Wickramasinghe and Abdalla 2000).  In addition, the deposition of PfHz, the insoluble 
product of parasitic Hb digestion, has not only been implicated in producing the pro-
inflammatory environment and cytokine dysregulation when deposited in phagocytic 
cells, but has been shown to directly inhibit erythropoiesis in children with PfHz bone 
marrow infiltration (Casals-Pascual, Kai et al. 2006; Lamikanra, Theron et al. 2009).  
Evidence also suggests that, while there is increased EPO secretion in asymptomatic 
children harboring malaria (Burchard, Radloff et al. 1995; Kurtzhals, Rodrigues et al. 
1997), in symptomatic children, EPO secretion may be inappropriate for the degree of 
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anemia (Vedovato, De Paoli Vitali et al. 1999), as evidenced by RPI values below two.  
However, EPO secretion is only the beginning of the erythropoietic cascade to correct 
anemia.  Human volunteers injected with LPS were found to release large amounts of 
IL-6 within three hours, and hepcidin at six hours, which elicited the expected 
hypoferremia (Kemna, Pickkers et al. 2005), and thereby demonstrates the contribution 
of G[-] bacteremia to anemia.  Three other inhibitors of erythropoiesis were also 
increased, with IFN-γ and TNF-α peaking at 1.5 hours, while IL-10 peaked at 2 hours, 
followed by peak IL-6 levels at 4 hours.  As noted above, TNF-α has the ability to inhibit 
the release of EPO, while IFN-γ thwarts erythropoiesis through an IL-15-dependant 
mechanism.  This collection of in vitro experiments suggests some of the mechanisms 
that may promote anemia via erythropoiesis inhibition.  However, a definitive 
inflammatory profile from children suffering from the co-infections investigated as part 
of this doctoral work has not been identified in a rural sub-Saharan pediatric population.   
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1.7  CO-INFECTIONS 
 
The three primary infectious diseases plaguing developing nations are malaria, HIV, and 
bacteremia.  Currently, sub-Saharan Africa is home to 90% of the world’s P. falciparum 
infections (WHO 2008) and 64% of the HIV-1 infections (UNAIDS 2008). Children are 
the most effected group in the population, with malaria and HIV-1 being responsible for 
18% and 6%, respectively, of deaths in sub-Saharan African children under the age of 
five (Rowe, Rowe et al. 2006).  However, Berkely et al. concluded after surveying 
19,339 Kenyan children that the major cause of death in that pediatric population was 
not malaria, acquired immunodeficiency syndrome (AIDS), or tuberculosis, but common 
bacterial infections (Berkley, Lowe et al. 2005).  Suffice to say, all three have 
contributed significantly to the pediatric morbidity and mortality in this region of world, 
with the predominant clinical sequelae being severe anemia (Ellaurie, Burns et al. 1990; 
Otieno, Ouma et al. 2006). 
 
1.7.1  Human immunodeficiency virus (HIV) 
 
 
1.7.1.1  Global epidemiology of HIV  Globally, there were approximately 33.2 
million people living with HIV in 2007, of which 2.5 million were children (UNAIDS 
2008).  In that year alone, approximately 420,000 of 2.5 million people were newly 
infected with HIV (UNAIDS 2008).  The epidemic is showing signs of slowing, mostly 
due to transmission reductions in India and sub-Saharan Africa, which resulted in a fall 
in prevalence from the 2001 adult prevalence of 5.8% to the 2007 level of 5.0%.  A 
cure for HIV remains elusive, and while treatments are evolving along with viral 
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resistance, anti-retroviral (ARV) drugs are still unavailable in much of the developing 
world.  This health care disparity resulted in 2.1 million AIDS deaths in 2007, or 5,700 
per day, the majority of which, 76%, occurred in sub-Saharan Africa (UNAIDS 2008). 
 
1.7.1.2  Pediatric HIV in east Africa  The women of sub-Saharan Africa bear the 
brunt of the adult HIV prevalence, as illustrated by 61% of the adult infections being in 
women.  Clearly the number of infected women will directly impact the number of HIV-
infected children, however, HIV prevalence in pregnant Kenyan women residing in urban 
and rural areas has declined by 25% since 2001 (UNAIDS 2008).  While transfusion still 
carries considerable risk in malaria-endemic areas, blood supply safety is improving, and 
vertical transmission still remains the main mode of HIV transmission to children 
(Wiktor, Ekpini et al. 1997).  There is a 25-40% risk of virus transmission to a child from 
conception to cessation of breast feeding, which can be broken down into a 10% risk of 
in utero transmission, 10-20% peri-partum, and another 10-20% during breast feeding 
(Dabis and Ekpini 2002).  In regions devoid of ARVs, children infected with HIV typically 
die before two years of age (Newell, Coovadia et al. 2004). 
 
1.7.1.3  Overview of HIV pathogenesis  The recent HIV literature indicates there 
are two distinct phases of the disease (Derdeyn and Silvestri 2005; Moanna, Dunham et 
al. 2005).  Immediately after transmission, there is an acute phase lasting two to three 
weeks, during which ~60% of the memory T-cells in the mucosa-associated lymphoid 
tissue (MALT) are destroyed.  The acute phase viremia that ensues shortly after 
infection is quickly brought under control, in part, by virus-specific cytotoxic T-
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lymphocyte responses (Musey, Hughes et al. 1997), and is followed by a chronic phase 
lasting years and leading to AIDS.  This latter phase is a state of chronic immune 
activation where a pro-inflammatory milieu taxes the immune system and eventually 
results in an immunocompromised condition due to infection of the activated immune 
cells and cellular fatigue because of their prolonged hyper-activated state (Picker 2006).  
The widespread infection of activated immune cells culminates in the loss of crucial 
CD4+ T-cells necessary to mount an immune response when encountering opportunistic 
pathogens (Veazey and Lackner 2003).  Interestingly, although the typical opportunistic 
infections are encountered as an HIV-1[+] child approaches AIDS, the primary 
manifestation of pediatric infection is anemia (van Eijk, Ayisi et al. 2002).  As in malaria, 
where parasite-mediated lysis of RBCs cannot account for the massive red cell loss that 
is observed, much of the anemia seen in pediatric HIV and malaria may be due to 
impairment of erythropoiesis in a pro-inflammatory milieu.  Exposure of the bone 
marrow and erythropoietic cascade to a pro-inflammatory milieu likely contributes to 
the anemia noted in HIV-1, malaria, and bacteremia (Casals-Pascual, Kai et al. 2006). 
 
1.7.1.4  Consequences of malaria and HIV co-infections  Plasmodium falciparum 
and HIV-1 are co-endemic in many tropical and sub-tropical countries, with the 
potential risk for marked clinical, hematological, and parasitological complications.  HIV 
is immunosuppressive and affects the backbone of the acquired immune response, 
CD4+ T-helper cells, impeding the development of a protective response that is vital to 
developing partial immunity to clinical malaria.  Despite the geographical overlap 
between malaria and HIV, earlier studies revealed little or no definitive interactions 
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between the two infections (Colebunders, Bahwe et al. 1990; Muller, Musoke et al. 
1990; Greenberg, Nsa et al. 1991; Kalyesubula, Musoke-Mudido et al. 1997).  
Previously, we have shown that there is a definitive interaction between HIV-1 and 
malaria in Kenyan children resulting in the exacerbation of anemia (Otieno, Ouma et al. 
2006).  There was a greater degree of SMA, defined as Hb <6.0g/dL, in children that 
were HIV-1 positive (HIV-1[+]) versus either the HIV-1 exposed (HIV-1[exp]) or HIV-1 
negative (HIV-1[-]) children, and was independent of parasite load.  Similarly, 
Grimwade et al. (Grimwade, French et al. 2004) evaluated the effect of HIV status on 
outcome of malaria infection, observing that the likelihood of a complicated malaria 
episode or death substantially increased in both scenarios, as indicated by adjusted 
odds ratios of 2.3 and 7.5, respectively.  Epidemiological analyses of our SMA study 
cohort in western Kenya have also shown that these children typically die within one 
year of viral RNA copies being detected in their blood (Davenport et al., 2008, 
unpublished observation), often due to the compounded anemia inflicted by HIV, as well 
as malaria.  Exacerbating the anemia seen in each disease, epidemiological evidence 
also shows that both Ugandan HIV-1-infected and uninfected infants have iron-
deficiency rates of 44.3% and 45.4%, respectively (Totin, Ndugwa et al. 2002).  Iron-
deficiency is, in part, caused and aggravated by IL-6 upregulation of hepcidin, which not 
only sequesters iron stores in the reticuloendothelial system (Jacober, Mamoni et al. 
2007), but also prevents intestinal absorption of iron (Yamaji, Sharp et al. 2004).  
Although our group (Otieno, Ouma et al. 2006) and others (van Eijk, Ayisi et al. 2002)  
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have previously shown that anemia is worsened in pediatric malaria and HIV-1 co-
infection, little is known about the cytokine milieu in these co-infected children. 
In addition to the anemia caused by both HIV-1 and malaria, viral load, and 
hence, HIV-1 progression and transmission are also serious concerns.  A prospective 
study published in 2005 by Kublin et al. (Kublin, Patnaik et al. 2005) showed that HIV-
1[+] study participants doubled their viral load when they became infected with 
malaria, however, their viral copies declined to baseline levels approximately eight 
weeks after treatment, while those remaining aparasitemic during the study had no 
appreciable changes in their HIV-1 RNA levels from those measured at baseline.  
Additional recent reports indicate that the interaction may not be completely deleterious 
when malaria precedes HIV-1 infection.  Moriuchi et al. (Moriuchi, Moriuchi et al. 2002) 
have shown that PBMC treated with supernatants from lysed schizonts (Pf-Ags) prior to 
HIV-1 infection caused a decrease in viral production by inducing cellular resistance to 
viral entry, even though the Pf-Ags up-regulated CCR5.  These studies further showed 
that treatment of cells with IFN-γ in the absence of Pf-Ags produced the same 
resistance to HIV-1 infection, while adding IFN-γ blocking antibodies abrogated the 
protective effect. Similarly, Gurney et al. (Gurney, Colantonio et al. 2004) demonstrated 
that CpG-treated thymic cells inhibited HIV-1NL4-3 replication by increased IFN-α 
production.  We have found similar results in our laboratory when PBMCs were treated 
with PfHz or sHz prior to exposing cells to HIV-189.6 dual-tropic virus.  Intracellular p24 
assays indicated that there was significantly less viral entry when cells were pre-treated  
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with PfHz or sHz indicating a cell membrane or receptor repertoire change (Davenport 
et al., 2008 American Society of Tropical Medicine and Hygiene annual meeting). 
Chemokine and chemokine receptor changes also play a significant role in the 
spread and amplification of HIV-1.  Ochiel et al. (Ochiel, Awandare et al. 2005) have 
shown in both ex vivo PBMCs from malaria-infected children, as well as with in vitro 
experiments, that malaria parasites and their products are associated with decreased 
levels of RANTES/CCL5, which may have implications for accessibility of HIV-1 to CCR5.  
Indeed, previous studies have shown a correlation between the likelihood of being 
infected and the level of CC chemokines found in the periphery (Zagury, Lachgar et al. 
1998; Wasik, Bratosiewicz et al. 1999).  In addition, healthy children with previous 
episodes of SMA were also found to have decreased RANTES/CCL5 levels, while those 
children with a history of only mild malaria had normal levels (Ochiel, Awandare et al. 
2005).  Similar in vitro experiments using CD14+ cells and PBMCs treated with either 
PfHz or sHz and assayed for surface expression of CCR5, CXCR4, or CD4 over the 
course of five days revealed that the co-receptors were both decreased at 48 hrs and 
increased above control at 120 hrs, while CD4 was increased three-fold over control at 
48 hrs and decreased by 50% at 120 hrs (Ochiel et al., 2004, unpublished data). 
 
1.7.2  Bacteremia 
 
 
1.7.2.1  Bacteremia in sub-Saharan Africa  Although malaria and HIV are still 
major infectious disease obstacles in sub-Saharan Africa, these two pathogens have 
received the majority of attention in the infectious disease realm.  Bacteremia has 
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received far less attention, perhaps because it is not strictly associated with sub-
Saharan African or is overshadowed by the devastation caused by HIV-1 and malaria.  
However, the need to address bacterial infection and elucidate its interactions with 
malaria are equally important, as emphasized by the findings of Berkely et al. (Berkley, 
Lowe et al. 2005).  Their group found that 26% of hospital deaths were attributed to 
bacteremia and the mortality rate of children with an admitting diagnosis of bacteremia 
was 28%.  In many of those cases the children had co-morbid conditions that 
contributed to their death such as HIV (18%) and malnutrition (37%).  Okwara et al. 
(Okwara, Obimbo et al. 2004) found that the presence of malaria parasitemia is not 
specifically associated with increased bacteremia risk  (OR 0.9%, 95% CI 0.4-0.7).  In 
our cohort of western Kenyan children, we found no exacerbation of anemia, and 
surprisingly, a reduction in parasitemia in both Gram positive (G[+]) and Gram negative 
(G[-]) co-infected children (presented here).  This striking finding deserves investigation 
to determine the inflammatory milieu that is controlling the parasitemia, while not 
exacerbating anemia. 
 
1.7.2.2  Consequences of malaria and bacteremia co-infection  Much focus has 
been given to malaria and HIV in sub-Saharan Africa, but the contribution of bacterial 
blood-borne infections to the death of 4.6 million African children per year has only 
been superficially explored.  Berkley et al. (Berkley, Lowe et al. 2005) surveyed 19,339 
Kenyan children in a malaria hyper-endemic region (10 – 100 infective bites annually) 
and found 12.8% of children less than 60 days of age had bacteremia, as well as an 
additional 5.9% of children over 60 days.  The two organisms most frequently isolated 
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were Streptococcus pneumoniae and non-Typhi Salmonella (NTS) species, with the 
incidences greatest in the <1 year old group and <2 year old group, respectively.  In 
the context of severe malaria, Brent et al. (Brent, Oundo et al. 2006) found that both 
anemia and malaria were independently associated with Salmonella bacteremia, and 
75% of those had current or recent malaria infections and were less than two years of 
age.  A similar study conducted in Malawi reported that both bacteremia and NTS 
prevalence were highest in children with SMA (11.7% and 7.6%, respectively), relative 
to CM, or CM with severe anemia (Bronzan, Taylor et al. 2007).  In addition, the 
increased incidence of sickle cell trait, which is tightly associated with malaria endemic 
areas due to its protective effects against malaria, also predisposes native Africans to 
bloodstream infections with encapsulated organisms (Overturf, Powars et al. 1977; 
Pearson 1977; Lobel and Bove 1982; Zarkowsky, Gallagher et al. 1986; Okuonghae, 
Nwankwo et al. 1993), as well as Salmonella bacteremia (Workman, Philpott-Howard et 
al. 1994; Wright, Thomas et al. 1997).  These data collected in a similar region to our 
study area indicate a significant association between malaria and NTS, and suggests an 
interaction and exacerbation of malarial anemia by the presence of G[-] bacteremia.  
Given the high incidence of NTS in our study population (44%; Were et al., 2009, 
unpublished results), and sub-Saharan Africa as a whole, the need to investigate the 
interaction with malaria is critical to ameliorating morbidity in pediatric populations in 
sub-Saharan Africa. 
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1.8  CONCLUSION 
 
Given the paucity of literature available on the inflammatory milieu of malaria co-
infections with HIV-1 and bacteremia, the current study contributes to the body of 
knowledge by characterizing the inflammatory milieu of co-infected Kenyan children 
living in a holoendemic region of malaria transmission.  Furthermore, through extensive 
parasitological, hematological, clinical, and genetic analyses of these children, as well as 
advanced statistical techniques, the following investigations have suggested the 
predictors of anemia common to these co-infections. 
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2.0  CHAPTER TWO:  SPECIFIC AIMS 
 
 
 
 
Severe anemia is the primary outcome of childhood malaria in holoendemic malaria 
transmission regions such as Kenya, where inhabitants may endure up to 300 infective 
bites annually.  Malaria is characterized by abundant production of pro-inflammatory 
cytokines, as well as a perturbed immune response caused by the deposition of the 
PfHz in monocytes and neutrophils.  The anemia stems from three distinct mechanisms 
resulting from a pro-inflammatory milieu and exposure to PfHz: RBC phagocytosis and 
destruction of infected and uninfected RBCs, dyserythropoiesis due to impaired 
development of erythroid precursors, and inhibition of erythropoiesis by a pro-
inflammatory environment.  Two diseases with equal importance in the Kenyan pediatric 
population are HIV-1/AIDS and bacteremia.  Similar to malaria, anemia is the hallmark 
trait of pediatric HIV-1 infection.  The chronic immune activation phase of HIV-1 
infection is also characterized by elevated levels of pro-inflammatory cytokines, as is 
bacteremia.  We have found that in HIV-1 and malaria co-infection, as well as in HIV-1[-
] children exposed to HIV-1 in utero, the anemia was substantially more severe than in 
malaria infection alone.  The opposite phenomenon was observed in bacteremia and 
malaria co-infection, with co-infected children having the same degree of anemia, but 
significantly lower parasitemias.  The association of a pro-inflammatory milieu with 
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anemia and the resistance to erythropoietin therapy has also been noted in chronic 
diseases with non-infectious origins, such as kidney disease and Lupus.  Rather than 
simply correlate individual inflammatory mediators with anemia, we sought to identify 
cytokines patterns and profiles associated with negative and positive hematolgic 
outcomes in co-infected children through the use of complex statistical modeling to 
identify the inflammatory milieus that are most conducive to controlling and clearing 
infection without adverse clinical consequences. 
 
 
 
2.1  SPECIFIC AIM 1 
 
 
To determine the parasitologic and hematologic predictors of anemia 
exacerbation in malaria and HIV-1 exposed and infected children residing in 
a holoendemic environment of western Kenya. 
 
Hypothesis 1:  Anemia will increase proportionally with the density of hemozoin-
containing monocytes and neutrophils, due to their induction of pro-inflammatory 
responses and thereby, the inihibition of erythropoiesis.  
 
Parasitologic, hematologic, microbiologic, and clinical data collected from malaria-
infected (Pf[+]) children between the ages of 3 - 36 months of age enrolled in the 
Severe Malarial Anemia study in Siaya District of western Kenya were analyzed to 
determine the predictors of worsening anemia.  HIV-1 exposure and HIV-1 infection 
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were determined using two rapid serological immunoassays and a pro-viral DNA PCR 
assay, respectively.  The children were stratified into three categories:  HIV-1 negative 
(HIV-1[-]), no evidence of circulating HIV-1 antibodies on two serologic assays; HIV-1 
exposed (HIV-1[exp]), a positive result on at least one of two serologic assays, and a 
negative HIV-1 DNA PCR result; and HIV-1 positive (HIV-1[+]), a positive result on at 
least one of two serologic assays for HIV-1 antibodies, and two positive consecutive 
HIV-1 DNA PCR results three months apart.  All children used in this analysis were free 
of bacteremia and hookworm infection.  Using previously established known predictors 
of anemia (i.e., age and HIV status), a Pearson correlation of potential factors with Hb 
values, and a hierarchical multiple regression model we identified and quantitated the 
factors contributing to worsening anemia in HIV-1 co-infected children. 
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2.2  SPECIFIC AIM 2 
 
 
To determine the inflammatory mediator profile associated with exacerbated 
severe anemia in children co-infected with Plasmodium falciparum  malaria 
and HIV-1.  
 
Hypothesis 1:  Infection with Plasmodium falciparum causes enhanced anemia in 
HIV-1-infected children through exacerbation of the chronic immune activation phase. 
 
Plasma samples were collected from Kenyan children at their first acute malaria hospital 
contact and stratified into the following categories: HIV-1[-], HIV-1[exp], and HIV-1[+].  
Circulating inflammatory mediator levels (cytokines, chemokines and growth factors) 
were measured using a BioSource™ human 25-plex Luminex® assay.  The data from 
these experiments, analyzed with a principal component factor analysis, identified the 
inflammatory mediator profile associated with enhanced severe anemia in HIV-1 and 
malaria co-infected children. 
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2.3  SPECIFIC AIM 3 
 
 
To determine the inflammatory mediator profile associated with lower 
parasitemia levels in children co-infected with Plasmodium falciparum  and 
bacteremia without worsening anemia.  
 
Hypothesis 1:  Blood borne bacterial infections elicit a unique profile of 
inflammatory mediators resulting in lower parasitemia levels without promoting 
enhanced anemia in co-infected children.   
 
Circulating blood was collected from Kenyan children at their first hospital contact with 
acute malaria with and without bacteremia.  Only HIV-1 negative children were included 
in this aim.  Presence of bacteremia were determined by microbial isolation using 
Wampole™ pediatric Isostat® Isolator™ tubes and standard microbiologic media.  
Circulating inflammatory mediators (cytokines, chemokines and growth factors) were 
measured using a BioSource™ human 25-plex Luminex® assay.  Children were then 
divided into three groups; malaria mono-infected (Pf[+]), Gram positive bacteremia and 
malaria co-infected (G[+]/Pf[+]), and Gram negative bacteremia and malaria co-
infected (G[-]/Pf[+]).  Using a multiple mediation model, these experiments identifed 
the unique inflammatory profile associated with decreased parasitemia, without 
worsening anemia, in children co-infected with malaria and bacteremia.   
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3.0 CHAPTER THREE:  RESULTS, SPECIFIC AIM 1 
 
 
 
 
To determine the hematologic and parasitologic predictors of exacerbated 
severe anemia in HIV-1[+] and HIV-1[exp] co-infected children. 
 
 
 
3.1  HYPOTHESIS 1, PRESENTATION OF MANUSCRIPT ENTITLED:  
HEMATOLOGICAL PREDICTORS OF INCREASED SEVERE ANEMIA IN KENYAN 
CHILDREN CO-INFECTED WITH PLASMODIUM FALCIPARUM AND HIV-1 
 
Hypothesis 1:  Anemia will increase proportionally with the density of hemozoin-
containing monocytes and neutrophils, due to their induction of pro-inflammatory 
responses and thereby, the inihibition of erythropoiesis.  
 
To address hypothesis 1, children enrolled in the SMA study and without 
bacteremia were divided into three groups according to their HIV-1 status: HIV-1[-], 
HIV-1[exp], and HIV-1[+].  The clinical, hematologic, and parasitologic parameters 
were collected and then ranked using correlational analysis.  Parameters demonstrating 
high correlation with Hb were included in a hierarchical multiple regression analysis to 
determine their influence on Hb values in HIV-1[exp] and HIV-1[+] children with more 
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severe anemia.  The findings from these analyses are presented in the following 
manuscript published in the American Journal of Hematology [Am J Hematol.  2010 
Apr; 85(4):227-33; reproduced with permission from Wiley-Blackwell Publishing]. 
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3.2  ABSTRACT 
 
 
Malaria and HIV-1 are co-endemic in many developing countries, with anemia being the 
most common pediatric hematological manifestation of each disease.  Anemia is also 
one of the primary causes of mortality in children mono-infected with either malaria or 
HIV-1.  Although our previous results showed HIV-1 positive (HIV-1[+]) children with 
acute Plasmodium falciparum malaria (Pf[+]) have more profound anemia, potential 
causes of severe anemia in co-infected children remain unknown.  As such, children 
with P. falciparum malaria (aged 3-36 mos., n=542) from a holoendemic malaria 
transmission area of western Kenya were stratified into three groups: HIV-1 negative 
(HIV-1[-]/Pf[+]); HIV-1 exposed (HIV-1[exp]/Pf[+]); and HIV-1 infected (HIV-
1[+]/Pf[+]).  Comprehensive clinical, parasitological, and hematological measures were 
determined upon enrollment.  Univariate, correlational, and hierarchical regression 
analyses were used to determine differences among the groups and to define predictors 
of worsening anemia.  HIV-1[+]/Pf[+] children had significantly more malarial pigment-
containing neutrophils (PCN), monocytosis, increased severe anemia (Hb <6.0g/dL), 
and nearly ten-fold greater mortality within three months of enrollment.  Common 
causes of anemia in malaria-infected children, such as increased parasitemia or reduced 
erythropoiesis, did not account for worsening anemia in the HIV-1[+]/Pf[+] group, nor 
did carriage of sickle cell trait or G6PD deficiency.  Hierarchical multiple regression 
analysis revealed that more profound anemia was associated with elevated PCM, 
younger age, and increasing HIV-1 status (HIV-1[-] → HIV-1[exp] → HIV-1[+]).  Thus,  
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malaria/HIV-1 co-infection is characterized by more profound anemia and increased 
mortality, with acquisition of monocytic pigment having the most detrimental impact on 
Hb levels. 
 
 
 
3.3  BACKGROUND 
 
 
Plasmodium falciparum and human immunodeficiency virus-1 (HIV-1) are co-endemic in 
many tropical and sub-tropical countries, with the potential risk for enhanced clinical, 
hematological, and parasitological complications.  Approximately 250 million malaria 
infections are reported annually, resulting in greater than one million deaths, primarily 
in African children less than five years of age (WHO 2008).  Sub-Saharan Africa also 
contains approximately 67% of the global HIV population, with an estimated 22 million 
HIV infections (UNAIDS 2008).  In 2007 alone, this region accounted for 75% of the 
global AIDS deaths and over 1.9 million individuals were newly infected (UNAIDS 2008).  
Despite the geographical overlap between malaria and HIV, a number of earlier studies 
revealed little or no definitive interactions between the two infections (Nguyen-Dinh, 
Greenberg et al. 1987; Colebunders, Bahwe et al. 1990; Muller, Musoke et al. 1990; 
Greenberg, Nsa et al. 1991; Kalyesubula, Musoke-Mudido et al. 1997).  However, more 
recent literature shows that malaria and HIV-1 co-infection results in adverse 
pathological outcomes in both diseases, such as, increased HIV-1 viral loads following 
acute malaria, increased malaria episodes in HIV-1 positive (HIV-1[+]) individuals, 
reduced hemoglobin (Hb) concentrations during malaria and HIV-1 co-infection, and 
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reduced efficacy of antimalarial drugs (Hoffman, Jere et al. 1999; Whitworth, Morgan et 
al. 2000; van Eijk, Ayisi et al. 2002; Grimwade and Swingler 2003; Grimwade and 
Swingler 2003; Grimwade, French et al. 2004; Mwapasa, Rogerson et al. 2004; Cohen, 
Karstaedt et al. 2005; Kublin, Patnaik et al. 2005). 
Mono-infection with either malaria or HIV-1 is associated with hematological 
complications, including anemia, monocytosis, and hemolysis (Abdalla 1990; Sen, 
Tewari et al. 1994; Shearer, Rosenblatt et al. 2003; Belperio and Rhew 2004).  
Additional hematological complications in malaria include splenomegaly, leukopenia, 
leukocytosis, eosinophilia, and thrombocytopenia (Abdalla 1990), while HIV-1 infection 
is characterized by suppression of all three major blood cell lineages (Shearer, 
Rosenblatt et al. 2003).  Although most interactions between malaria and HIV-1 have 
been described in adults [reviewed in (Brentlinger, Behrens et al. 2007)], our recent 
investigation demonstrated that HIV-1[+] children had a significantly higher risk of 
developing severe anemia (SA) during acute falciparum malaria than HIV-1 negative 
(HIV-1[-]) children (Otieno, Ouma et al. 2006).  In addition, enhanced pathogenesis has 
been extensively described in pregnant women with malaria and HIV co-infection (ter 
Kuile, Parise et al. 2004; Briand, Badaut et al. 2009). 
 Our previous findings (Keller, Yamo et al. 2006; Awandare, Ouma et al. 2007), and 
those of others (Nguyen, Day et al. 1995; Amodu, Adeyemo et al. 1998; Lyke, Diallo et 
al. 2003), revealed that pigment-containing monocytes (PCM) and pigment-containing 
neutrophils (PCN) are important markers of malaria disease severity.  Malarial pigment 
(hemozoin, PfHz) is a crystalline structure formed from monomeric heme and released 
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as a by-product of parasitic proteolysis of host Hb (Egan 2002).  Phagocytic cells 
acquire PfHz through ingestion of parasitized red blood cells (pRBC) (Arese and 
Schwarzer 1997) and by scavenging free PfHz released into circulation following rupture 
of pRBC (Schwarzer, Alessio et al. 1998).  To date, the impact of naturally-acquired 
intraleukocytic PfHz on Hb concentrations in co-infected individuals has not been 
reported.      
To investigate etiologies of worsening anemia in HIV-1[+]/Pf[+] children, we 
performed comprehensive hematological analyses and examined potential causes of 
anemia in three groups of children (n=542; 3-36 mos. of age): HIV-1[-]/Pf[+]; HIV-1 
exposed [exp]/Pf[+], and HIV-1[+]/Pf[+].  The study was conducted in a holoendemic 
P. falciparum transmission area of western Kenya in which SA is the primary 
manifestation of severe malaria in children less than 48 mos. of age, with pediatric 
cerebral malaria occurring only in rare cases (Snow, Omumbo et al. 1997; McElroy, Lal 
et al. 1999). 
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3.4  METHODS 
 
 
3.4.1  Study site and participants 
 
 
Children aged 3-36 months (n=542) with P. falciparum parasitemia (Pf[+], any density) 
were recruited at Siaya District Hospital, western Kenya, during their first hospital 
contact for malaria from March 2004 to January 2006.  Siaya District is a holoendemic P. 
falciparum transmission area where residents receive up to 300 infective bites per 
annum (Beier, Oster et al. 1994).  None of the children in the study had bacteremia, 
cerebral malaria, or non-falciparum malarial infections.  A detailed description of the 
study area and pediatric population can be found in our previous publication (Ong'echa, 
Keller et al. 2006).  
Children with P. falciparum malaria were divided into three groups: HIV-1 
negative (HIV-1[-], negative HIV serological results by both Determine® and Uni-Gold™ 
assays); HIV-1 exposed (HIV-1[exp], at least one (of two) positive serological tests with 
Determine® and Uni-Gold™ and negative HIV-1 DNA PCR); and HIV-1 positive (HIV-
1[+], at least one (of two) positive serological result with the Determine® and Uni-
Gold™ tests, and positive HIV-1 DNA PCR results on two consecutive HIV-1 DNA PCR 
assays three months apart according to our previously published methods (Otieno, 
Ouma et al. 2006)).    For the PCR analyses, HIV-1 gp41 primers were selected for 
highly conserved HIV-1 group M, N, and O sequences for use in western Kenya 
(Cappadoro, Giribaldi et al. 1998; Ruwende and Hill 1998).   Although the maternal 
HIV-1 status was unknown, based on the approved informed consent process for 
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enrollment into the study, HIV-1[exp] children presumably acquired HIV-1 antibodies 
from their mother during gestation and/or through breastfeeding.  It is important to 
note that none of the children in the cohort had received prior blood transfusions.  Pre- 
and post-test HIV counseling were provided for the parents/guardians of all 
participants.  Children positive for one or both HIV-1 serological tests were 
prophylactically treated with trimethoprim–sulfamethoxazole from the time of 
enrollment onward.  None of the children had been initiated on antiretroviral (ARV) 
therapy at the time of enrollment since ARVs were not available during the study 
period.   Children in all three groups were followed for three months post-enrollment to 
examine mortality.  The parents/guardians of all children were asked to report to the 
hospital three months post-enrollment.  For those children that did not report, members 
of the study team traveled to the residence and inquired about the child’s health status.  
In addition, parents/guardians were asked to return to the hospital during each febrile 
episode that their child experienced prior to the three month follow-up visit.    
 Severe anemia was categorized according to a geographically appropriate 
definition for this holoendemic region (i.e., Hb <6.0g/dL) based on previous longitudinal 
Hb measures in children (<48 months of age; n>14,000) (McElroy, Lal et al. 1999).  
The WHO standard of SA (i.e., Hb <5.0g/dL) (2000) was also utilized to frame the 
current findings into a broader global context.  Children were treated according to 
Ministry of Health, Kenya, guidelines that included intravenous quinine for the treatment 
of severe malaria and oral CoartemTM for non-severe malaria.  Written informed consent  
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was obtained from the participants’ parents/guardians.  Approval for the study was 
granted by the ethical and scientific review committees at the University of Pittsburgh, 
University of New Mexico, and the Kenya Medical Research Institute.  
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3.4.2  Laboratory methods 
 
     
Asexual malaria trophozoites were determined with thick and thin Giemsa-stained 
peripheral blood smears prepared from venous blood samples for malaria parasite 
identification and quantification according to our previous methods (Otieno, Ouma et al. 
2006).  Complete blood counts were performed with a Beckman Coulter© Ac-T diff2™ 
(Beckman Coulter, Inc.) on blood obtained prior to administration of antimalarials 
and/or antipyretics.  Glucose-6-phosphate dehydrogenase (G6PD) deficiency was 
assessed using the G6PDH Screening Kit (Trinity Biotech, PLC) according to the 
manufacturer’s instructions.  The presence of Hb variants in sample hemolysates was 
detected using a Hb electrophoresis kit, which allowed for detection of HbS, HbC, HbF, 
and HbA, in either the heterozygous or homozygous states (Helena laboratories).  The 
reticulocyte count, absolute reticulocyte number (ARN), reticulocyte production index 
(RPI), and prevalence and quantity of pigment-containing neutrophils (PCN) and 
pigment-containing monocytes (PCM) were determined per our previous methods 
(Were, Hittner et al. 2006).   
 Presence of bacteremia was performed by blood culture according to our 
previous report (Awandare, Ouma et al. 2007).  Since bacteremia is a common cause of 
anemia in African children (Brent, Oundo et al. 2006; Calis, Phiri et al. 2008), which 
may have potentially confounding effects on results presented here, all children found 
to have bacteremia were excluded from the current study.      
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3.4.3  Statistical analyses 
 
 
Data were analyzed using SPSS (version 15.0).  Inter-group clinical, demographic, and 
hematological measures were compared by either analysis of variance (ANOVA) or 
Kruskal-Wallis tests, followed by pair-wise post-hoc comparison with Student’s t-test or 
Mann-Whitney U test, respectively.  Pearson’s Chi Square (χ2) or Fisher’s exact test was 
used for comparing proportions. The conventional level of statistical significance was set 
at P≤0.05.  Pearson correlations were performed to select (i.e., P≤0.05) and prioritize 
potential predictors of Hb to be entered into a hierarchical multiple regression model. 
 
 
 
3.5  RESULTS 
 
 
3.5.1  Demographic, clinical, and hematologic characteristics 
 
 
Children were stratified into three categories: HIV-1[-]/Pf[+], n=406; HIV-1[exp]/Pf[+], 
n=112; and HIV-1[+]/Pf[+], n=24.  The demographic, clinical, and hematological 
characteristics of the study participants are listed in Table 1.  Age (mos.) differed across 
the groups (P=0.055) with the HIV-1[+]/Pf[+] group being the oldest.  Additional 
significant inter-group differences included absolute monocyte count (×103/µL; 
P=0.007), Hb concentration (g/dL; P=0.009), hematocrit (Hct, %; P=0.012), red blood 
cell (RBC) count (×106/µL, P=0.022), mean corpuscular Hb concentration (MCHC, g/dL, 
P=0.069), and RBC distribution width (RDW; P=0.018).  Post-hoc testing of these 
significant values revealed that, relative to the HIV-1[-]/Pf[+] and HIV-1[exp]/Pf[+] 
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groups, the HIV-1[+]/Pf[+] group had higher monocyte counts (P=0.002 and P=0.006, 
respectively), decreased Hb levels (P=0.004 and P=0.012, respectively), reduced RBC 
counts (P=0.011 and P=0.045, respectively), lower MCHCs (P=0.066 and P=0.027, 
respectively), and greater RDWs (P=0.007 and P=0.041, respectively).  Evaluation of 
malaria parasitological indices revealed that median peripheral (/µL) and geometric 
mean (/µL) parasitemias were not significantly different across the groups (P=0.205 
and P=0.123, respectively).   
 
3.5.2  Genetic variants 
 
   
Certain genetic traits confer protection against severe malaria, namely sickle cell trait 
and G6PD deficiency (Min-Oo and Gros 2005; Cappellini and Fiorelli 2008).  As shown in 
Table 1, HIV-1[+]/Pf[+] children had a lower incidence of sickle cell trait than either the 
HIV-1[-]/Pf[+] or HIV-1[exp]/Pf[+] children (P=0.198).  In contrast, prevalence of 
G6PD deficiency increased across the groups, with the HIV-1[+]/Pf[+] group having the 
highest proportion of G6PD deficiency (P=0.084, Table 1).   
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3.5.3  Severe anemia distribution 
 
 
Severe anemia is the primary manifestation of severe malaria and accounts for a 
substantial proportion of mortality in western Kenya, with the peak incidence occurring 
between ages 7-24 mos. (Bloland, Ruebush et al. 1999; McElroy, Lal et al. 1999).  As 
such, children were classified according to a geographically appropriate definition of SA 
(i.e., Hb <6.0g/dL) (McElroy, Lal et al. 1999) and the WHO definition (i.e., Hb <5.0g/dL) 
(2000).  The proportion of SA at Hb <6.0g/dL progressively increased with HIV-1 status 
(P=0.020), while the proportion of SA at Hb <5.0g/dL was comparable in the HIV-1[-
]/Pf[+] and HIV-1[exp]/Pf[+] groups, and highest in co-infected children (P=0.026, Fig. 
1).  Differences between the HIV-1[+]/Pf[+] and the HIV-1[-]/Pf[+] groups were 
significant for both Hb <6.0g/dL (P=0.008) and Hb <5.0g/dL (P=0.025), and between 
the HIV-1[+]/Pf[+] and HIV-1[exp]/Pf[+] groups (P=0.016) with the WHO standard 
(Fig. 1).   
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3.5.4  Mortality associated with co-infection 
 
    
In holoendemic P. falciparum transmission areas such as Siaya District, approximately 
30% of the mortality in children less than three years of age is due to P. falciparum-
promoted SA (Waitumbi, Opollo et al. 2000).  Examination of the three-month, post-
enrollment mortality revealed that HIV-1[+]/Pf[+] children had significantly more 
mortality than both the HIV-1[-]/Pf[+] and HIV-1[exp]/Pf[+] groups (P<0.001, for both 
categories, Fig. 1). The number of children that died during the three-month follow-up 
period was 13 (3.2%) in HIV-1[-]/Pf[+] group, 6 (5.4%) in the HIV-1[exp]/Pf[+] group, 
and 8 (33.3%) in the HIV-1[+]/Pf[+] group.     
 
3.5.5  Erythropoietic indices 
 
   
To determine if altered erythropoietic responses were responsible for more profound 
anemia in co-infected children, measures of erythropoiesis were examined in the three 
groups.  As shown in Table 2, the reticulocyte count and ARN did not significantly differ 
across the groups.  We have previously shown that children with severe malarial anemia 
(SMA) have suppression of erythropoiesis (Awandare, Goka et al. 2006), as evidenced 
by an RPI<2 (Lee 1999).  Although the majority of children in all three groups had 
suppression of erythropoiesis, the inter-group proportions were not significantly 
different (P=0.766, Table 2).   
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3.5.6  Intraleukocytic hemozoin 
 
   
Previous investigations illustrated that intracellular PfHz levels in circulating neutrophils 
and monocytes are associated with malaria disease severity (Nguyen, Day et al. 1995; 
Amodu, Adeyemo et al. 1998; Luty, Perkins et al. 2000).  As shown in Fig. 2, the 
percentage of children with PCN was highest in the HIV-1[+]/Pf[+] group (P=0.029, 
inter-group difference).  Post-hoc testing revealed that PCN was greater in the HIV-
1[+]/Pf[+] group than the HIV-1[exp]/Pf[+] group (P=0.016), while the differences 
between the HIV-1[+]/Pf[+] and HIV-1[-]/Pf[+] groups, and HIV-1[exp]/Pf[+] and HIV-
1[-]/Pf[+] groups were not significant (P=0.079 and P=0.121, respectively).  In 
addition, the median concentration of PCN (/μL) was highest in children co-infected with 
malaria and HIV-1, but the across-group differences were not significant (P=0.249, Fig. 
2).  Examination of intra-monocytic PfHz revealed that the percentage of children with 
PCM and the median concentration of PCM (/μL) were similar across the groups 
(P=0.852 and P=0.456, respectively, Fig. 2). 
 
3.5.7  Linear correlation analyses 
 
   
As an initial step to explore variables that were potentially important in predicting Hb 
levels, Pearson correlations were performed in the full sample (n=542) between the 
following measures: HIV-1 status (i.e., HIV-1[-]/Pf[+], HIV-1[exp]/Pf[+], and HIV-
1[+]/Pf[+]); age; PCM; PCN; and Hb.  There were significant correlations between 
progressing HIV-1 status (HIV-1[-] → HIV-1[exp] → HIV-1[+]) and age (r= 0.091, 
P=0.034) as well as Hb (r= -0.105, P=0.017).   Significant relationships with age were 
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also identified for PCM (r= -0.099, P=0.021) and Hb (r= 0.193, P<0.001).  The 
strongest relationship observed was between PCM and Hb (r= -0.413, P<0.001).   
 
3.5.8  Predictors of Hb concentrations 
 
   
Following the bivariate correlation analyses, a hierarchical multiple regression analysis 
was performed to identify predictors of Hb concentrations (Table 3).  The influence of 
HIV-1 was determined by entering HV-1 status (HIV-1[-] → HIV-1[exp] → HIV-1[+]) 
into the model.  Variables were entered as predictors in two sequential blocks with Hb 
as the dependent variable.  Block 1 consisted of age and HIV-1 status (HIV-1[-] → HIV-
1[exp] → HIV-1[+]) as covariates, while block 2 was comprised of PCN and PCM.  Prior 
to performing the regression, both PCM and PCN were inverse-transformed to 
approximate univariate normality.  The hierarchical multiple regression model 
demonstrated that both age (P<0.001) and HIV-1 status (P=0.011) were significant 
predictors of Hb with block 1 being highly significant (P<0.001) and accounting for 
4.4% of the variability in Hb.  For block 2, PCM was also a significant predictor of Hb 
(P<0.001), whereas PCN did not significantly influence Hb levels (P=0.138).  This 
second block was highly significant (P<0.001) and accounted for 14.8% of the 
variability in Hb.  Examination of the squared semipartial correlations indicated that age, 
HIV-1 status, and PCM accounted for 2.8%, 1.2%, and 14.4% of the unique variance in 
Hb, respectively. 
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3.6  DISCUSSION 
 
 
The current investigation presents a comprehensive examination of the hematological 
factors that contribute to worsening anemia in Kenyan children residing in a 
holoendemic P. falciparum environment with a high prevalence of HIV-1 infection.  Co-
infection with malaria and HIV-1 was associated with significantly higher rates of SA, 
regardless of whether the geographically-relevant definition (Hb <6.0g/dL) of anemia, 
or the WHO definition (Hb <5.0g/dL), was applied.  Results presented here show that 
two prominent causes of anemia (i.e., malaria parasitemia and reduced erythropoiesis) 
were not responsible for worsening anemia in co-infected children.  However, results 
presented here show that acquisition of PfHz by monocytes appears central to the 
pathogenesis underlying more profound anemia in HIV-1[+]/Pf[+] children with 
falciparum malaria.  This study is also the first investigation showing that malaria and 
HIV-1 co-infection is associated with significantly higher rates of pediatric mortality.   
 Results presented here demonstrate a progressive decline in Hb levels and 
increased SA in the HIV-1[exp]/Pf[+] and HIV-1[+]/Pf[+] groups, with HIV-1[+]/Pf[+] 
children having the greatest degree of SA.  Malaria contributes to anemia through a 
number of different mechanisms, including RBC lysis, organ sequestration and 
destruction of erythrocytes, phagocytosis of uninfected and infected RBCs, and 
dyserythropoiesis [reviewed in (Ghosh 2007)].  Although all three groups in this study 
had decreased MCV, normal MCH values, and MCHC in the low normal range, none of 
these values were significantly different across the groups, with the exception of 
decreased MCHC values in the HIV-1[+]/Pf[+] group.  This hematological profile is 
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suggestive of a microcytic hypochromic anemia, a finding typically attributed to iron 
deficiency, which may be a consequence of sequestered iron due to elevated levels of 
IL-6, and consequently hepcidin (Nemeth, Valore et al. 2003; Nemeth, Rivera et al. 
2004; Ganz 2006).  Studies are currently ongoing in our laboratory to confirm this 
hypothesis.  The RDW was substantially greater in the HIV-1[+]/Pf[+] group, 
suggesting that, despite the relative consistency in the RPIs across the groups, children 
with the greatest anemia also had the greatest compensation for their anemia, as 
indicated by variability in RBC size.  Calis et al. (Calis, Phiri et al. 2008) reported similar 
RDWs in their study participants, but concluded that folate and iron deficiency were not 
contributing factors in Malawian children with SA.  However, it remains to be 
determined if folate and iron deficiency are important contributors to worsening anemia 
in malaria and HIV-1 co-infected children.    
 It is estimated that 15 to 20% of untreated HIV-1[+] infants will progress to 
AIDS, and ultimately death, by four years of age in developed nations (Mayaux, Burgard 
et al. 1996), although the rate is likely much higher in African children.  A study with 
participants from the U.S. and Puerto Rico reported 32% had progressed to CDC Clinical 
Category C or had died by 18 months (Rich, Fowler et al. 2000).  Consistent with these 
data, the HIV-1[+]/Pf[+] group in our study had nearly 10 times more mortality 
(33.3%) over the three month follow-up period.  However, while the proportion of SA 
cases and mortality was significantly increased in the HIV-1[+]/Pf[+] children, there 
was no correlation between death and Hb.  Furthermore, upon longitudinally examining 
deceased children from the three groups, there were no significant differences between 
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acute (febrile, non-parasitemic) or parasitemic visits, median Hb over those visits, or 
age at which children died.  These data may be explained by the fact that substantially 
more children died at home versus at hospital, and therefore, cause of death, 
parasitemia status, and Hb levels were not available.   
 While not reaching statistical significance, there was a progressive increase in 
G6PD deficiency across the groups.  The 7.5% prevalence of G6PD deficiency in our 
overall study population was similar to the 8.5% reported in a meta-analysis of two 
previous Kenyan studies (Nkhoma, Poole et al. 2009).  Interestingly, the HIV-
1[exp]/Pf[+] and HIV-1[+]/Pf[+] individuals in the present study had greater than 
twice the frequency of G6PD deficiency than the HIV-1[-]/Pf[+] children.  This X-linked 
deficiency provides mild protection against malaria infection (Cappadoro, Giribaldi et al. 
1998; Ruwende and Hill 1998), due to stunted parasite growth inside the G6PD-
deficient RBC (Clark and Hunt 1983; Miller, Golenser et al. 1984).  However, oxidative 
stress caused by infections and various drugs can result in acute hemolysis and 
subsequent chronic anemia (Cappellini and Fiorelli 2008).  Therefore, while this 
deficiency may provide some protection against acquisition of malarial infection and 
hyperparasitemia, anemia may be exacerbated once the host becomes infected and 
treatment ensues.   
  Although the proportion of children with sickle cell trait was not significant across 
the groups, there was a three-fold decrease in carriage of HbAS in HIV-1[+]/Pf[+] 
children.  Failure to achieve statistical significance may be due to the sample size in the 
HIV-1[+]/Pf[+] group.  Since HbAS confers 90% protection against severe malaria and 
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mortality (Aidoo, Terlouw et al. 2002), sickle cell trait may be bolstering the more 
favorable outcomes (i.e., less severe anemia and fewer fatalities) seen in the HIV-1[-
]/Pf[+] and HIV-1[exp]/Pf[+] groups.  However, when G6PD deficiency and sickle cell 
status were entered into the multiple regression analysis, neither of these factors 
significantly predicted Hb levels.  
 Our previous study showed that SMA was associated with suppression of 
erythropoiesis (Were, Hittner et al. 2006).  However, the erythropoietic response was 
not significantly different between the groups examined here, suggesting that neither 
HIV-1 exposure nor HIV-1 positivity antagonized erythropoiesis beyond that observed in 
malaria mono-infection.  In addition, parasitemia levels were 46% and 37% lower in the 
HIV-1[exp]/Pf[+] and HIV-1[+]/Pf[+] groups, respectively, than in the HIV-1[-]/Pf[+] 
children, demonstrating that the degree of parasitemia does not correlate with the 
severity of anemia, as we (Awandare, Ouma et al. 2007) and others (Waitumbi, Opollo 
et al. 2000) have previously reported.  However, the fact that the erythropoietic indices 
are nearly identical, while the degree of anemia is substantially more severe across the 
groups, indicates that a proportional response to the worsening anemia had not been 
achieved in the HIV-1[+]/Pf[+] group. 
 By examining PfHz burden in neutrophils and monocytes, it is possible to 
determine if individuals suffer from recent (acute) versus prolonged (chronic) malaria 
infection, since monocytes remain in circulation longer than neutrophils (Tomas Ganz 
1995).   Our previous study in Kenya demonstrated that SMA is characterized by 
increased chronicity of infection, resulting in higher levels of PCM and lower levels of 
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PCN (Awandare, Ouma et al. 2007).  However, our present data show that co-infection 
is associated with a higher percentage of PCN, suggesting that HIV-1[+]/Pf[+] children 
suffer from more acute malaria.  Although the reason for this finding remains unclear, 
HIV-1[+]/Pf[+] children presumably had worse overall health status, which may result 
in more rapid treatment-seeking behavior by their caregiver.  Additional longitudinal 
follow-up studies with active surveillance are required to confirm this hypothesis.   
 To investigate predictors of Hb levels, we first performed Pearson correlations 
followed by a hierarchical multiple regression analysis to determine those variables with 
the greatest influence on Hb.  Results of the regression model indicated that increasing 
age was significantly associated with higher Hb levels.  In contrast, increasing HIV-1 
status (i.e., HIV-1[-] → HIV-1[exp] → HIV-1[+]) in children with falciparum malaria was 
a significant predictor of worsening anemia.  This finding supports the higher proportion 
of SA found in HIV-1[+]/Pf[+] children.  Increasing PCM was associated with worsening 
anemia, and of all the factors examined, was the strongest predictor of Hb.  The 
negative correlation between PCM and Hb supports our previous findings (Keller, Yamo 
et al. 2006; Awandare, Ouma et al. 2007) and those of others (Lyke, Diallo et al. 2003) 
illustrating that PCM is a significant predictor of anemia.  Moreover, results presented 
here extend previous findings by demonstrating that monocytic acquisition of PfHz is 
also a significant predictor of Hb in children with malaria and HIV-1 co-infection.   
  Taken together, results presented here demonstrate that children with malaria 
and HIV-1 co-infection have more profound anemia and increased mortality relative to 
HIV-1[-]/Pf[+] children.  These findings also demonstrate that unlike parasitemia levels 
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and suppression of erythropoiesis, PfHz may play a central role in the pathogenesis of 
anemia in children co-infected with malaria and HIV-1.  Since phagoctyosis of PfHz by 
monocytes and neutrophils promotes dysregulation in inflammatory mediators known to 
cause inflammatory-derived anemia (Sherry, Alava et al. 1995; Perkins, Moore et al. 
2003; Keller, Kremsner et al. 2004; Casals-Pascual, Kai et al. 2006), it will be important 
to determine if altered expression of cytokines, chemokines, and hematopoietic growth 
factors are responsible for more profound anemia in co-infected children. 
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Table 1.  Clinical, demographic, and hematologic characteristics of the study participants.   
 
   
Characteristic HIV-1[-]/Pf[+] HIV-1[exp]/Pf[+] HIV-1[+]/Pf[+] P 
Number of  subjects 406 112 24 N/A 
Age (mos.) 10.5 (10.5) 9.0 (6.2) 12.1 (9.6) 0.055 
Gender, male/female  a 219/187 57/55 14/10 0.755 
Axillary temperature (°C)  37.5 (1.7) 37.5 (1.6) 37.6 (1.0) 0.913 
Glucose (mMol/L) 5.1 (1.3) 4.9 (1.5) 4.8 (1.2) 0.544 
Hematologic Indices 
WBC (×109/µL) 11.2 (6.6) 11.7 (6.7) 13.3 (8.4) 0.144 
Lymphocytes (×103/µL) 50.0 (19.2) 51.9 (17.4) 49.4 (16.7) 0.163 
Monocytes (×103/µL) 8.9 (5.8) 8.8 (5.2) 13.0 (6.3) 0.007 
Granulocytes (×103/μL) 41.0 (22.8) 38.0 (18.6) 35.6 (21.1) 0.124 
Platelets (×103/µL) 163 (124) 140 (108) 158 (82) 0.129 
Hemoglobin (g/dL) 6.9 (3.5) 6.2 (2.7) 5.2 (2.9) 0.009 
Hematocrit (%) 22.0 (10.4) 20.5 (7.8) 17.7 (6.5) 0.012 
RBC (×106/µL) 3.2 (1.8) 3.1 (1.5) 2.5 (1.6) 0.022 
MCV (fL) 70.3 (12.3) 68.8 (11.8) 73.3 (11.4) 0.361 
MCH (fL/cell) 22.6 (4.4) 22.2 (3.5) 22.1 (4.1) 0.899 
MCHC (g/dL) 32.1 (2.6) 32.3 (2.3) 30.5 (4.1) 0.069 
RDW 21.3 (4.7) 22.2 (5.2) 23.5 (7.6) 0.018 
Parasitologic Indices 
Parasitemia (/µL) 22,281 (51,064) 15,299 (37,040) 16,220 (43,127) 0.205 
Geomean parasitemia (/µL) b 15,739 12,736 11,850 0.123 
Genetic Variants 
Sickle cell trait, n (%) c 57 (14.1) 18 (16.1) 1 (4.3) 0.198 
G6PD deficiency, n (%) c,d 25 (6.7) 13 (12.5) 3 (15.0) 0.084 
 
 
Data are presented as median (interquartile range) and compared using the Kruskal-Wallis test unless 
stated otherwise.  a Differences in the proportion of gender were compared using Pearson’s χ2 test.  b 
Geometric mean parasitemia was compared using ANOVA.  c  Differences in the proportion of individuals 
with sickle cell trait (HbAS) and G6PD deficiency were compared using Pearson’s χ2 test.  d G6PD 
deficiency was defined as hemizygous in males and homozygous in females, since it is an X-linked gene.  
Children were grouped as follows: HIV-1[-]/Pf[+], negative reaction on the Determine® and Uni-Gold™ 
HIV-1 serology tests; HIV-1[exp]/Pf[+], positive reaction on one or both serology tests and a negative 
reaction for HIV-1 by PCR; HIV-1[+]/Pf[+], positive reaction on one or both serology tests and a positive 
reaction on two consecutive HIV-1 PCR assays three months apart.  The number and species of asexual 
Plasmodium organisms per 300 white blood cells (WBC) were determined using Giemsa-stained thin and 
thick smear venous blood.  Complete blood counts were determined in venous blood using a Coulter® AcT 
diff2™ (Beckman Coulter Corp.). Mean Corpuscular Volume (MCV); Mean Corpuscular Hemoglobin (MCH); 
Mean Corpuscular Hemoglobin Concentration (MCHC); and Red Blood Cell Distribution Width (RDW). 
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Table 2.  Erythropoietic indices.   
 
 
Characteristic HIV-1[-]/Pf[+] HIV-1[exp]/Pf[+] HIV-1[+]/Pf[+] P 
Number of  subjects 406 112 24 N/A 
Reticulocyte Count (%)  b 2.7 (4.1) 3.0 (3.9) 3.3 (6.7) 0.319 
ARN (×1012/L)  a 0.065 (0.08) 0.064 (0.08) 0.066 (0.10) 0.966 
RPI (/µL)  a 1.45 (1.90) 1.45 (1.94) 1.76 (2.66) 0.974 
RPI<2, n (%)  b 234 (61.6) 66 (62.9) 12 (54.5) 0.766 
 
 
a Data are presented as median (interquartile range) and differences between the three groups were 
compared using Kruskal-Wallis test.  b Differences in the reticulocyte count (%) were compared using 
Pearson’s χ2 test.  Reticulocyte production index (RPI) and absolute reticulocyte number (ARN) were 
calculated as follows:  Reticulocyte Index (RI) = reticulocyte count × hematocrit / 30.7 (average 
hematocrit of children <5yrs of age in Siaya district); Maturation Factor (MF) = 1 + 0.05 (30.7 – 
hematocrit); RPI = RI / MF; ARN = (RI × RBC count) / 100. 
 
 
Table 3.  Predictors of hemoglobin concentrations.   
 
 
Variable β-weight Semipartial r2 P Block ∆ statistics 
Age 0.133 0.017 0.004  
HIV-1 Status  -0.113 0.013 0.014  
Block 1 Summary:    R
2=0.033 
P<0.001 
PCM -0.415 0.155 <0.001  
PCN  0.071 0.005 0.102  
Block 2 Summary:    R
2=0.159 
P<0.001 
 
 
Hierarchical multiple regression analysis was performed to determine predictors of Hb levels.  Age (mos.) 
and HIV-1 status (i.e., HIV-1[-] → HIV-1[exp] → and HIV-1[+]) were entered in block 1; and pigment-
containing monocytes (PCM) and pigment-containing neutrophils (PCM) were entered into block 2.  The 
full model was significant at F(5, 512)= 18.748, P<0.001, R=0.441, R2=0.194. 
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Figure 1.  Increased anemia and mortality in HIV-1(+) children.  Bars represent percentage of 
children with SA (left y-axis), while lines depicts mortality percentage (right y-axis) in each HIV status.  
Differences in the proportion of individuals with SA (P=0.020) and those deceased (P<0.001) were 
compared using Pearson’s χ2 test.  Pair-wise comparison revealed significant differences between 
proportions of children with SA and mortality in the HIV-1[-]/Pf[+] vs. HIV-1[exp]/Pf[+] groups (P=0.045 
and P<0.001, respectively) and HIV-1[-]/Pf[+] vs. HIV-1[+]/Pf[+] groups (P=0.008 and P<0.001, 
respectively).  There were 13 (3.2%) HIV-1[-]/Pf[+], 6 (5.4%) HIV-1[exp]/Pf[+], and 8 (33.3%) HIV-
1[+]/Pf[+] children that died within the three-month follow-up period after enrollment.  SA (Hb 
<6.0g/dL) cases were as follows: 137 (35.2%) HIV-1[-]/Pf[+]; 44 (41.1%) HIV-1[exp]/Pf[+]; and 14 
(63.6%) HIV-1[+]/Pf[+].   
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Figure 2.  Increased intraleukocytic PfHz in HIV-1[+]/Pf[+] children.  Bars represent mean 
PCN/µL (black) and PCM/µL (grey) concentrations and are associated with the left y-axis, while 
percentage of children with intraleukocytic PfHz are depicted with a broken line (PCN) and grey line 
(PCM) and associated with the right y-axis.  Differences in the proportion of individuals with PCN (9.4% 
HIV-1[-]/Pf[+], 4.5% HIV-1[exp]/Pf[+], 20.8% HIV-1[+]/Pf[+]; P=0.029) and PCM (48.3% HIV-1[-
]/Pf[+], 48.2% HIV-1[exp]/Pf[+], 54.2% HIV-1[+]/Pf[+]; P=0.852) were compared using Pearson’s χ2 
test, while PCN (HIV-1[-]/Pf[+], 0.24/µL; HIV-1[exp]/Pf[+], 0.16/µL; HIV-1[+]/Pf[+], 0.54/µL;  P=0.249) 
and PCM concentrations (HIV-1[-]/Pf[+], 3.09/µL; HIV-1[exp]/Pf[+], 2.75/µL; HIV-1[+]/Pf[+], 4.13/µL; 
P=0.456) were compared across the groups using the Kruskal-Wallis test.  Pair-wise comparisons were 
performed using either Pearson’s χ2 test, for categorical variables, or Mann-Whitney U, for continuous 
variables.  A total of 30 monocytes and 100 neutrophils were examined per slide and expressed as a 
percentage of the counted monocytes and neutrophils, and then PCM and PCN concentrations were 
derived by multiplying the percentages by the total absolute monocyte and neutrophil counts, 
respectively. 
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4.0  CHAPTER FOUR: RESULTS, SPECIFIC AIM 2 
 
 
 
To determine the inflammatory mediator profiles in HIV-1[exp]/Pf[+] and 
HIV-1[+]/Pf[+] co-infected children with exacerbated severe anemia. 
 
 
 
4.1  HYPOTHESIS 1, PRESENTATION OF MANUSCRIPT ENTITLED: 
INFLAMMATORY MEDIATOR PATTERNS ASSOCIATED WITH EXACERBATED 
SEVERE ANEMIA IN KENYAN CHILDREN WITH PLASMODIUM FALCIPARUM 
AND HIV-1 CO-INFECTION . 
 
Hypothesis 1:  Infection with Plasmodium falciparum causes enhanced anemia in HIV-1-
infected children through exacerbation of the chronic immune activation phase. 
 
To address this hypothesis, a subset of children from the previous aim were 
randomly selected in each group while preserving the overall median Hb value so the 
results were generalizable to the entire study population.  The plasma from these 
children were analyzed using a multiplex bead-array assay to determine the 
concentrations of 25 cytokines, chemokines, and growth factors.  In addition to 
assessing the difference in the 25 inflammatory mediators across the three groups, a 
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principal component factor analysis procedure was used to mathematically group 
related cytokines into components based on their variance relatedness.  In this way, the 
components, and ultimately, the cytokines, having the most influence on RPI and Hb 
values, and were most influenced by PCN and PCM, for each HIV-1 status were 
determined.  The results of these findings are presented in the following manuscript 
prepared for submission. 
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4.2  ABSTRACT 
 
 
Malaria and HIV-1 are co-endemic in many developing countries, with anemia being the 
most common pediatric hematological manifestation of each disease.  Since we 
previously demonstrated that malaria/HIV-1 co-infection was associated with 
exacerbation of severe anemia (SA), immunological mechanisms that promote anemia 
were investigated.  Kenyan children (aged 3-36 mos., n=542) infected with P. 
falciparum and residing in a holoendemic transmission area were stratified into three 
groups: HIV-1 negative (HIV-1[-]/Pf[+]); HIV-1 exposed (HIV-1[exp]/Pf[+]); and HIV-1 
infected (HIV-1[+]/Pf[+]).  Clinical and hematological measures were determined by 
standard methods and immunological profiles were determined with a human 25-plex 
bead array assay.  Worsening anemia was associated with dysregulation in inflammatory 
mediators (IM), but not indices of either parasitemia or erythropoiesis.  Malaria/HIV-
1[+] co-infected children had elevated levels of IL-12, IFN-γ, MIG/CXCL9, 
eotaxin/CCL11, and GM-CSF.  To identify unique IM profiles associated with anemia, a 
principle components factor analysis was performed with 25 effector molecules and 5 
inflammatory ratios.  This analysis revealed six principal components that explained 
69% of the variance in the IM inter-correlation matrix.  Correlation analyses between 
the principal components and HIV-1[+]/Pf[+] co-infected children revealed an inverse 
relationship between component 2 (IL-1β, IL-2, GM-CSF, IL-1β:IL-10, IL-1β:IL-1Ra, IL-
2:IL-2R) and pigment-containing neutrophils (PCN), and a direct relationship between 
component 4 (IL-4, IL-5, IL-12, Eotaxin/CCL11) and hemoglobin (Hb).  Post-hoc analysis 
in the HIV-1[+]/Pf[+] group revealed that IL-12 was the most influential variable on Hb 
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levels, while the IL-1β:IL-10 ratio was most influenced by PCN.  Thus, malaria/HIV-1 co-
infection is defined by significantly enhanced anemia that is associated with unique 
inflammatory profiles known to exacerbate anemia. 
 
 
 
4.3  INTRODUCTION 
 
 
Currently, sub-Saharan Africa is home to 90% of the world’s Plasmodium falciparum 
infections (WHO 2008) and 64% of the HIV-1 infections (UNAIDS 2008).  Children are 
the most affected group in the population, with malaria and HIV-1 being responsible for 
18% and 6%, respectively, of deaths in sub-Saharan African children under the age of 
five (Rowe, Rowe et al. 2006).  The primary pediatric manifestation of each of these 
diseases is anemia. 
 One important mechanism common to both diseases, which may substantially 
contribute to the development of severe anemia (SA), is perturbation in inflammatory 
mediator (IM) production (Luty, Perkins et al. 2000; Perkins, Weinberg et al. 2000; Lyke, 
Burges et al. 2004; Awandare, Kremsner et al. 2007; Awandare, Ouma et al. 2007).  
Results from our laboratory and others have demonstrated that dysregulation in the 
balance of type 1 [e.g., interleukin (IL)-1β, IL-6, IL-12, interferon (IFN)-γ, and tumor 
necrosis factor (TNF)-α] and type 2 (e.g., IL-4 and IL-10) cytokines is associated with 
enhanced immuno-pathogenesis of severe malarial anemia (SMA) (Mshana, Boulandi et 
al. 1991; Kurtzhals, Akanmori et al. 1999; Luty, Perkins et al. 2000; Perkins, Weinberg 
et al. 2000; McDevitt, Xie et al. 2004; Prakash, Fesel et al. 2006).  We have also shown 
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that children with malaria have altered levels of β-chemokines, including macrophage 
inflammatory protein (MIP)-1α/CCL3, MIP-1β/CCL4, and regulated upon activation, 
normal T-cell expressed and secreted (RANTES/CCL5) (Ochiel, Awandare et al. 2005; 
Awandare, Goka et al. 2006).  Changes in the relative levels of IMs may promote the 
pathogenesis of SMA by altering the erythropoietic cascade.  For example, TNF-α 
rapidly and irreversibly inhibits human erythroid progenitors (Means, Dessypris et al. 
1992), while IFN-γ directly suppresses human erythroid colony-forming units (CFU-E) 
(Means, Dessypris et al. 1992).  IFN-γ also upregulates IL-15, which in turn, inhibits 
erythropoiesis at the CFU-E stage (Mullarky, Szaba et al. 2007).    In addition, our 
previous results showed that pediatric malarial anemia is characterized by suppression 
of IL-12 (Luty, Perkins et al. 2000; Perkins, Weinberg et al. 2000). 
 Presence of malarial pigment (hemozoin, PfHz) within macrophages, monocytes, 
and neutrophils may also contribute to impairment of the immune response commonly 
observed in P. falciparum infections (Sherry, Alava et al. 1995; Perkins, Moore et al. 
2003; Deshpande and Shastry 2004; Moore, Chaisavaneeyakorn et al. 2004; Coban, 
Ishii et al. 2005; Nti, Slingluff et al. 2005; Huy, Trang et al. 2006; Keller, Yamo et al. 
2006; Awandare, Ouma et al. 2007).  Hemozoin is a crystalline structure formed from 
monomeric heme and released as a by-product of parasitic proteolysis of host 
erythrocyte hemoglobin (Hb) [reviewed in (Hanscheid, Egan et al. 2007)].  Our previous 
findings (Keller, Yamo et al. 2006; Awandare, Ouma et al. 2007), and those of others 
(Nguyen, Day et al. 1995; Amodu, Adeyemo et al. 1998; Lyke, Burges et al. 2004; 
Hanscheid, Langin et al. 2008), revealed that pigment-containing monocytes (PCM) and 
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pigment-containing neutrophils (PCN) are important markers of malaria disease severity.  
We previously found in the cohort of children investigated here that PCM was the 
primary predictor of Hb concentrations in malaria/HIV-1 co-infected children, after HIV 
status and age had been accounted for as co-variates (Davenport, Ouma et al. 2010).  
However, the mechanism by which intraleukocytic PfHz acts on the erythropoietic 
cascade, and ultimately affects Hb levels, has yet to be elucidated. 
 Shortly after HIV-1 infection, resolution of the transient viremia is followed by a 
state of chronic immune activation characterized by increased pro-inflammatory 
cytokine release (Barcellini, Rizzardi et al. 1996), which potentially depletes CD4+ T-
cells required to mount an effective immune response (Hazenberg, Otto et al. 2003; 
Deeks, Kitchen et al. 2004; Appay and Sauce 2008).  The chronic immune activation 
phase is associated with elevated levels of IL-1β (Molina, Scadden et al. 1989; Roux-
Lombard, Modoux et al. 1989), IL-6 (Nakajima, Martinez-Maza et al. 1989; Scala, 
Ruocco et al. 1994), IL-10 (Clerici, Seminari et al. 2000), IFN-γ (Clerici, Seminari et al. 
2000), TNF-α (Molina, Scadden et al. 1989; Roux-Lombard, Modoux et al. 1989), MIP-
1α/CCL3 (Canque, Rosenzwajg et al. 1996; Muthumani, Kudchodkar et al. 2000), MIP-
1β/CCL4 (Muthumani, Kudchodkar et al. 2000), and RANTES/CCL5 (Canque, 
Rosenzwajg et al. 1996; Schmidtmayerova, Sherry et al. 1996; Cremer, Vieillard et al. 
2000; Muthumani, Kudchodkar et al. 2000), and decreased IL-12 levels (Chehimi, Starr 
et al. 1994; Daftarian, Diaz-Mitoma et al. 1995; Chougnet, Wynn et al. 1996; Vigano, 
Balotta et al. 1996).  Thus, changes in IM production are common to both malaria and 
HIV-1 mono-infections.      
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 Given the immunological complexity of malaria and HIV-1, and their anemia 
commonality, our goal was to define the soluble mediator milieu in co-infected children 
associated with the failure to mount an effective erythropoietic response to worsening 
anemia.  As such, parasitological, hematological, and immunological profiles were 
investigated in malaria-infected children with and without HIV-1 from a holoendemic P. 
falciparum transmission area. 
 
 
 
4.4  METHODS 
 
 
4.4.1  Study participants 
 
 
Children aged 3 - 36 months (n=542) with P. falciparum parasitemia (any density) were 
recruited at Siaya District Hospital, western Kenya, during their first hospital contact for 
malaria, and matched for age and gender.  Siaya District is a holoendemic P. falciparum 
transmission area where residents receive up to 300 infective bites per annum (Beier, 
Oster et al. 1994).  None of the children included in the data analysis plan had cerebral 
malaria, non-falciparum malarial infections, bacteremia, or hookworm infections.  A 
detailed description of the study area and pediatric anemia in the population can be 
found in our previous publication (Ong'echa, Keller et al. 2006).  
All children in the study had P. falciparum infections.  Children with malaria were 
divided into three groups: HIV-1 negative (HIV-1[-]/Pf[+], negative HIV-1 serological 
results, n=148]; HIV-1 exposed (HIV-1[exp]/Pf[+], at least one (of two) positive 
serological test and negative HIV-1 DNA PCR on two separate blood draws ~3 mos. 
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apart, n=30); and HIV-1 positive (HIV-1[+]/Pf[+], at least one (of two) positive 
serological tests and positive HIV-1 DNA PCR results on two separate blood draws ~3 
mos. apart, n=16).  Although the HIV-1 status of mothers was unknown, HIV-
1[exp]/Pf[+] children presumably acquired HIV-1 antibodies from their mothers during 
gestation and/or through breastfeeding.  It is important to note that none of the 
children in the cohort had received prior blood transfusions.  HIV-1[+]/Pf[+] children 
were not further stratified according to disease stages due to the reduced sample size 
(i.e., n=16).  Pre- and post-test HIV counseling were provided for the parents/guardians 
of all participants.  Children positive for one or both HIV-1 serological tests were 
prophylactically treated with trimethoprim–sulfamethoxazole.  At the time of enrollment, 
none of the children had been initiated on antiretroviral therapy.  Children were also 
stratified into SA (Hb <6.0g/dL) and non-SA (Hb 6.0–10.9g/dL and free from the 
symptoms of severe malaria, such as hypoglycemia).  Definitions of SA were based on 
previous longitudinal Hb measures (>14,000) in children (<48 mos. of age) in western 
Kenya (McElroy, Lal et al. 1999).  Children were treated according to Ministry of Health, 
Kenya, guidelines and written informed consent was obtained from the participants’ 
parents/guardians. Approval for the study was granted by the University of New Mexico, 
University of Pittsburgh, and the Kenya Medical Research Institute (KEMRI). 
 
4.4.2 Laboratory measurements 
 
 
Asexual malaria trophozoites (Were, Hittner et al. 2006) and the number of PCM and 
PCN were determined according to previous methods (Nguyen, Day et al. 1995; Lyke, 
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Diallo et al. 2003).  Briefly, thick and thin peripheral blood smears were prepared from 
venous blood samples and stained with Giemsa reagent for malaria parasite 
identification and quantification by microscopy.  Asexual malaria trophozoites were 
counted against 300 leukocytes based on absolute counts of white blood cells (WBC)/µL 
of blood, and parasite density was estimated as follows: parasites/µL = WBC count/µL x 
trophozoites/300.  Complete blood counts were performed with a Beckman Coulter© Ac-
T diff2™ (Beckman Coulter, Inc.) on blood obtained prior to administration of 
antimalarials and/or antipyretics.  The reticulocyte count was determined using a thin 
smear slide stained with New Methylene Blue.  The following indices were then 
calculated to ascertain the reticulocyte production index (RPI):  Reticulocyte Index (RI) 
= reticulocyte count x hematocrit / 30.7 (average hematocrit of children <5yrs in Siaya 
district); Maturation Factor (MF) = 1 + 0.05 (30.7 – hematocrit); RPI = RI / MF; ARN 
(absolute reticulocyte number) = (RI x RBC count) / 100.  HIV-1 status was determined 
using two rapid serological antibody tests (i.e., Uni-Gold™, Trinity Biotech and; 
Determine®, Abbott Laboratories) and HIV-1 DNA PCR analysis was performed 
according to our previously published methods (Davenport, Ouma et al. 2010). 
 
4.4.3  Multiplex assay 
 
 
Venous blood samples were centrifuged immediately and plasma was separated, 
aliquoted, and stored at -70°C until use.  Samples were then thawed and clarified by 
centrifugation (14,000 rpm for 10 min) before assaying.  IM levels were determined by 
the Cytokine 25-plex Antibody Bead Kit, Human (BioSource™ International) according 
 
 
86 
 
to the manufacturer’s instructions.  Plates were read on a Luminex® 100™ system 
(Luminex® Corporation) and analyzed using the Bio-plex manager software (Bio-Rad 
Laboratories).  Analyte detection limits were: 3pg/mL (IL-5, IL-6, IL-8/CXCL8); 4pg/mL 
[monokine induced by IFN-γ (MIG/CXCL9)]; 5pg/mL (IL-1α, IL-3, IL-4, IL-10, eotaxin-
1/CCL11, IFN-γ, IP-10/CXCL10); 6pg/mL (IL-2); 10pg/mL (IL-7, IL-13, IL-15, IL-17, MIP-
1α/CCL3, MIP-1β/CCL4, monocyte chemotactic protein [MCP-1/CCL2], TNF-α); and 
15pg/mL (IL-1β, IL-12p40/p70, granulocyte-macrophage colony-stimulating factor [GM-
CSF], IFN-α, RANTES/CCL5). 
 
4.4.4  Statistical analyses 
 
 
Data were analyzed using SPSS (version 15.0).  Clinical, demographic, hematological, 
and immunological measures were compared inter-group by either analysis of variance 
(ANOVA) or Kruskal-Wallis tests, followed by pairwise post-hoc comparison with 
student’s t-test or Mann-Whitney U test, respectively.  Pearson’s Chi-Square (χ2) or 
Fisher’s exact test were used for comparing proportions.  Statistical significance was 
determined at P≤0.05.  However, in light of the small number of SA children available in 
our secondary analyses and, hence, the correspondingly lowered statistical power, we 
adopted a more liberal P-value criterion (P≤0.075) when interpreting the Kruskal-Wallis 
results.  Our rationale for utilizing a more liberal criterion when interpreting the omnibus 
Kruskal-Wallis test is to minimize the probability of committing Type II errors.  In order 
to reduce and synthesize the large number of IMs from the multiplex assay, the IMs 
were subjected to a principal components factor analysis (PCA), and the resulting 
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components were correlated with Hb, RPI, and PfHz burden for the entire sample of 
children and for the three HIV-1 status groups separately.  Analyses of variance were 
also performed to examine whether, and to what extent, mean levels of the principal 
components differed across the three HIV-1 status groups. 
 
 
 
4.5  RESULTS 
 
 
4.5.1  Demographic, clinical, and hematologic characteristics 
 
 
Children with falciparum malaria were stratified into three categories: malaria alone 
(HIV-1[-]/Pf[+], n=148); HIV-1[exp]/Pf[+], n=30; and co-infected (HIV-1[+]/Pf[+], 
n=16).  Study participant demographics and clinical characteristics are listed in Table 4.  
Children in the three groups had similar ages (P=0.592) and gender proportions 
(P=0.921).  Hematologically, Hb concentrations differed across the groups (P=0.017) 
and progressively declined with increasing HIV-1 status (HIV-1[-]→HIV-1[exp]→HIV-
1[+]) and therefore, more cases of SA (Hb<6.0, P=0.023) were seen in the HIV-
1[+]/Pf[+] group, however, RPI was not different (P=0.554).  White blood cell (WBC) 
and granulocyte counts were also similar across the groups, although, there was a 
distinct monocytosis in the HIV-1[+]/Pf[+] group (P=0.033).  Finally, parasitemia 
(P=0.112), geometric mean parasitemia (P=0.086), and PCM (P=0.728) were 
comparable among the groups.  However, a marked increase in the concentration of 
PCN was noted in the HIV-1[+]/Pf[+] group (P=0.018). 
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4.5.2  Pro- and anti-inflammatory cytokine production  
 
Since dysregulation in IM production plays an important role in promoting anemia (Clark 
and Chaudhri 1988; Ratajczak and Ratajczak 1994; Lyke, Burges et al. 2004; Awandare, 
Goka et al. 2006; Thawani, Tam et al. 2006; Ong'echa, Remo et al. 2007), circulating 
levels of cytokines, chemokines, and growth factors were determined with a hu 25-plex 
bead array assay.  Our previous investigations (Perkins, Weinberg et al. 2000; Keller, 
Davenport et al. 2006; Keller, Yamo et al. 2006; Ong'echa, Remo et al. 2007), and those 
of others (Luty, Perkins et al. 2000; Lyke, Burges et al. 2004), demonstrated that 
childhood malaria is characterized by altered production of pro- and anti-inflammatory 
cytokines, which is closely associated with disease severity.  However, the profile of 
cytokine production in HIV-1[exp] and HIV-1[+] children with falciparum malaria is 
largely unreported.  Analyses of circulating cytokines revealed that IL-12 was 
significantly different across the groups (P=0.003, Table 5).  Relative to the HIV-1[-
]/Pf[+] group, IL-12 was increased in the HIV-1[exp]/Pf[+] group (P=0.055), and 
highest in the HIV-1[+]/Pf[+] group (P=0.002, Table 5).  In addition, the difference in 
IFN-γ across the groups was of borderline significance (P=0.050), with the highest 
levels observed in HIV-1[exp]/Pf[+] children, followed by the HIV-1[+]/Pf[+] group 
(P=0.031 and P=0.220 vs. HIV-1[-]/Pf[+], respectively, Table 5).  None of the other 
pro- or anti-inflammatory cytokines showed significant inter-group differences (Table 5). 
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4.5.3  Chemokine and growth factor production 
 
 
Previous investigations in our laboratory demonstrated that β-chemokines are 
dysregulated in children with falciparum malaria (Ochiel, Awandare et al. 2005; Were, 
Hittner et al. 2006). Although altered regulation of chemokines is well-documented in 
HIV-1[+] children (Resino, Bellon et al. 2001; Tiemessen and Kuhn 2006), the pattern 
of chemokine production in co-infected children has not been characterized.  Results 
presented here demonstrate that eotaxin/CCL11 levels differed across the three groups 
(P=0.003, Table 5).  Relative to the HIV-1[-]/Pf[+] group, eotaxin/CCL11 was 1.3-fold 
higher in the HIV-1[exp]/Pf[+] group (P=0.156) and 1.6-fold higher in HIV-1[+]/Pf[+] 
children (P=0.001, Table 5).  Circulating concentrations of the hematopoietic and 
immune-regulatory cytokine, GM-CSF, also differed across the groups (P=0.011, Table 
5), with 4.5-fold and 6.8-fold higher concentrations in the HIV-1[exp]/Pf[+] and HIV-
1[+]/Pf[+] groups compared to the HIV-1[-]/Pf[+] group (P=0.020 and P=0.030, 
respectively, Table 5).  MIG/CXCL9 also showed a significant inter-group difference 
(P=0.027) and was increased in the HIV-1[exp]/Pf[+] and HIV-1[+]/Pf[+] groups 
relative to HIV-1[-]/Pf[+] children (P=0.038 and P=0.058, Table 5).  No significant 
inter-group differences were observed for the other chemokines. 
 
4.5.4  Inflammatory ratios 
 
 
We (Perkins, Weinberg et al. 2000; Awandare, Goka et al. 2006; Keller, Yamo et al. 
2006; Ouma, Davenport et al. 2008) and others (May, Lell et al. 2000; Dodoo, Omer et 
al. 2002) have previously shown that ratios of pro- and anti-inflammatory mediators 
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(e.g., TNF-α:IL-10, IL-1β:IL-1Ra, and IL-2:IL-2R) are more biologically informative than 
their absolute values.  Of the five biologically relevant inflammatory ratios examined, 
only the IL-2:IL-2R ratio approached significance (P=0.063, Table 5).  However, there 
was a trend towards a more pro-inflammatory environment in the HIV-1[exp]/Pf[+] and 
HIV-1[+]/Pf[+] groups. 
 
4.5.5  Principal component analysis of inflammatory mediators 
 
 
To identify unique profiles of IMs associated with malaria/HIV-1 co-infection, twenty-five 
IMs and five IM ratios were subjected to a principal component factor analysis (PCA) 
with a varimax rotation and Kaiser normalization.  The purpose of PCA is to reduce a 
complex multivariable set of data into a smaller, and more manageable, number of 
composite variables.  This is accomplished by forming weighted linear composites of 
variables such that each composite (or factor/component) contains highly interrelated 
variables thought to measure a common construct or phenomenon.  When the 
components are subjected to an orthogonal (i.e., uncorrelated) mathematical rotation, 
as is performed with a varimax rotation, inter-component variance is minimized.  This 
process enhances the distinctness and interpretability of each component.   
The initial analysis of our PCA results, based on the scree plot and eigenvalue-
greater-than-one rule, suggested a seven component solution.  However, given that 
only two IMs loaded unambiguously on component 7, and considering the minimal 
variance accounted for by the 7th component, the PCA was re-computed with a six 
component solution.  As shown in Table 6, PCA revealed the following six components: 
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component 1 (IL-6, IL-8, IL-15, TNF-α, MIP-1β/CCL4, and MCP-1/CCL2); component 2 
(IL-1β, IL-2, GM-CSF, IL-1β:IL-10, IL-1β:IL-1Ra, and IL-2:IL-2R); component 3 (IL-1Ra, 
IL-7, IL-17, IFN-α, IFN-γ, and MIG/CXCL9); component 4 (IL-4, IL-5, IL-12, and 
Eotaxin/CCL11); component 5 (IP-10/CXCL10, IL-10, and TNF-α:IL-10); and component 
6 (IL-2R, IL-13, MIP-1α/CCL3, and MIP-1α:MIP-1β).  Component scores were calculated 
for each child by first multiplying the IMs and IM ratios by their respective factor 
loadings and then, for each component, summing the relevant IMs and IM ratios.  
Descriptive analyses of the resulting component score distributions indicated that all six 
components were normally distributed, as evidenced by small and non-significant 
skewness and kurtosis estimates.  The six principal components provided an excellent 
fit of the data and accounted for 69.03% of the variance in the IM inter-correlation 
matrix.  The eigenvalues and variance estimates for each component are shown in 
Table 6.   
 
4.5.6  Unique associations between the principal components and HIV-1 
status 
 
  
A series of ANOVAs were then performed to examine whether the mean levels of the six 
components differed across the three HIV-1 status groups.  Results indicated that 
components 2 [F(2, 207)=5.95, P=0.003], 3 [F(2, 194)=4.72, P=0.010], and 4 [F(2, 
207)=4.16, P=0.017] significantly differed across the HIV-1 status groups.  Post hoc 
pairwise comparisons, using Fisher’s Least Significant Difference (LSD) test, indicated 
that the HIV-1[exp]/Pf[+] group (M=3.22) scored higher on component 2 than the HIV-
1[-]/Pf[+] group (M=1.09, P=0.001).  For component 3, the HIV-1[exp]/Pf[+] group 
 
 
92 
 
(M=6.14) scored higher than the HIV-1[-]/Pf[+] group (M=5.27, P=0.006), while on 
component 4, the HIV-1[+]/Pf[+] group (M=4.01) scored higher than the HIV-1[-
]/Pf[+] group (M=3.46, P=0.006).  Thus, there are unique profiles of IM production 
that differ according to HIV-1 status, suggesting that the inflammatory pathways differ 
in children co-infected with malaria and HIV-1. 
 
4.5.7  Relationship between inflammatory mediator profiles, intraleukocytic 
PfHz, and anemia 
 
 
Since there were unique patterns of IM production that differed according to HIV-1 
status, Pearson correlation analyses were then conducted to examine the associations 
between the six IM-derived components and key indices of malaria-related morbidity 
and mortality.  In particular, we examined PfHz burden (i.e., PCM and PCN) and anemia 
status (i.e., RPI and Hb).  Analyses that included all of the children, revealed that PCN 
was negatively correlated with both components 2 (r=-0.187, P=0.007) and 4 (r=-
0.157, P=0.023), RPI was negatively correlated with component 5 (r=-0.200, P=0.004), 
and Hb was positively correlated with component 3 (r=0.167, P=0.019).   
For the HIV-1[-]/Pf[+] group, PCN was negatively correlated with component 4 
(r=-0.200, P=0.013), RPI was negatively correlated with component 5 (r=-0.209, 
P=0.010), and Hb was positively correlated with component 3 (r=0.170, P=0.040, Table 
7).  There were no significant correlations for the HIV-1[exp]/Pf[+] group (Table 7).  
For the HIV-1[+]/Pf[+] group, PCN was negatively correlated with component 2 (r=-
0.671, P=0.004), while Hb was positively correlated with component 4 (r=0.490, 
P=0.054, Table 7). 
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 The two correlations for the HIV-1[+]/Pf[+] group are particularly impressive 
given their large magnitudes and the small number of HIV-1[+]/Pf[+] children in the 
analysis (n=16).  To further probe these correlations, a leave-one-out-method was 
adopted whereby, for each component, each IM was systematically removed from the 
component and the correlation between the component and Hb (or PCN) was re-
calculated.  The purpose of these post hoc analyses is to ascertain which IMs exert the 
greatest influence on the PCN- and Hb-component correlations.  For example, if Hb is 
correlated with a component consisting of four IMs (labeled 1, 2, 3, and 4), in 
accordance with the leave-one-out-method, four new components would be created 
(i.e., 123, 124, 134, and 234), and each new component would then be correlated with 
Hb.  The correlation showing the largest decrement in relation to the original 
component correlation would indicate which constituent IM is most important in driving 
the Hb correlation.  When applying this methodology to the significant HIV-1[+]/Pf[+] 
correlations, we found that of the four IMs that comprise component 4, IL-12 exerted 
the greatest influence on the correlation between Hb and this component.  Upon 
exclusion of IL-12 from component 4, the magnitude of the correlation decreased from 
0.490 to 0.340, which represents a 30.6% reduction.  For the relationship between the 
HIV-1[+]/Pf[+] group’s IM profiles and PCN, we found that of the six IMs that comprise 
component 2, the IL-1β:IL-10 ratio exerted the greatest influence on the correlation 
between PCN and this component.  When the IL-1β:IL-10 was excluded from 
component 2, the absolute magnitude of the correlation changed from -0.671 to -0.587, 
which represents a 12.5% reduction. 
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4.6  DISCUSSION 
 
 
Our recent investigations in Kenyan children demonstrated that co-infection with malaria 
and HIV-1 was associated with increased susceptibility to SA (Otieno, Ouma et al. 2006; 
Davenport, Ouma et al. 2010).  However, the underlying mechanisms of worsening 
anemia in co-infected children are largely undetermined.  Since perturbations in the 
inflammatory milieu promote enhanced anemia through a number of different 
mechanisms (Macdougall and Cooper 2002; Macdougall and Cooper 2002; Tilg, Ulmer 
et al. 2002; Mullarky, Szaba et al. 2007), comprehensive inflammatory mediator 
analyses were performed.       
 We and others have shown that acquisition of PfHz by phagocytic cells is an 
important source of IM dysregulation (Amodu, Adeyemo et al. 1998; Awandare, Ouma 
et al. 2007) and a significant predictor of SMA (Day, Pham et al. 1996; Casals-Pascual, 
Kai et al. 2006).  By examining PfHz burden in neutrophils and monocytes, it is possible 
to determine if individuals suffer from recent (acute) versus prolonged (chronic) malaria 
infection, since monocytes remain in circulation approximately 10 times longer than 
neutrophils (Tomas Ganz 1995).  Our previous study in western Kenya demonstrated 
that SMA is characterized by increased chronicity of infection, resulting in higher levels 
of PCM and lower levels of PCN (Awandare, Ouma et al. 2007).  Consistent with this 
investigation, a follow-up study in malaria and HIV-1 co-infected children in the same 
region revealed that PCM was the strongest predictor of reduced Hb levels, whereas 
parasitemia was largely unrelated to anemia status (Davenport, Ouma et al. 2010).  
Thus, it appears that phagocytosis of PfHz by circulating monocytes may be a primary 
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mechanism through which cytokine dysregulation promotes enhanced anemia in 
children with malaria mono-infection and in those co-infected with HIV-1.   
 Recent literature outlining the causes of ‘anemia of inflammation’ suggests that 
immune activation has a significant and lasting effect on Hb concentrations (reviewed in 
(Bertero and Caligaris-Cappio 1997; Ganz 2006)).  Although studies by our group 
(Perkins and Kniss 1999; Luty, Perkins et al. 2000; Perkins, Kremsner et al. 2001; Keller, 
Hittner et al. 2004; Ochiel, Awandare et al. 2005; Awandare, Goka et al. 2006; 
Awandare, Hittner et al. 2006; Awandare, Ouma et al. 2006; Awandare, Kremsner et al. 
2007) and others (Ammann 1993; Chaisavaneeyakorn, Moore et al. 2002; McDevitt, Xie 
et al. 2004; Moore, Chaisavaneeyakorn et al. 2004; Tiemessen and Kuhn 2006) 
demonstrated that both malaria and HIV-1 cause significant changes in inflammatory 
mediator production, a comprehensive evaluation of the inflammatory milieu in co-
infected children was previously not reported.  Newer technologies, such as the micro 
bead assays, that concomitantly measure an inclusive panel of inflammatory mediators, 
in small volumes of blood available from anemic children, allowed us to determine the 
inflammatory profile in malaria/HIV-1 co-infected children.   
 Of the 16 pro- and anti-inflammatory cytokines investigated, only IL-12 and IFN-γ 
emerged as markedly different across the HIV-1 status groups.  While we and others 
have previously shown that children with malarial anemia have progressively declining 
IL-12 levels with increasing anemia severity (Luty, Perkins et al. 2000; Perkins, 
Weinberg et al. 2000; Keller, Yamo et al. 2006), our findings here showed increasing 
concentrations of IL-12 across the HIV status groups despite the worsening anemia.  A 
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study in HIV/tuberculosis co-infected patients from Zimbabwe reported similar findings, 
with IL-12 levels increasing with the acquisition of serological HIV positivity (Gordeuk, 
Moyo et al. 2009).  Since children in the current study were in the early phases of HIV 
disease in which non-specific immune activation is ongoing, this may explain elevated 
IL-12 levels that differ from findings in the malaria literature and those of chronically-
infected HIV patients.  For example, Byrnes et al. (Byrnes, Harris et al. 2008) found 
significantly elevated IL-12p70 levels in acutely- (<2 months post-infection) and early 
(2-12 months)-infected HIV patients compared to healthy controls.  Circulating IL-12 
levels in both of these groups remained significantly elevated six months after 
diagnosis, regardless of whether the patient received highly active anti-retroviral 
therapy (HAART) treatment.  Framed in the context of acute/early HIV-1 infection, 
elevated IL-12 levels are not surprising in the current study in children that were less 
than one year of age.  These results highlight the fact that elevated IL-12 levels alone 
cannot salvage a child from worsening anemia. 
 Following the same pattern as IL-12, IFN-γ was lowest in the HIV-1[-]/Pf[+] 
group and elevated in both the HIV-1[exp]/Pf[+] and HIV-1[+]/Pf[+] groups.  IFN-γ is 
important for a robust response to infection and has been shown to decrease with HIV 
disease progression (Clerici, Seminari et al. 2000).  Previous studies also illustrated that 
IFN-γ suppresses erythropoiesis through up-regulation of IL-15 (Mullarky, Szaba et al. 
2007).  Studies in murine models demonstrated that blockade of IFN-γ, but not IL-12, 
TNF-α, IFN-α, IL-1α, or IL-1β, ameliorated suppression of erythropoiesis induced by 
CpG-oligodeoxynucleotide (CpG-ODN) administration (Thawani, Tam et al. 2006).  
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However, results presented here showing that IFN-γ was highest in the HIV-
1[exp]/Pf[+] group and elevated in the HIV-1[+]/Pf[+] children, both of which have 
progressively worsening anemia, but comparable reticulocyte responses relative to the 
HIV-1[-]/Pf[+] children, suggests that IFN-γ is not responsible for the worsening anemia 
in co-infected children.  One possible explanation for the current findings may be due to 
the fact that IFN-γ alters the erythropoietic cascade via an indirect fashion through 
perturbations in a number of other cytokines, all of which were not significantly 
different between the groups that showed progressively worsening degrees of anemia 
with increasing HIV-1 status (i.e., HIV-1[-]→HIV-1[exp]→HIV-1[+]).   
 Examination of chemokines and growth factors demonstrated that 
eotaxin/CCL11, MIG/CXCL9, and GM-CSF progressively increased across the groups.  
While little has been reported on the role of eotaxin/CCL11 in either malaria or HIV-1, 
decreased circulating eosinophils have been reported in children with P. falciparum, 
suggesting that tissue penetration is presumably directed by a chemotactic agent, such 
as eotaxin/CCL11 (Kurtzhals, Adabayeri et al. 1998).  In addition, eosinophilia during 
the convalescent phase of disease is associated with a favorable recovery from malarial 
anemia (Camacho, Wilairatana et al. 1999).  The impact of increased circulating 
eotaxin/CCL11 levels on recovery from malarial anemia in co-infected children, however, 
could not be determined using the current cross-sectional data.  The discovery of 
increased MIG/CXCL9 in co-infected children is consistent with the fact that this group 
had monocytosis.  In addition, progressively higher levels of GM-CSF across the groups, 
with decreasing Hb concentrations, likely reflects an attempt to compensate for the 
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worsening anemia, since GM-CSF stimulates erythroid progenitor expansion and 
maturation (Wu, Liu et al. 1995).  Although the clinical impact of increased 
eotaxin/CCL11, MIG/CXCL9, and GM-CSF in co-infected children remains to be 
determined, these novel findings provide a foundation for future investigations.   
 The principal component factor analysis mathematically determined six principal 
components from the 25 cytokines, chemokines, growth factors, and five inflammatory 
ratios that we examined.  Comparing the mean levels of these six components within 
the three HIV-1 groups revealed that the HIV-1[exp]/Pf[+] group had higher levels of 
components 2 and 3 than the HIV-1[-]/Pf[+] children, while the HIV-1[+]/Pf[+] group 
had higher levels of component 4 than the HIV-1[-]/Pf[+] children.  Since components 
2 and 3 are predominantly pro-inflammatory, elevation of these components in the HIV-
[exp]/Pf[+] group indicates a type 1 inflammatory process even in the absence of 
viremia.  Moreover, although the HIV-1[+]/Pf[+] group had the highest values for seven 
of 12 IMs in these two components, the HIV-1[exp]/Pf[+] group had a significant 
representation with five of the greatest mean values in IL-1β:IL-10, IL-2:IL-2R, IL-7, IL-
17, and IFN-γ, indicating that circulating virus is not necessary for a pro-inflammatory 
millieu, and the subsequent anemia associated with such an environment.  Finally, 
component 4 is comprised of the prototypical type 1 and type 2 cytokines, IL-12 and IL-
4, respectively, as well as the two eosinophil modulators, IL-5 and eotaxin/CCL11.  
While the interpretability of this predominantly type 2 component in the HIV-1[+]/Pf[+] 
group is likely complex, it may suggest a waning of type 1 non-specific immune 
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activation (often seen early in HIV-1 infection), and the initiation of a type 2 skewing of 
the immune response (Clerici and Shearer 1993; Klein, Dobmeyer et al. 1997). 
 Pearson correlations were then used to identify associations between these 
components and PCM and PCN, as well as RPI and Hb.  A model that included all of the 
children identified significant negative correlations between PCN and components 2 (IL-
1β, IL-2, GM-CSF, IL-1β:IL-10, IL-1β:IL-1Ra, IL-2:IL-2R) and 4 (IL-4, IL-5, IL-12, 
Eotaxin/CCL11), indicating that as PCN concentration increases, the cytokine milleu is 
skewed towards a type 2 immune response.  A negative correlation was also identified 
between RPI and component 5 (IP-10/CXCL10, IL-10, IL-10:TNF-α), suggesting a type 2 
immune response is associated with dyserythropoiesis and a poor response to anemia.  
In addition, there was a positive correlation between Hb and component 3 (IL-1Ra, IL-7, 
IL-17, IFN-α, IFN-γ, MIG/CXCL9), indicating that healthier Hb levels are associated with 
a more pro-inflammatory environment.  Overall, these results suggest that a potent 
type 1 pro-inflammatory immune response is necessary to maintain an appropriate 
erythropoietic response to anemia, and hence greater Hb levels, and that elevated PCN 
in co-infected children may be driving this phenomenon.   
 Analyses of the HIV-1[+]/Pf[+] group demonstrated that PCN was significantly 
correlated with component 2, as seen in results that included all of the children.  In 
addition, Hb was significantly associated with component 4 (IL-4, IL-5, IL-12, 
Eotaxin/CCL11).  The most interesting finding of this analysis is the transition of Hb 
correlating with component 3 (IL-1Ra, IL-7, IL-17, IFN-α, IFN-γ, MIG/CXCL9) in the HIV-
1[-]/Pf[+] children (P<0.050), with no evidence of correlation (P>0.500) with 
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component 4 (IL-4, IL-5, IL-12, Eotaxin/CCL11), and vice versa in the HIV-1[+]/Pf[+] 
group.   While components 3 and 4 each contain type 1 (IFN-γ, IFN-α, IL-12, IL-17) and 
type 2 (IL-4, IL-5, IL-7) cytokines, component 3 is comprised of the potent 
erythropoietic inhibitors IL-17, IFN-α, and IFN-γ, which will be increasing with Hb 
concentrations because of the positive association and thwarting erythropoiesis, while 
component 4 contains IL-12, also increasing due to a positive association, but 
supporting erythropoiesis (Dybedal, Larsen et al. 1995; Mohan and Stevenson 1998; 
Mohan and Stevenson 1998).  Further analysis of the HIV-1[+]/Pf[+] children revealed 
that Hb was strongly positively associated with component 4, with IL-12 being the 
greatest contributor to that component.  These findings parallel the patterns seen in the 
IL-12 concentrations in the three groups, with IL-12 increasing from the levels found in 
HIV-1[-]/Pf[+] children to the HIV-1(+)/Pf[+] group, but differ from studies previously 
reported by our group (Perkins, Weinberg et al. 2000; Keller, Yamo et al. 2006) and 
others (Luty, Perkins et al. 2000; Malaguarnera, Pignatelli et al. 2002; Malaguarnera, 
Pignatelli et al. 2002), showing that IL-12 is crucial and directionally proportional to 
hemoglobin levels in children recovering from malaria.  Clearly, the presence, or even 
exposure, to HIV-1 has a significant impact on the IL-12 levels in these children, and 
while IL-12 is linked to positive hematologic outcomes in malaria [reviewed in 
(Stevenson, Su et al. 2001)], elevated IL-12 levels, along with IL-1, IL-6, TNF-α, and 
IFN-γ, have been linked to poor responses to erythropoietin in dialysis patients 
[reviewed in (Macdougall and Cooper 2002; Macdougall and Cooper 2002)].  PCN 
showed negative associations with components 2 in the HIV-1[+]/Pf[+] group and 
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component 4 in the HIV-1[-]/Pf[+] group.  In addition, the negative association 
between PCN and component 2 was found to be most influenced by the IL-1β:IL-10 
ratio.  This finding suggests that PCN is associated with a type 2 skewing of the immune 
response, which agrees with previous findings of increased IL-10 upon exposure to PfHz 
(Peyron, Burdin et al. 1994; Keller, Yamo et al. 2006).  Conversely, there were no 
components associated with PCM, however, both the HIV-1[-]/Pf[+] and HIV-
1[exp]/Pf[+]  groups approach significance with component 1, while the HIV-
1[+]/Pf[+]  group showed no association.  This result was surprising given our previous 
findings by multiple regression analysis that PCM is the strongest predictor of Hb, but 
given the lack of PCM concentration differences across the groups, the failure to find 
significant correlations with the components is expected. 
 Taken together, these results demonstrate that children with malaria and HIV-1 
have enhanced anemia severity and more acute malaria infections relative to HIV-1[-
]/Pf[+]  children.  Although suppression of erythropoiesis did not account for enhanced 
anemia in co-infected children, unique patterns of inflammatory mediator dysregulation 
were observed.  Elevated IL-2, IFN-α, and IFN-γ levels may be important causes of 
anemia exacerbation in co-infected and exposed children.  In addition to potential 
erythropoietic consequences of IM dysregulation, cytokines such as IL-1 and TNF-α may 
also be encouraging splenic (Clark, Alleva et al. 2008; Buffet, Safeukui et al. 2009) and 
capillary sequestration of RBCs in SA through upregulation of receptors, such as 
thrombospondin, CD36, and intercellular adhesion molecule [reviewed in (Chulay and 
Ockenhouse 1990; Clark, Alleva et al. 2004)].  Furthermore, downstream molecules, 
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such as nitric oxide induced by IFN-α, reduces RBC deformability and oxygen delivery, 
and may contribute to RBC capture in the spleen (Kor, Van Buskirk et al. 2009).  
Increased eotaxin/CCL11, MIG/CXCL9, and GM-CSF levels may also play an important 
role in promoting enhanced HIV-1 pathogenesis (Reinhart 2003; McClure, van't Wout et 
al. 2007).  In addition to the direct influence of the pathogens on immune dysregulation 
presented here, additional factors (not examined here), such as the potential for poor 
nutritional status in the HIV-1[exp]/Pf[+] and HIV-1[+]/Pf[+] groups, may indirectly 
affect soluble mediator production and enhance anemia.  Future investigations focusing 
on the significantly dysregulated inflammatory mediators and the underlying cause(s) of 
immune dysregulation may offer novel insight into the molecular mechanisms 
responsible for enhanced SA in co-infected children. 
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4.8 TABLES 
 
 
Table 4.  Clinical characteristics of study participants.   
 
 
Characteristic HIV-1[-]/Pf[+] HIV-1[exp]/Pf[+] HIV-1[+]/Pf[+] P 
Number of  subjects 148 30 16 N/A 
Age (mos) a 10.2 (8.8) 9.2 (7.3) 12.1 (9.2) 0.592 
Gender, male/female b 77 / 71 15 / 15 9 / 7 0.921 
Severe anemia, n (%)b 136 (35.8) 44 (41.9) 14 (63.6) 0.023 
Hemoglobin (Hb, g/dL) a 7.0 (4.0) 6.2 (2.4) 5.2 (3.6) 0.017 
RPI a 1.4 (2.2) 2.0 (1.7) 1.4 (2.6) 0.554 
WBC (x109/µL) a 11.7 (6.2) 11.1 (6.2) 12.0 (6.4) 0.784 
Granulocytes (x103/µL) a 42.3 (23.0) 40.3 (15.0) 37.4 (19.0) 0.436 
Monocytes (x103/µL) a 8.5 (5.0) 9.1 (5.0) 12.6 (7.0) 0.033 
Parasitemia (/µL) a 25,619 (59,721) 25,659 (35,865) 14,405 (25,599) 0.112 
Geomean parasitemia (/µL) c 18,615 17,658 7,861 0.086 
PCM (/µL) c 3.32 (0.47) 2.40 (0.65) 3.81 (1.11) 0.728 
PCN (/µL) c 0.38 (0.12) 0 (0) 0.81 (0.50) 0.018 
  
 
Data are presented as median (interquartile range) unless stated otherwise.  a Differences in the age, 
reticulocyte production index (RPI), Hb levels, white blood cell (WBC) count, monocytes, granulocytes, 
and parasitemia were compared using the Kruskal-Wallis test. b Differences in the proportions of gender 
and severe anemia were compared using Pearson’s χ2 test.  c Data are presented as mean (SEM) and 
differences in the geometric mean parasitemia, pigment-containing monocytes (PCM), and pigment-
containing neutrophils (PCN) were compared using ANOVA. 
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Table 5.  Multiplex analyses of inflammatory mediators.   
 
 
Analyte HIV-1[-]/Pf[+] HIV-1[exp]/Pf[+] HIV-1[+]/Pf[+] P 
Cytokines (pg/mL) 
IL-1β 148.7 (282.8) 224.4 (579.0) 227.0 (393.6) 0.105 
IL-1Ra 1,717 (2,306) 1,894 (5,012) 3,566 (4,763) 0.116 
IL-2 29.7 (69.6) 39.6 (168.0) 47.3 (78.5) 0.149 
IL-2R 1,713 (1,725) 1,425 (1,531) 1,590 (3,008) 0.643 
IL-4 4.1 (15.3) 6.3 (19.7) 13.3 (15.4) 0.123 
IL-5 1.7 (3.0) 1.3 (2.8) 3.0 (3.7) 0.503 
IL-6 89.8 (160.4) 76.8 (189.0) 87.9 (198.6) 0.421 
IL-7 1.4 (34.0) 25.7 (48.9) 11.7 (36.3) 0.166 
IL-10 262.9 (658.2) 246.9 (473.9) 254.1 (292.1) 0.833 
IL-12 362.0 (222.2) 475.7 (362.7) 604.9 (798.8) 0.002 
IL-13 28.1 (40.0) 30.5 (41.6) 44.8 (79.3) 0.282 
IL-15 29.4 (57.4) 33.2 (202.6) 46.0 (83.6) 0.314 
IL-17 5.6 (15.1) 5.7 (22.8) 5.4 (14.5) 0.772 
TNF-α 28.6 (36.7) 22.1 (75.7) 36.0 (44.5) 0.553 
IFN-α 10.6 (63.0) 5.0 (48.0) 26.4 (70.0) 0.391 
IFN-γ 4.6 (22.6) 17.9 (48.5) 11.1 (28.5) 0.050 
Chemokines & Growth Factors (pg/mL) 
Eotaxin/CCL11 39.0 (24.1) 48.9 (40.8) 62.3 (26.2) 0.003 
IL-8/CXCL8 14.7 (24.0) 12.9 (16.7) 19.0 (42.9) 0.146 
IP-10/CXCL10 254.0 (683.8) 220.9 (343.5) 363.5 (455.2) 0.444 
MCP-1/CCL2 196.0 (226.6) 211.7 (279.5) 207.5 (401.4) 0.529 
MIG/CXCL9 131.8 (162.8) 198.8 (261.9) 209.2 (125.2) 0.027 
MIP-1α/CCL3 115.4 (97.7) 124.3 (149.5) 109.2 (84.8) 0.380 
MIP-1β/CCL4 391.3 (387.6) 357.6 (450.8) 449.7 (390.2) 0.874 
RANTES/CCL5 15,195 (64,333) 9,679 (17,061) 30,851 (124,301) 0.171 
GM-CSF 36.6 (150.1) 170.3 (531.0) 259.1 (352.5) 0.011 
Inflammatory Ratios 
IL-1β:IL-1Ra 0.070 (0.190) 0.141 (0.260) 0.061 (0.060) 0.185 
IL-2:IL-2R 0.017 (0.080) 0.046 (0.160) 0.014 (0.190) 0.063 
IL-1β:IL-10 0.489 (1.770) 0.793 (1.930) 0.894 (1.33) 0.139 
TNF-α:IL-10 0.098 (0.230) 0.113 (0.180) 0.149 (0.140) 0.461 
MIP-1α:MIP-1β 0.269 (0.360) 0.439 (0.400) 0.269 (0.210) 0.355 
 
 
Data are presented as median (interquartile range) and compared using Kruskal-Wallis test.  Plasma serum 
samples collected at the initial parasitemic visit were snap frozen at -70°C until the day of assay.  Samples 
were thawed and centrifuged at 14,000 rpm for 10 minutes and stored on ice until assayed.  Twenty-five 
effector molecules were measured with the Cytokine 25-plex Ab Bead Kit, Hu (BioSource™ International) 
according to the manufacturer’s instructions.  Plates were read on a Luminex® 100™ system (Luminex® 
Corporation) and analyzed using the Bio-plex manager software (Bio-Rad Laboratories). 
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Table 6.  Rotated component matrix for the principal component factor analysis.   
 
 
Component Inflammatory Mediators 
Loading 
Factor 
Cumulative 
Eignevalue 
Percent 
Variance 
Cumulative 
Percent Variance 
 IL-6 0.835    
 IL-8 0.605    
 IL-15 0.507    
 TNF-α 0.790    
 MIP-1β/CCL4 0.843    
1 MCP-1/CCL2 0.696 7.702 25.673 25.673 
 IL-1β 0.902    
 IL-2 0.871    
 GM-CSF 0.669    
 IL-1β:IL-10 0.783    
 IL-1β:IL-1Ra 0.769    
2 IL-2:IL-2R 0.852 4.999 16.664 42.337 
 IL-1Ra 0.712    
 IL-7 0.617    
 IL-17 0.558    
 IFN-α 0.406    
 IFN-γ 0.654    
3 MIG/CXCL9 0.604 2.769 9.229 51.565 
 IL-4 0.517    
 IL-5 0.642    
 IL-12 0.684    
4 Eotaxin/CCL11 0.769 2.012 6.708 58.273 
 IP-10/CXCL10 0.488   
 IL-10 0.642   
5 TNF-α:IL-10 0.854 1.944 6.479 64.752 
 IL-2R 0.583  
 IL-13 0.742  
 MIP-1α/CCL3 0.555  
6 MIP-1α:MIP-1β 0.483 1.283 4.278 69.030 
 
 
Twenty-five inflammatory mediators and five inflammatory ratios were entered into the factor analysis 
model.  Variables were placed into six components based on a total per component Eigenvalue >1 
(range 1.283-7.702) value. 
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Table 7.  Association between the principal components and disease outcomes.   
 
 
Component / Variable 1 2 3 4 5 6 
HIV-1[-]/Pf[+] CHILDREN 
PCM Pearson Corr. 0.141 -0.037 0.027 -0.016 0.014 0.067 
 P-value 0.081 0.650 0.749 0.843 0.867 0.408 
 N 154 155 146 154 155 156 
PCN Pearson Corr. -0.022 -0.107 -0.027 -0.200 0.018 0.013 
 P-value 0.788 0.186 0.748 0.013 0.826 0.873 
 N 154 155 146 154 155 156 
RPI Pearson Corr. -0.033 0.022 0.105 0.093 -0.209 -0.059 
 P-value 0.687 0.785 0.212 0.260 0.010 0.475 
 N 149 150 142 149 150 151 
Hb Pearson Corr. -0.029 0.007 0.170 0.047 0.002 -0.063 
 P-value 0.724 0.932 0.040 0.562 0.981 0.438 
 N 154 155 146 154 155 156 
HIV-1[exp]/Pf[+] CHILDREN 
PCM Pearson Corr. -0.260 -0.069 -0.120 -0.059 -0.149 -0.042 
 P-value 0.105 0.678 0.479 0.717 0.358 0.796 
 N 40 39 37 40 40 40 
PCN Pearson Corr. N/A N/A N/A N/A N/A N/A 
 P-value N/A N/A N/A N/A N/A N/A 
 N 40 39 37 40 40 40 
RPI Pearson Corr. -0.192 -0.033 -0.188 -0.072 -0.272 -0.227 
 P-value 0.235 0.844 0.264 0.661 0.090 0.158 
 N 40 39 37 40 40 40 
Hb Pearson Corr. 0.039 -0.060 0.207 0.074 0.254 -0.140 
 P-value 0.812 0.717 0.219 0.648 0.114 0.388 
 N 40 39 37 40 40 40 
HIV-1[+]/Pf[+] CHILDREN 
PCM Pearson Corr. 0.005 -0.347 0.248 -0.054 0.254 -0.092 
 P-value 0.986 0.187 0.392 0.841 0.361 0.735 
 N 15 16 14 16 15 16 
PCN Pearson Corr. 0.122 -0.671 0.191 -0.134 0.434 0.190 
 P-value 0.664 0.004 0.513 0.621 0.106 0.482 
 N 15 16 14 16 15 16 
RPI Pearson Corr. -0.236 -0.466 -0.126 0.285 -0.242 -0.114 
 P-value 0.396 0.069 0.667 0.285 0.385 0.675 
 N 15 16 14 16 15 16 
Hb Pearson Corr. -0.074 0.001 0.175 0.490 -0.134 0.153 
 P-value 0.793 0.997 0.549 0.054 0.634 0.572 
 N 15 16 14 16 15 16 
 
 
Pearson correlations between the six components from the PCA analysis and four predictors/outcomes 
were performed using each HIV-1 status to explore the unique associations with the principal 
components in each subset.  Post-hoc analysis of the HIV-1[+]/Pf[+] group employing a leave-one-out 
method revealed IL-1β:IL-10 ratio was the most influential variable (12.52%) in the PCN/component 2 
correlation, and IL-12 was the most influential variable (30.61%) in the Hb/component 4 correlation.  The 
components contain the following effector molecules and inflammatory ratios: 1)  IL-6, IL-8/CXCL8, IL-15, 
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TNF-α, MIP-1β/CCL4, MCP-1/CCL2; 2)  IL-1β, IL-2, GM-CSF, IL-1β:IL-10, IL-1β:IL-1Ra, IL-2:IL-2R; 3)  IL-
1Ra, IL-7, IL-17, IFN-α, IFN-γ, MIG/CXCL9; 4)  IL-4, IL-5, IL-12, Eotaxin/CCL11; 5)  IP-10/CXCL10, IL-10, 
IL-10:TNF-α; 6)  IL-2R, IL-13, MIP-1α/CCL3, MIP-1α:MIP-1β. 
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5.0  CHAPTER FIVE:  RESULTS, SPECIFIC AIM 3 
 
 
 
To determine the cytokine milieu responsible for lower parasitemia without 
worsening anemia in malaria and bacteremia co-infected children. 
 
 
 
5.1  HYPOTHESIS 1, PRESENTATION OF MANUSCRIPT ENTITLED:  
PLASMODIUM FALCIPARUM AND BACTEREMIA CO-INFECTION IN KENYAN 
CHILDREN IS ASSOCIATED WITH DECREASED PARASITEMIA  IN THE 
ABSENCE OF WORSENING ANEMIA  
 
Hypothesis 1:  Blood borne bacterial infections elicit a unique profile of inflammatory 
mediators resulting in lower parasitemia levels without promoting enhanced anemia in 
co-infected children.   
 
To address this hypothesis, we grouped the HIV-1[-] children enrolled in the 
Severe Malarial Anemia study into three groups based on their bacteremia status on 
initial contact:  malaria infection only, Pf[+]; malaria and bacteremia with a G[+] 
organism (G[+]/Pf[+]); and malaria and bacteremia with a G[-] organism (G[-]/Pf[+]).  
Plasma from these children was assayed using a multiplex bead-array assay for 16 
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cytokines to determine the inflammatory mediator profile for each group.  Using a 
multiple mediation model, with infection status as the independent variable and 
parasitemia as the dependent variable, we identified the cytokines responsible for 
decreased parasitemia in the bacteremia co-infected children.  The results of these 
findings are presented in the following manuscript prepared for submission. 
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5.2  ABSTRACT 
 
 
Bacteremia is associated with malnutrition in resource-poor settings and has been 
shown to exacerbate malarial anemia.  We previously demonstrated that children co-
infected with malaria and bacteremia had significantly decreased parasitemia, but no 
exacerbation of anemia.  Our objective was to determine the inflammatory mediator 
profile associated with the reduced parasitemia in co-infected children.  P. falciparum-
infected children (n=192, aged <3yrs) were divided into three categories: malaria 
alone, Pf[+]; Gram negative bacteremia plus malaria, G[-]/Pf[+]; and Gram positive 
bacteremia plus malaria, G[+]/Pf[+].  Since a pro-inflammatory milieu is known to 
control parasitemia, but adversely affect erythropoiesis, circulating levels of 16 
inflammatory mediators were determined with a human bead-based Multiplex assay.  
Staphylococcus aureus and non-Typhi Salmonella were the two most frequently isolated 
G[+] and G[-] organisms, respectively.  Compared to the Pf[+] group, both co-infected 
groups had lower parasitemia and mean corpuscular hemoglobin concentration.  In 
addition, both co-infected groups had significantly increased IL-4, IL-5, IL-7, IL-12, IL-
15, IL-17, IFN-γ, IFN-α, and decreased TNF-α levels relative to the Pf[+] group.  
Additional significant findings included higher IL-1β, IL-1Ra, and lower IL-10 in the G[-
]/Pf[+] versus the Pf[+] group.  The G[-]/Pf[+] group also had significantly higher 
levels of WBC, granulocytes, and IFN-γ than the G[+]/Pf[+] group.  A multiple 
mediation model examining the molecules responsible for decreased parasitemia in the 
bacteremia co-infected groups, but not the malaria-only group, identified IL-4, IL-10, IL-
12, and IFN-γ as the key molecules in decreasing parasitemia while not exacerbating 
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anemia.  Enhanced immune activation in co-infected children appears to promote 
reduced parasitemia without adversely affecting anemia outcomes.  By comprehensively 
examining the inflammatory profile in malaria mono-infected and co-infected children 
we can begin to elucidate both common and unique inflammatory pathways responsible 
for differing clinical outcomes in children with malaria and bacteremia. 
 
 
 
5.3  INTRODUCTION 
 
 
Co-infection with bacteremia is a common cause of malaria severity in and mortality 
among children in sub-Saharan Africa (Berkley, Bejon et al. 2009).  Studies in malaria 
endemic settings have estimated 3.1 - 5.4% of children with malaria are co-infected 
with bacteremia resulting in 18 - 22% mortality (Brent, Ahmed et al. 2006; Bassat, 
Guinovart et al. 2009; Sigauque, Roca et al. 2009).   In western Kenya, an area of 
Plasmodium falciparum holendemic transmission, severe malaria is primarily 
characterized by severe malarial anemia (SMA, Hb <6.0g/dL) (McElroy, Lal et al. 1999).  
In this population, childhood anemia is exercabated by co-infection with bacteremia, 
human immunodeficiency virus (HIV)-1, hookworm, and high levels of malnutrition co-
endemic in this region (Brent, Ahmed et al. 2006; Ong'echa, Keller et al. 2006; Otieno, 
Ouma et al. 2006; Berkley, Bejon et al. 2009; Sigauque, Roca et al. 2009; Davenport, 
Ouma et al. 2010).  
Bacteremia is an important co-morbid factor in P. falciparum malaria and is 
associated with severe life-threatening manifestations such as SMA, cerebral malaria, 
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respiratory distress, and hepatosplenomegaly (Bassat, Guinovart et al. 2009).  In 
addition, bacteremia is involved in increasing the mortality rates associated with these 
syndromes (Berkley, Bejon et al. 2009).  Gram negative (G[-]) bacteremia caused by 
non-Typhi Salmonella (NTS) is the most common and important cause of severe 
syndromes and mortality in malaria and bacteremia co-infected children (Rabsch, 
Tschape et al. 2001; Morpeth, Ramadhani et al. 2009; Roux, Butler et al. 2010).  A 
number of studies from across Africa demonstrated that SMA, cerebral malaria, 
respiratory distress, and malnutriution are associated with increased prevalence of NTS 
bacteremia in children with malaria (Friedland 1992; Walsh, Phiri et al. 2000; Bahwere, 
Levy et al. 2001; Bwibo and Neumann 2003; Berkley, Lowe et al. 2005; Sigauque, Roca 
et al. 2009).  Our recent studies showed an 11.7% prevalence of bacteremia in P. 
falciparum-infected children, with NTS (42.4%) and Staphylococcus aureus (35.6%) 
being the predominant G[-] and Gram positive (G[+]) isolates, respectively (Were et al., 
unpublished results).  Despite the apparent importance of bacteremia, little is known 
about the underlying pathophysiological mechanisms governing the interactions 
between bacteremia and malaria.  Accumulating evidence indicates that both diseases 
elicit potent type 1 inflammatory responses characterized by increased production of 
TNF-α, IL-1β, IL-6 cytokines that may lead to septic shock in the early stages of disease 
and suppression of erythropoiesis in the chronic stage (Suarez-Santamaria, Santolaria et 
al. ; Dahmer, Randolph et al. 2005; Bozza, Salluh et al. 2007).  Previous studies 
demonstrated that a successful type 1 response to malaria infection is characterized by 
controlled-release of interleukin (IL)-12, interferon (IFN)-γ and tumor necrosis factor 
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(TNF)-α, which aids in the control of parasitemia and preservation of erythropoiesis 
(Crutcher, Stevenson et al. 1995; Stevenson, Tam et al. 1995; Stevenson, Su et al. 
2001).  Subsequently, these responses are followed by a controlled type 2 cytokine 
response that abrogates the pro-inflammatory response and prevents inflammatory-
mediated damage to the human host (Clark, Budd et al. 2006).  Our previous studies, 
and those of others, demonstrated suppression of IL-12 through intra-leukocytic 
accumulation of hemozoin (PfHz) promotes elevated production of IL-10 in children with 
SMA (Kalyesubula, Musoke-Mudido et al. 1997; Aste-Amezaga, Ma et al. 1998; Casals-
Pascual, Kai et al. 2006; Keller, Yamo et al. 2006).  In addition, elevated circulating 
levels of TNF-α, IL-1β, and IL-6 are associated with severe malaria (Grau, Taylor et al. 
1989; Kwiatkowski, Hill et al. 1990; Kurtzhals, Adabayeri et al. 1998).   The host 
immune response to bacteremia is characterized by an early secretion of IL-1, IL-6, IL-8, 
IL-10, and TNF-α (Pinsky, Vincent et al. 1993; Blackwell and Christman 1996; Bertero 
and Caligaris-Cappio 1997).  Previous studies showed that elevated production of IL-6 
occurs within three hours of lipopolysaccharide (LPS) injection in humans volunteers 
(Bertero and Caligaris-Cappio 1997).  In addition, peak elevations of IFN-γ and TNF-α 
are present at 1.5 hours, IL-10 at 2 hours, and peak IL-6 at 4 hours (Bertero and 
Caligaris-Cappio 1997).  Thus, both severe malaria and bacteremia are diseases that 
result from the inappropriate timing and magnitude of cytokine responses.   
Many cytokines and effector molecules are known to be instrumental in inhibiting 
parasite growth.  Unfortunately, these same molecules can have detrimental effects on 
erythropoiesis.  The findings in this research study are unique in that reduced 
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parasitemia is observed with no significant effect on hemoglobin (Hb) levels, and in the 
absence of appreciable increases in body temperature.  The primary goal of this study 
was to determine the inflammatory milieu responsible for a lower parasitic burden in co-
infected children, without resulting in worsening anemia. 
 
 
 
5.4  METHODS 
 
 
5.4.1  Study participants 
 
 
Children aged 3-36 months (n=192) with P. falciparum parasitemia (any density) were 
recruited at Siaya District Hospital, western Kenya, during their first hospital contact for 
malaria, and matched for age and gender.  Siaya District is a holoendemic P. falciparum 
transmission area where residents receive up to 300 infective bites per annum (Beier, 
Oster et al. 1994).  None of the children had cerebral malaria or non-falciparum malarial 
infections.  A detailed description of the study area and population can be found in our 
recent publication (Ong'echa, Keller et al. 2006).  
Children with malaria were divided into three groups: malaria only (Parasitemic, 
Pf[+], n=156); co-infected with Gram negative bacteremia (G[-]/Pf[+], n=22); and co-
infected with Gram positive bacteremia (G[+]/Pf[+], n=14).  In addition, a healthy 
control group (n=14) composed of afebrile, uninfected children with Hb >11.0g/dL 
were enrolled during routine immunization visits.  All children were tested for antibody 
and viral evidence of HIV-1 exposure and infection using two rapid serological assays 
and pro-viral HIV DNA PCR, respectively.  HIV-1 serological status was determined using 
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two rapid antibody tests (i.e., Uni-Gold™, Trinity Biotech; and Determine®, Abbott 
Laboratories), while HIV-1 positivity was determined by HIV-1 DNA PCR analysis 
according to our previously published methods (Davenport, Ouma et al. 2010).  All 
children with positive HIV-1 serology or HIV-1 viremia were excluded from the study, 
since our previous investigation demonstrated significant inflammatory mediator 
perturbations in children exposed or infected with HIV-1 (Davenport et al.; in 
preparation).  Pre- and post-test HIV counseling were provided for the 
parents/guardians of all participants. 
Children were also stratified into SMA (Hb <6.0g/dL and <5.0g/dL) and non-SMA 
(Hb 6.0–10.9g/dL and free from the symptoms of severe malaria, such as 
hypoglycemia).  Definitions of malarial anemia were based on previous longitudinal Hb 
measures (>14,000) in children (<48 months of age) living in western Kenya (McElroy, 
Lal et al. 1999) (Hb <6.0g/dL), and the World Health Organization definition of SMA 
(Hb <5.0g/dL) (WHO 2000).  Children were treated according to Ministry of Health, 
Kenya, guidelines which included the use of Coartem® (artemether/lumefantrin) for 
uncomplicated malaria, quinine for severe malaria, and broad spectrum antibiotics such 
as trimethoprim/sulfamethoxazole for bacterial infections.  Written informed consent 
was obtained from the participants’ parents/guardians before enrollment.  Approval for 
the study was granted by the University of Pittsburgh, University of New Mexico, and 
the Kenya Medical Research Institute (KEMRI). 
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5.4.2  Blood culture 
 
   
Blood culture was performed upon enrollment and during acute visits whenever a child 
showed signs of sepsis.  The phlebotomy site and Wampole Isostat® Pediatric 1.5 tube 
stopper were cleaned with 70% ethanol prior to venipuncture.  The blood was 
processed according to the manufacturer’s instructions and plated on standard 
microbiological media.  Briefly, the entire Isostat supernatant was plated on Chocolate 
Agar and incubated for 18-24 hrs and then inspected for growth.  Unique colonies were 
sub-cultured to standard microbiological media (Chocolate Agar, MacConkey’s Agar, 
Mannitol Salt Agar, and Blood Agar) and incubated for 18-24 hrs in a 35°C CO2 
incubator.  If no growth was detected after the initial incubation, an additional 
incubation period of four days was performed with daily inspection for growth.  Unique 
colonies from sub-culture were identified using standard microbiological and 
biochemical techniques (i.e., Gram stain, colony characteristics, API biochemical panels, 
and agglutination tests).  Specifically, G[-] isolates were identified using API® 20E for 
oxidase negative Enterobacteriaceae, or 20NE for oxidase positive organisms 
(bioMerieux, Inc.), while G[+] organisms were identified using various biochemical 
techniques (i.e. catalase, hemolysis patterns, serological grouping, and coagulase test).  
Gram positive bacilli and coagulase-negative Staphylococcus were considered 
laboratory/skin contaminants and were not included in analyses. 
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5.4.3  Laboratory measurements 
 
 
Asexual malaria trophozoites (Were, Hittner et al. 2006) and the number of pigment-
containing monocytes (PCM) and pigment-containing neutrophils (PCN) were 
determined according to previous methods (Nguyen, Day et al. 1995; Lyke, Diallo et al. 
2003).  Complete blood counts were performed with a Beckman Coulter© Ac-T diff2™ 
(Beckman Coulter, Inc.) on blood obtained prior to administration of antimalarials 
and/or antipyretics.  The reticulocyte count, absolute reticulocyte number (ARN), 
reticulocyte production index (RPI) were determined per our previous methods (Were, 
Hittner et al. 2006).  Glucose-6-phosphate dehydrogenase (G6PD) deficiency was 
assessed using the G6PDH Screening Kit (Trinity Biotech, PLC) according to the 
manufacturer’s instructions.  The presence of Hb variants in sample hemolysates was 
detected using a Hb electrophoresis kit, which allowed for detection of HbS, HbC, HbF, 
and HbA, in either the heterozygous or homozygous states (Helena laboratories). 
 
5.4.4 Multiplex assay 
 
 
Venous blood samples were centrifuged and plasma was separated immediately, 
aliquoted, and stored at -70°C until used for inflammatory mediator measurements.  
Samples were thawed and clarified by centrifugation (14,000 rpm for 10 min) before 
assaying. Inflammatory mediator levels were determined by the Cytokine 25-plex 
Antibody Bead Kit, Human (BioSource™ International) according to the manufacturer’s 
instructions.  Plates were read on a Luminex 100™ system (Luminex Corporation) and 
analyzed using the Bio-plex manager software (Bio-Rad Laboratories).  Analyte 
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detection limits were: 3 pg/mL (IL-5, IL-6); 5 pg/mL (IL-1Ra, IL-3, IL-4, IL-10, IFN-γ); 6 
pg/mL (IL-2); 10 pg/mL (IL-7, IL-13, IL-15, IL-17, TNF-α); and 15 pg/mL (IL-1β, IL-
12p40/p70, GM-CSF, IFN-α). 
 
5.4.5  Statistical analyses 
 
 
Data were analyzed using SPSS (version 15.0).  Clinical, demographic, hematological, 
and immunological measures were compared across groups by either analysis of 
variance (ANOVA) or Kruskal-Wallis tests, followed by pair-wise post-hoc comparison 
with student’s t-test or Mann-Whitney U test, respectively.  Pearson’s chi square (χ2) or 
Fisher exact test were used for proportion comparisons.  In the event that the cell sum 
of categorical analyses was less than 20, as in the mortality data, pair-wise contrasts 
were employed to determine significance.  Statistical significance was set at P≤0.05. 
 A multiple mediation model was performed to determine the inflammatory 
mediators (IMs) responsible for decreased parasitemia in co-infected children.  The 
SPSS macro set (indirect.sps) and details for its use are located on the following website 
http://www.comm.ohio-state.edu/ahayes/SPSS%20programs/indirect.htm (Preacher 
and Hayes 2008). 
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5.5  RESULTS 
 
 
5.5.1  Distribution of bacterial isolates 
 
 
The two predominant blood culture isolates were Staphylococcus aureus (36.1%) and 
Salmonella enterica ssp. enterica ser. Typhimurium (44.4%), while NTS comprised 
52.8% of the overall isolates (Table 8).  Children selected for this study were free of 
other co-infections (i.e., HIV-1 and hookworm) and had the following bacterial isolate 
distribution:  61.2% G[-] (Acinetobacter sp., Escherichia coli, Pseudomonas aeruginosa, 
Salmonella enterica  ssp. enterica ser. Arizonae, S. enterica ssp. enterica ser. Enteritidis, 
S. enterica ssp. enterica ser. Typhimurium) and 38.9% G[+] (Enterococcus sp. and S. 
aureus) organisms. 
 
5.5.2  Demographic, clinical, and hematologic characteristics 
 
 
Children with falciparum malaria were stratified into three categories: malaria alone 
(Parasitemic, Pf[+], n=156); G[-]/Pf[+] co-infected (n=22); and G[+]/Pf[+] co-infected 
(n=14) (Table 9).  A healthy control group was also included for comparison (n=14), 
but were not included in the omnibus statistical comparisons due to their ability to skew 
the results.  Study participant demographics and clinical characteristics are listed in 
Table 2.  The two co-infected groups had 38.5% and 28.6% more females than males 
for the G[-]/Pf[+] and G[+]/Pf[+] groups, respectively, while age, axillary temperature, 
and glucose were comparable across the groups.  Hematologically, there were 
significant inter-group differences in white blood cell counts (WBC, P=0.047), absolute 
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granulocyte counts (P=0.010), and mean corpuscular hemoglobin concentrations 
(MCHC, P=0.003, Table 9).  Post-hoc testing revealed that, relative to the parasitemic 
and G[-]/Pf[+] groups, the G[+]/Pf[+] group had lower WBC counts (P=0.022 and 
P=0.026, respectively) and granulocyte counts (P=0.003 and P=0.007, respectively), 
while the MCHC of both the G[-]/Pf[+] and G[+]/Pf[+] groups (P=0.008 and P=0.016, 
respectively) were lower than those of the parasitemic group.  In addition, the red cell 
distribution width (RDW) approached statistical significance with higher values in the 
co-infected children, potentially indicating that they are either recovering from greater 
anemia, or they have a more robust erythropoietic response (P=0.053).  Finally, while 
there were no fatalities in the G[+]/Pf[+] group, the greatest percentage of mortality 
was observed in the G[-]/Pf[+] children.  Pair-wise contrasts revealed a significant 
difference in mortality between the Pf[+] and G[+]/Pf[+] groups (P=0.013, Table 9).  
Although previous reports have suggested an association between G6PD deficiency and 
altered cytokine expression (Wilmanski, Villanueva et al. 2007), as well as increased 
susceptibility to bacteremia in those carrying sickle cell alleles (Williams, Uyoga et al. 
2009), no significant differences were found between the three parasitemic groups for 
either G6PD deficiency (χ2=2.505, P=0.644) or sickle cell trait/disease (χ2=0.158, 
P=0.924). 
 
5.5.3 Parasitologic indices 
 
 
Across-group comparison of the three parasitemic groups showed a significant 
difference in parasitemia densities (P=0.001, Figure 3A).  Pair-wise comparison revealed 
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that children with G[-]/Pf[+] co-infections (6,461 malaria parasites [MPS]/µL), but not 
G[+]/Pf[+] co-infected children (8,704 MPS/µL, P=0.217), had lower parasite densities 
relative to Pf[+] group (25,619 MPS/µL, P<0.001, Figure 3A).  In addition, the 
geometric mean parasitemia was greater in children with malaria alone relative to those 
with G[-]/Pf[+] co-infection (P=0.001, Figure 3B).  Similarly, the Pf[+] group had a 
much greater percentage (72.4%) of children with high-density parasitemia (HDP, 
>10,000 parasites/µL, P=0.002 inter-group), compared to the G[-]/Pf[+] (40.9%, 
P=0.004) and G[+]/Pf[+] (42.9%, P=0.031) groups (Figure 3C). 
 
5.5.4  Erythropoietic indices and intraleukocytic hemozoin 
 
 
Our previous studies and those of others (Schellenberg, Menendez et al. 1999; Keller, 
Yamo et al. 2006; Ong'echa, Keller et al. 2006; Awandare, Ouma et al. 2007; Dondorp, 
Lee et al. 2008; Davenport, Ouma et al. 2010), showed that susceptibility to SMA is 
independent of the degree of parasitemia in holoendemic P. falciparum transmission 
regions.  While there was reduced parasitemia in the bacteremic children, the 
percentage of children with SMA remained equivocal between the three groups, 
regardless of the appropriate regional standard (i.e., Hb <6.0g/dL, P=0.628, Table 3) 
(McElroy, Lal et al. 1999) or the WHO standard (Hb <5.0g/dL, P=0.562) (WHO 2000).  
Moreover, there were no significant differences in the reticulocyte production index 
(RPI, P=0.837, Table 10), or the percentage of children with an RPI <2 (P=0.453), 
which is a metric for an appropriate erythropoietic response for the degree of anemia.  
Although there were prominent differences in parasitemia levels and HDP between the 
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Pf[+] mono-infected and co-infected groups, no difference in the percent of children 
with pigment deposition, which has been correlated with disease severity (Nguyen, Day 
et al. 1995; Amodu, Adeyemo et al. 1998; Luty, Perkins et al. 2000; Davenport, Ouma 
et al. 2010), was seen across the groups for either PCM (P=0.957, Table 10) or PCN 
(P=0.455). 
 
5.5.5  Pro-inflammatory cytokine production 
 
 
Since IM dysregulation is an integral part of both malaria and bacteremia pathogenesis 
and associated sequelae (Clark and Chaudhri 1988; Ratajczak and Ratajczak 1994; 
Lyke, Burges et al. 2004; Ulloa and Tracey 2005; Awandare, Goka et al. 2006; Thawani, 
Tam et al. 2006; Bozza, Salluh et al. 2007; Ong'echa, Remo et al. 2007), circulating 
levels of cytokines were determined with a 25-plex bead array assay.  Moreover, 
cytokine dysregulation is central to the pathological processes of SMA, cerebral malaria, 
and sepsis [reviewed in (Clark, Alleva et al. 2008)].  We (Perkins, Weinberg et al. 2000; 
Keller, Davenport et al. 2006; Keller, Yamo et al. 2006; Ong'echa, Remo et al. 2007) and 
others (Luty, Perkins et al. 2000; Lyke, Burges et al. 2004) have demonstrated that 
childhood malaria and the subsequent process of anemia is influenced by dysregulation 
of pro- and anti-inflammatory cytokines.  However, the circulating inflammatory 
mediator profile in malaria and bacteremia co-infected children has yet to be 
characterized.  Measurement of circulating inflammatory mediators reveled that IL-1β 
and its receptor antagonist (IL-1Ra) were significantly different across groups (P=0.027 
and P=0.005, respectively).  Pair-wise analysis showed elevated levels of IL-1β and IL-
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1Ra in children with G[-]/Pf[+] co-infection (Figure 4A, P=0.009 and Figure 4B, 
P=0.001, respectively) compared to the Pf[+]-only group.  However, the ratio for these 
inflammatory mediators (IL-1:IL-1Ra, P=0.854, Figure 4C), and that of IL-2 (P=0.068, 
Figure 4D) and the IL-2:IL-2R ratio (Figure 4E, P=0.226), showed no significant 
differences across the three groups.  The highest levels of IL-6 were also seen in the 
G[-]/Pf[+] co-infected children, which parallels the pattern of axillary temperature (see 
Table 9).  However, the difference in IL-6 levels across the groups was not significant 
(P=0.115, Figure 3F).  IL-12 has been reported to be a key molecule in the appropriate 
response and recovery from malaria (Luty, Perkins et al. 2000; Perkins, Weinberg et al. 
2000; Malaguarnera, Pignatelli et al. 2002).  There was a significant difference in IL-12 
across the groups (P<0.001, Figure 5A).  The highest IL-12 concentrations were found 
in the G[-]/Pf[+]  co-infected group (P<0.001 vs. Pf[+]), followed by the G[+]/Pf[+] 
co-infected group (P=0.034 vs. Pf[+]), and lowest in the Pf[+] group.  The healthy 
control group also had greater IL-12 values than the Pf[+] children (P=0.036).  An 
identical pattern and magnitude was observed in IL-15 levels (across-group P<0.001, 
Figure 5B), with the G[-]/Pf[+]  and G[+]/Pf[+]  groups both having higher levels than 
the Pf[+] children (P<0.001 and P<0.001, respectively), as well as the healthy controls 
(P<0.001 and P=0.002, respectively).  There were similar levels of IL-17 (inter-group 
P=0.002, Figure 5C) in the healthy controls, G[-]/Pf[+] co-infected, and G[+]/Pf[+] co-
infected groups, compared to the significantly lower levels observed in the Pf[+] group 
(P=0.018, P=0.016, and P=0.003, respectively).  IFN-γ levels (across-group P<0.001, 
Figure 5D) mimicked the patterns seen in IL-12 and IL-15, with the G[-]/Pf[+] group 
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having the highest levels, relative to the moderate levels in the G[+]/Pf[+] group 
(P=0.006), and negligible levels in the Pf[+] children (P<0.001) and healthy controls 
(P=0.023).  The G[+]/Pf[+] co-infected group also has higher levels of IFN-γ relative to 
the malaria-only group (P=0.008).  Unexpectedly, TNF-α levels (inter-group P=0.003, 
Figure 5E) were highest in the healthy control group, followed by the Pf[+] children and 
the two co-infected groups, while the G[-]/Pf[+] (P=0.030) and G[+]/Pf[+] (P=0.004) 
co-infected groups’ TNF-α concentrations were significantly lower than the Pf[+] group.  
The Pf[+] group had significantly depressed levels of IFN-α (P<0.001 inter-group, 
Figure 5F) compared to the G[-]/Pf[+] (P<0.001) and G[+]/Pf[+] (P<0.001) co-infected 
groups (Figure 5F).  Thus, while the co-infected children have higher pro-inflammatory 
cytokine levels, these levels do not appear to contribute to exacerbating SMA, but may 
assist in controlling parasitemia. 
 
5.5.6  Anti-inflammatory cytokine production 
 
 
The anti-inflammatory cytokines, particularly IL-10, are known to play a key role in 
abrogating a robust initial pro-inflammatory response to malaria, as well as recovery 
from anemia (Couper, Blount et al. 2008; Scholzen, Mittag et al. 2009).  However, we 
have previously shown that phagocytized PfHz promotes over-production of IL-10, 
which in turn suppresses IL-12, thereby exacerbating anemia and slowing parasite 
clearance (Keller, Yamo et al. 2006).  Upon examination of the anti-inflammatory 
cytokines, we observed similar patterns to those seen in the pro-inflammatory 
molecules, with the co-infected children showing the greatest levels relative to the 
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mono-infected Pf[+] group, with a few important exceptions.  Circulating concentrations 
of IL-4, IL-5, and IL-7 differed across-groups (Kruskal-Wallis [K-W] P<0.001, Figure 6A) 
and were significantly elevated in the G[+]/Pf[+] and G[-]/Pf[+] co-infected children 
relative to children with malaria co-infection (P<0.01) and healthy controls (P<0.05), 
respectively.  Consistent with our previous findings, circulating IL-10 concentrations 
differed across the groups (K-W P=0.042, Figure 6D) and were higher in the Pf[+], G[-
]/Pf[+], and G[+]/Pf[+] groups relative to healthy controls (P<0.001, P=0.038, 
P=0.035, respectively).  However, the G[-]/Pf[+] group had lower levels compared to 
Pf[+] group (P=0.016).  Although no significant differences were noted in circulating IL-
13 levels across the three infected groups after exclusion of the healthy controls from 
the initial omnibus Kruskal-Wallis test (P=0.366), IL-13 levels were generally suppressed 
in the infected children compared to the healthy controls, with the lowest levels being 
found in the G[+]/Pf[+] group (Figure 6E).  Although the TNF-α:IL-10 ratio was not 
significantly different across the groups (P=0.329, Figure 6F), there was a general 
skewing towards a type 2 millieu in the infected children relative to the healthy controls.  
Overall, we noted a greater cytokine response in the co-infected children, with higher 
concentrations of both pro- and anti-inflammatory cytokines.  However, lower levels in a 
few key cytokines, such as TNF-α and IL-10, may be central to controlling parasitemia 
without exacerbating anemia. 
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5.5.7  Multiple mediation model 
 
 
Since the primary finding of this study was a decreased level of parasitemia in the 
absence of exacerbated anemia in the co-infected children, we determined the 
combination of IMs responsible for this outcome.  We first performed a Pearson 
correlation between the IMs and the dependent variable (i.e., parasitemia, Figure 7, P-
values right of IMs) to select variables with significant correlations for populating the 
indirect.sbs SPSS macro.  We also determined the correlation between the independent 
variable (Infection status: 0, Pf[+] only; 1, Bacteremia co-infected) and the IMs (Figure 
7, P-values left of IMs).  These analyses revealed that 13 of the IMs were correlated 
with the independent variable (i.e., infection status), with the following presented in 
order of strength of significance: IL-4; IL-5; IL-7; IL-15; IFN-α; IL-12; IFN-γ; IL-17; IL-
1Ra; TNF-α; IL-1β; IL-10; and IL-2.  Of these, only TNF-α and IL-10 had negative 
associations with infection status, while the others were positively associated with 
infection status, indicating that levels were greater in the bacteremia co-infected 
children than the Pf[+] mono-infected children.  The dependent variable, parasitemia, 
was correlated with the following IMs, in order of strength of association: IL-10; IL-12; 
TNF-α; IFN-γ; IL-1β; IL-6; IL-5; IL-2; IL-4; and IL-7.  Most of the IMs were negatively 
associated with parasitemia, except IL-10, TNF-α, and IL-6.  The multiple mediation 
model was processed with 10,000 bootstrap samples and yielded four significant IMs: 
IL-4; IL-10; IL-12; and IFN-γ (Figure 7, significant IMs, black text; non-significant IMs, 
white text).  The bootstrapped paired contrasts subsequently indicated that IL-4 had the 
strongest strength of association with infection status and parasitemia. 
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5.6  DISCUSSION 
 
 
We have characterized the inflammatory milieu in children mono-infected with malaria, 
or co-infected with either G[+] bacteremia or G[-] bacteremia and Pf[+] residing in a 
holoendemic P. falciparum region.  Following exclusion of HIV-1 seropositive and pro-
viral DNA positive children, G[-]/Pf[+] and G[+]/Pf[+] co-infected children presented 
with reduced parasitemia and similar hemoglobin levels.  Although most inflammatory 
molecules are associated with control of parasitemia and exacerbation of anemia in 
malaria, a multiple mediation model identified unique inflammatory mediators 
associated with decreased parasitemia in bacteremia co-infected children.       
 Consistent with previous studies (Graham, Molyneux et al. 2000; Morpeth, 
Ramadhani et al. 2009), NTS were the most prevalent bacterial isolates in Pf[+]-co-
infected children in the current study.  Although the risk factors for this phenomenon 
include increased malnutrition, malarial anemia, unclean food and water, HIV infection, 
contact with animals, age <3 years, excessive iron availability from hemolysis and 
anemia, and sickle cell allele carriage [reviewed in (Morpeth, Ramadhani et al. 2009)], 
co-existence of these factors in differing proportions appear the most plausible 
explanation of increased prevalence of NTS bacteremia in African children.  There was a 
notable absence of typical childhood pathogens such as S. pneumoniae and H. 
influenzae, which may be partially explained by the fact that the enrollment criteria 
excluded children who presented with symptoms indicative of respiratory tract 
infections, most of which result from infection with these pathogens.  In addition, the 
recent vaccination efforts in Kenya (HiB conjugate vaccination began in November 
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2001; pneumococcal vaccine expected in 2010), the fastidiousness of these organisms, 
and unprescribed antimicrobial treatment may lead to reduced pathogen recovery, 
particularly in individuals with low bioburdens.  Our results showing a higher rate of S. 
aureus are consistent with studies elsewhere in Africa (Sigauque, Roca et al. 2009).  
 Although gender did not differ in our clinical categories, prevalence of female 
gender was higher in both co-infected groups relative to the malaria-only group.  This 
observation may be related to the fact that the caregiver may view girls as less resilient 
and seek care earlier or more frequently than with co-infected males (Schlagenhauf, 
Chen et al. ; Lallement, Teyssier et al. 1986), or the result of more frequent urinary 
tract infections in females, which have been left untreated (Hoberman, Chao et al. 
1993).  We also noted fewer WBCs, specifically granulocytes, in the G[+]/Pf[+] co-
infected group relative to the Pf[+]-alone and G[-]/Pf[+] groups.  The decrease in 
leukocyte lineages in the infected children potentially indicate increased migration to 
lymphoid tissues and/or apoptosis, which are known to follow acute malaria in African 
children (Toure-Balde, Sarthou et al. 1996; Hviid, Kurtzhals et al. 1997).  As such, it will 
be important to explore the chemokine milieu in co-infected children and its association 
with the leukocytic indices.  Additional hematological findings presented here showing 
decreased MCHC in the co-infected children relative to the mono-infected children 
appear to indicate a microcytic hypochromic anemia.  Although Hb levels were similar 
across the groups and appear to suggest iron deficiency anemia based on the low 
MCHC, reduced Hb concentrations may also result from the increased levels of pro- 
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inflammatory cytokines, particularly in the co-infected groups (Anderson, Aronson et al. 
2000; Bwibo and Neumann 2003; Doherty 2007; Prentice, Ghattas et al. 2007).   
 In addition, our findings indicating lower parasite burdens in co-infected children 
in the absence of worsening anemia are similar to previous studies in Mozambique, 
showing lower parasite densities in the absence of changes in hematocrit in children 
with severe malaria and bacteremia (Bassat, Guinovart et al. 2009).  Consistent with 
lower parasite densities, co-infected children had almost half the prevalence of HDP as 
the mono-infected group, with the G[-]/Pf[+] co-infected children having had nearly 
five-fold lower median parasitemia. Moreover, parasite reduction in the G[+]/Pf[+] co-
infected children was approximately one-third of that observed in the mono-infected 
group, likely due to the superior inflammatogenic potential of lipopolysaccharide (LPS) 
versus the G[+] cell wall constituents previously demonstrated in in vitro experiments 
(Hessle, Andersson et al. 2005).  Though slightly elevated, changes in axillary 
temperature cannot explain the decreases in parasitemia observed in the G[-]/Pf[+] and 
G[+]/Pf[+] co-infected groups, suggesting mechanisms other than fever in controlling 
parasitemia. 
 Although our previous studies revealed intraleukocytic acquisition of PfHz 
contributes to suppression of erythropoiesis and dysregulation in the inflammatory 
milieu (Were, Hittner et al. 2006; Keller, Ouma et al. 2009; Ouma, Keller et al. 2010) 
PCM and PCN were not associated with co-infection status in the current study, 
suggesting that PfHz may not be involved in promoting IM production in bacteremic 
children exposed to holoendemic malaria.  Additional results presented here illustrating 
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similarities in Hb levels and prevalence of SMA and RPI between co-infected and mono-
infected children suggest that the cytokine profile may contribute to parasitemia control 
without impacting negatively on Hb and erythropoietic responses given the negative 
influence of type 1 cytokines on erythropoiesis (Bertero and Caligaris-Cappio 1997; 
Ershler 2003; Means 2004).    
 The inflammatory mediator profiles indicated there were elevated pro-
inflammatory cytokine levels, which decreased in magnitude from the G[-]/Pf[+] co-
infected group, to the G[+]/Pf[+] group, and finally, the malaria mono-infected group.  
This regressive inflammatory mediator profile paralleled the parasitemia pattern 
indicating the potential induction of anti-parasite inhibitory and elimination events.  This 
premise is supported by results showing elevations in IL-1β, IL-1Ra, IL-12, IL-15, IL-17, 
IFN-α, and IFN-γ in G[-]/Pf[+] co-infected children compared to malaria mono-infection.   
However, a net increase in IL-1β in G[-]/Pf[+] co-infected children appears to be 
counter-balanced by a similar increase in IL-1Ra, as evidenced by similarities in the IL-
1β:IL-1Ra ratio across the groups.  An increase in IL-12 in the co-infected groups and a 
decrease in malaria mono-infection is consistent with previous studies indicating 
suppression of IL-12 in children with malaria (Luty, Perkins et al. 2000; Perkins, 
Weinberg et al. 2000; Keller, Yamo et al. 2006).  The increase in IL-12 in the co-infected 
groups, in the absence of marked Hb reductions, may be associated with increased 
parasitemia control as previously shown in human and murine studies (Normaznah, 
Halim et al. 1999; Luty, Perkins et al. 2000; Perkins, Weinberg et al. 2000; Su and 
Stevenson 2002; Boutlis, Lagog et al. 2003).  The upregulation in IL-15 in co-infected 
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children compared to malaria mono-infection and healthy control may be related to the 
potent type 1 immune activities of IL-15, which include parasite and bacterial clearance, 
and induction of humoral responses (Hirose, Suzuki et al. 1998; Ing, Gros et al. 2005).  
However, previous studies demonstrating that IL-15 enhances the erythropoiesis-
stunting effect of IFN-γ (Zoumbos, Gascon et al. 1984; Means, Krantz et al. 1994; 
Mullarky, Szaba et al. 2007) may be related to increases in both cytokines in the current 
study for maintaining the balance involved in controlling anemia development.  
Although IL-15 is known to induce production of IL-17 from CD4+ T cells (Ziolkowska, 
Koc et al. 2000), plasma IL-17 was suppressed in malaria mono-infected children with 
similar levels in the other groups.  This finding is similar to previous studies in Indian 
malaria patients showing reduced plasma IL-17 in mild malaria relative to cerebral 
malaria and healthy controls (Jain, Armah et al. 2008).  Additional pro-inflammatory 
cytokine results showing elevated IFN-γ and IFN-α in co-infected children relative to the 
mono-infected and healthy controls is consistent with reduced parasite densities in 
these individuals.  This premise is supported by previous malaria studies demonstrating 
that IFN-γ mediates clearance of plasmodial parasites, while IFN-α may contribute to 
parasite clearance through induction of effector molecules such as nitric oxide (NO) 
(Kremsner, Winkler et al. 1996; Perkins, Kremsner et al. 1999).  In contrast, reduced 
TNF-α levels in the co-infected children relative to the malaria mono-infected children 
may be related to the counter-regulatory effects of IFN-γ-induced NO, which 
downregulates nitric oxide synthase (NOS)-inducing cytokines, such as TNF-α, through 
a feedback mechanism (Florquin, Amraoui et al. 1994).  Taken together, these results 
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indicate upregulation of pro-inflammatory cytokine production in co-infected children, 
with the exception of TNF-α, a cytokine that if overproduced may lead to increased 
malarial anemia through its ability to enhance both erythrophagocytosis and 
dyserythropoiesis (Clark and Chaudhri 1988).   
 The profile of anti-inflammatory cytokine response was similar to the pattern 
observed for the pro-inflammatory mediators.  Plasma IL-4, IL-5, and IL-7 levels were 
elevated in co-infected children, while IL-10 levels were reduced in co-infected children.  
Our findings of elevated IL-4 in co-infected children differs from  recent studies by 
Cabantous et al. (Cabantous, Poudiougou et al. 2009) in Malian children showing 
elevation of IL-4 in SMA compared to uncomplicated malaria.  While it appears that 
down-regulation of the type 1 immune response may have exacerbated malaria in the 
Malian children, elevated IL-4 levels in co-infected children points to counter-regulatory 
activity of IL-4 on the potentially-damaging type 1 response, as well as the synergistic 
effect of IL-4 on EPO and IL-12 (Peschel, Paul et al. 1987), and IL-6 (Rennick, Jackson 
et al. 1989; Dybedal, Larsen et al. 1995) in promoting erythropoiesis.  This hypothesis 
appears plausible since the type 1 response was too potent to be attenuated by IL-4.  
Elevated IL-7 levels in co-infected children may be related to its activity in supporting 
erythropoiesis (Aiello, Keller et al. 2007), and hence protecting against reductions in Hb 
levels in the markedly, potent pro-inflammatory environment observed in these children.  
Additional findings showing reduced IL-10 levels in co-infected children that were 
associated with increased parasitemia control parallels previous studies showing that 
the degree of parasitemia is closely correlated with the pattern of IL-10 production 
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(Jason, Archibald et al. 2001; Hugosson, Montgomery et al. 2004).  Our findings are 
also supported by previous studies showing that increased IL-10 secretion by CD4+ T-
cells inhibits parasite killing in malaria infection (Kobayashi, Morii et al. 1996; Couper, 
Blount et al. 2008).  In addition, our previous investigations and those of others 
demonstrated poor recovery from malarial anemia in children with elevated IL-10 levels 
(Ong'echa, Remo et al. 2007), largely through reduced IL-12 production (Mohan and 
Stevenson 1998; Keller, Yamo et al. 2006).   
 Multiple mediation modeling identified IL-4, IL-10, IL-12, and IFN-γ as the most 
prominent mediators that influenced parasitemia. In this analysis, IL-4 emerged as the 
most closely associated with both infection status and parasitemia.  In addition, Pearson 
correlations, used to load the mediation model, showed inverse associations between 
IL-4, IL-12, and IFN-γ, and parasitemia, and a positive correlation between IL-10 and 
parasitemia.  This finding suggests that a combination of type 1 and type 2 responses is 
required to control parasitemia.  Furthermore, the modeling revealed that there are the 
key differences in cytokine production that controls parasitemia in malaria mono-
infection versus co-infection, and that co-infection appears to promote an optimal 
response for controlling parasitemia with minimal impact on hemoglobin levels.    
 While it is not unexpected that the G[-]/Pf[+] co-infected children had the lowest 
parasitemia, given the potent immune response generated by LPS, it is interesting that 
these children did not have more anemia.  One possible explanation for this 
phenomenon would be the temporal effects of cytokine production.  For example, the 
pro-inflammatory cytokine response acts rapidly to control parasitemia, but requires a 
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sustained type 1 inflammatory environment response for an extended period to impact 
the erythropoietic pathway and thereby decrease the Hb.  In addition, absolute cytokine 
levels at any given point in time may not comprehensively represent the overall 
inflammatory response since the timing and magnitude of inflammatory mediators are 
critical in determining the outcome of infection.  Previous studies by Kobayashi et al. 
(Kobayashi, Ishida et al. 2000) support this notion by demonstrating that administration 
of IL-10 in a lethal P. yoelii infection promotes prolonged survival, but has no impact on 
parasitemia levels.  Moreover, IL-10 secretion too early in infection allows unfettered 
parasite replication, while a late IL-10 response may allow type 1 cytokines to have a 
detrimental effect on erythropoiesis by either delaying Hb recovery or leading to severe 
anemia and death.  Although results from the mediation model suggest that both type 1 
and 2 responses are important for controlling parasitemia, we postulate that the 
significant association with type 2 mediators (IL-4 and IL-10) may be critical for 
preserving erythropoiesis by attenuating the considerable type 1 environment elicited by 
co-infection. 
 Results presented here demonstrate the cytokine profile that predominates in 
malaria and bacteremic co-infected children living in a holoendemic P. falciparum 
transmission area.  In addition, we show the specific IMs that are responsible for 
improved control over malaria parasitemia without worsening anemia.  While there 
remains a rudimentary understanding of the cytokine pathways involved in control and  
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recovery from various infections, novel findings presented here suggest an important 
role for cytokines that were previously largely unexplored in human malaria, such as IL-
4. 
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5.8  TABLES AND FIGURES 
 
 
Table 8.  Bacterial isolate distribution.   
 
 
Organism Isolates Percent of Isolates 
Gram negative organisms 
Acinetobacter sp. 1 2.8 
Escherichia coli 1 2.8 
Pseudomonas aeruginosa 1 2.8 
Salmonella enterica ssp. arizonae 1 2.8 
Salmonella enterica ssp. enteritidis 2 5.6 
Salmonella enterica ssp. typhimurium 16 44.4 
Gram positive organisms 
Enterococcus sp. 1 2.8 
Staphylococcus aureus 13 36.1 
 
 
Organisms isolated from pediatric blood culture according to Gram reaction category that were included 
in these analyses.  Blood was drawn into pediatric Isostat tubes, plated onto Chocolate agar plates, and 
incubated for 18 hrs at 37°C with 5% CO2.  Subcultured colonies were incubated 18-24 hrs on inverted 
specialty media (Chocolate Agar, MacConkey’s Agar, Mannitol Salt Agar, and Blood Agar Plates).  Plates 
were incubated for an additional four days if no growth was obtained in the first 24 hrs.  Plates were 
inspected daily, and unique colonies identified through standard microbiological and biochemical 
techniques (i.e., Gram stain, colony characteristics, API biochemical panels, and agglutination tests). 
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Table 9.  Clinical, demographic, and hematological characteristics of the study participants.   
 
   
Characteristic  Healthy Controls Pf[+] G[-]/Pf[+] G[+]/Pf[+] P * 
Number of  subjects  14 156 22 14 N / A 
Age; months  7.07 (11.39) 9.08 (8.70) 7.38 (7.50) 12.11 (9.94) 0.161 
Gender; male/female  **  8/6 88/68 6/16 5/9 0.041 
Axillary temperature (°C)  36.4 (0.4) 37.5 (1.7) 38.0 (1.5) 37.1 (1.6) 0.141 
Glucose (mMol/L)  4.89 (0.59) 4.90 (1.48) 5.59 (1.70) 5.10 (4.94) 0.067 
WBC (x109/µL)  10.50 (3.95) 11.75 (6.95) 13.35 (9.15) 9.10 (4.60) 0.047 
Lymphocytes (x103/µL)  6.70 (2.05) 5.60 (3.87) 6.65 (4.20) 4.80 (4.95) 0.431 
Monocytes (x103/µL)  0.80 (0.55) 1.10 (0.90) 1.15 (0.67) 0.60 (0.90) 0.161 
Granulocytes (x103/μL)  3.10 (2.35) 4.75 (4.17) 4.75 (5.80) 2.60 (2.30) 0.010 
Hemoglobin (Hgb, g/dL)  11.7 (0.8) 5.9 (3.7) 5.8 (1.8) 6.0 (2.8) 0.594 
Hematocrit (Hct, %)  35.2 (1.9) 18.8 (11.7) 19.1 (4.7) 19.7 (7.4) 0.792 
RBC (x106/µL)  4.82 (0.31) 2.85 (1.90) 2.69 (1.27) 2.93 (1.09) 0.642 
MCHC (g/dL)  33.4 (0.9) 32.5 (2.5) 30.9 (4.2) 30.9 (2.8) 0.003 
RDW  16.4 (4.3) 21.2 (4.8) 22.4 (3.9) 22.7 (5.8) 0.053 
Platelets (x103/µL)  355 (219) 153 (111) 159 (107) 160 (98) 0.720 
Mortality; n (%)  ***  1 (7.1) 6 (3.8) 2 (9.1) 0 (0) 0.537 
 
 
HIV-1 negative children (aged <3 yrs) infected with P. falciparum malaria were divided into parasitemic (Pf[+]), G[-]/Pf[+] co-infected, 
and G[+]/Pf[+] bacteremia co-infected groups.  In addition, a cohort of afebrile healthy children without parasitemia and hemoglobin 
(Hb) >11.0g/dL were included as controls to detect depressed cytokine levels associated with infection.  WBC (white blood cells); RBC 
(red blood cells); MCHC (mean corpuscular hemoglobin concentration); RDW (red cell distribution width).  * Data are presented as 
median (interquartile range) and compared using the Kruskal-Wallis test unless stated otherwise.  ** Differences in categorical variables 
were compared using Pearson’s χ2 test.  *** Pair-wise contrasts among independent proportions were chosen as the statistical method to 
evaluate the categorical mortality data.  The P-value for a chi square test would be uninterprettable since the cell sum was less than 20.  
Complete blood counts were determined in venous blood using a Coulter® AcT diff2™ (Beckman Coulter Corp.). 
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Table 10.  Erythropoietic indices and intraleukocytic hemozoin.   
 
 
Attribute Pf[+] G[-]/Pf[+] G[+]/Pf[+] P  * 
Number of  subjects  153 22 14 N / A 
SMA, Hb <6.0g/dL; n (%) a  81 (52.9) 14 (63.6) 8 (57.1) 0.628 
SMA, Hb <5.0g/dL; n (%) a  42 (27.5) 6 (27.3) 2 (14.3) 0.562 
RPI; median (IQR) b  0.98 (1.44) 0.86 (1.00) 0.92 (2.57) 0.837 
RPI <2; n (%) a  36 (23.8) 3 (13.6) 4 (30.8) 0.453 
PCM; n (%) a  83 (53.2) 12 (54.5) 8 (57.1) 0.957 
PCN; n (%) a  22 (14.1) 1 (4.5) 2 (14.3) 0.455 
 
 
SMA (severe malarial anemia); RPI (reticulocyte production index); PCM (pigment-containing 
monocytes); PCN (pigment-containing neutrophils).  A total of 30 monocytes and 100 neutrophils 
were examined per slide, and the number of PCN and PCM were expressed as a percentage of the 
total number of neutrophils and monocytes, respectively.  a Differences in categorical variables 
were compared using Pearson’s χ2 test.  b Data are presented as median (interquartile range) and 
differences between the three groups were compared using Kruskal-Wallis test. 
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Figure 3.  Parasitologic indices.  Data are presented as box plots with whiskers and outliers.  The box represents the interquartile range, 
while the whiskers represent the 10th and 90th percentiles.  The line across the box indicates the median value, open circles (°) represent 
extremes, and asterisks (*) depict outliers.  Differences between groups were determined using Mann-Whitney U test. (A)  MPS [Malaria 
Parasites] (Kruskal-Wallis test P=0.001).  (B)  Geometric Mean parasitemia (ANOVA P=0.011).  (C)  Proportion of High Density Parasitemia (%) 
(Kruskal-Wallis test P=0.002). 
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Figure 4.  Pro-inflammatory mediator profiles. Data are presented as box plots with whiskers and outliers.  The box represents the 
interquartile range, while the whiskers represent the 10th and 90th percentiles.  The line across the box indicates the median value, open circles 
(°) represent extremes, and asterisks (*) depict outliers.  Pair wise comparisons between groups were conducted with Mann-Whitney U test.  All 
units are in pg/mL.  (A)  IL-1β (Kruskal-Wallis test P=0.027).  (B)  IL-1Ra (Kruskal-Wallis test P=0.005).  (C)  IL-1 Ratio (Kruskal-Wallis test 
P=0.854).  (D)  IL-2 (Kruskal-Wallis test P=0.068).  (E)  IL-2 Ratio (Kruskal-Wallis test P=0.575).  (F)  IL-6 (Kruskal-Wallis test P=0.115). 
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Figure 5.  Pro-inflammatory mediator profiles. Data are presented as box plots with whiskers and outliers.  The box represents the 
interquartile range, while the whiskers represent the 10th and 90th percentiles.  The line across the box indicates the median value, open circles 
(°) represent extremes, and asterisks (*) depict outliers.  Pair wise comparisons between groups were conducted with Mann-Whitney U test.  All 
units are in pg/mL.  (A)  IL-12 (Kruskal-Wallis test P<0.001).  (B)  IL-15 (Kruskal-Wallis test P<0.001).  (C)  IL-17 (Kruskal-Wallis test P=0.002).  
(D)  IFN-γ (Kruskal-Wallis test P<0.001).  (E)  TNF-α (Kruskal-Wallis test P=0.003).  (F)  IFN-α (Kruskal-Wallis test P<0.001). 
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Figure 6.  Anti-inflammatory mediator profiles. Data are presented as box plots with whiskers and outliers.  The box represents the 
interquartile range, while the whiskers represent the 10th and 90th percentiles.  The line across the box indicates the median value, open circles 
(°) represent extremes, and asterisks (*) depict outliers.  Pair wise comparisons between groups were conducted with Mann-Whitney U test.  All 
units are in pg/mL.  (A)  IL-4 (Kruskal-Wallis test P<0.001).  (B)  IL-5 (Kruskal-Wallis test P<0.001).  (C)  IL-7 (Kruskal-Wallis test P<0.001).  (D)  
IL-10 (Kruskal-Wallis test P=0.042).  (E)  IL-13 (Kruskal-Wallis test P=0.366).  (F)  TNF-α:IL-10 ratio (Kruskal-Wallis test P=0.329). 
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Figure 7.  Multiple mediation model.  Inflammatory mediators were correlated with the independent 
variable (Infection Status, P-values to left of mediators) and Parasitemia (P-values to the right of 
mediators) individually, and those with significant correlations with the dependent variable (Parasitemia) 
were used to populate the multiple mediation model.  All nonparametric variables were log transformed.  
“Infection Status” was dummy coded as follows:  0, Pf[+] mono-infected; 1, bacteremia co-infected.  The 
multiple mediation model was populated with 10 inflammatory mediators that showed significant 
correlation with Parasitemia, with age used as a covariate, and processed using 10,000 bootstrap 
samples.  Post-hoc pair wise contrasts for the four significant mediators (black type; IL-4, IL-10, IL-12, 
IFN-γ) were evaluated by examining the bootstrapped confidence intervals, with those intervals not 
including zero being significant. 
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6.0  DISCUSSION 
 
 
Children residing in holoendemic regions of sub-Saharan Africa endure a near-constant 
assault from P. falciparum-infected mosquitoes.  Mosquito net use for children is 
sporadic at best, especially in the poorer, rural regions of western Kenya.  The result of 
these chronic bites from infected Anopheles mosquitoes is repeated infection 
throughout childhood.  For those fortunate enough to emerge from their early childhood 
alive and without permanent sequelae, they enjoy life-long protection from severe 
disease as long as they continue to inhabit that region.  Unfortunately, the majority of 
children endure at least transient anemia from their chronic infections, and many 
develop severe disease in the form of SMA, which carries a substantial risk of death.  
While CM carries a significantly higher mortality rate, and spans more years at risk, SMA 
affects far more children, resulting in many more hospital visits and significantly greater 
childhood mortality.  If malaria was the only serious risk in these P. falciparum regions it 
would garner significant attention due to the sheer numbers of people affected; 
however, these same regions have been impacted the greatest by the HIV epidemic as 
well.  In addition, whether it be due to a genetic predisposition or lack of clean water 
and food supplies, invasive Salmonellosis, as well as other bacterial pathogens, are 
more frequently isolated from the blood cultures of children residing in sub-Saharan 
Africa, particularly those regions hardest hit by malaria.  This body of work attempts to 
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elucidate the cytokine profiles associated with these infections and co-infections, as well 
as the predictors of anemia and hematologic outcomes resulting from these infections, 
on Kenyan children. 
 Initially, a small number of hastily assembled studies, which were poorly 
controlled and underpowered, failed to find an interaction between malaria and HIV-1 
(Nguyen-Dinh, Greenberg et al. 1987; Colebunders, Bahwe et al. 1990; Muller, Musoke 
et al. 1990; Greenberg, Nsa et al. 1991; Kalyesubula, Musoke-Mudido et al. 1997).  Now 
we know that HIV viral load increases substantially during malaria infection (Hoffman, 
Jere et al. 1999; Ma, Sun et al. 2000; Mwapasa, Rogerson et al. 2004; Kublin, Patnaik 
et al. 2005), as do malaria episodes (Whitworth, Morgan et al. 2000) and anemia (van 
Eijk, Ayisi et al. 2002; Grimwade, French et al. 2004; Cohen, Karstaedt et al. 2005) 
during HIV infection.  Since the primary manifestation of HIV-1 in children is anemia, it 
stands to reason that having two anemia-inducing infections will result in a net 
decrease in Hb greater than from either infection alone.  We have previously shown 
significantly more anemia in HIV-1[+] children co-infected with malaria (Otieno, Ouma 
et al. 2006).  Surprisingly, we also discovered significantly more anemia in antibody 
positive and virus negative children, i.e. HIV-1[exp], born to HIV-1[+] mothers (Otieno, 
Ouma et al. 2006; Davenport, Ouma et al. 2010).  This is a striking finding being that 
their only infection was malaria, suggesting that their exacerbated anemia may be the 
result of gestation in an HIV-1[+] mother.  We have also determined that this additional 
anemia is not the result of discrepancy in care, as the HIV-1[+]/Pf[+] and HIV-
1[exp]/Pf[+] children do not have more wasting or stunting that the HIV-1[-]/Pf[+] 
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children (Davenport et al., unpublished data).  Interestingly, the two major contributors 
to anemia in malaria, parasitemia and dyserythropoiesis, were not significantly different 
across the groups.  The caveat to this finding is that erythropoiesis should be 
proportional to the degree of anemia, so by the mere fact that the Hb values were 
different, the erythropoietic indices should differ as well.  As for parasitemia, both of the 
HIV-1[exp]/Pf[+] and HIV-1[+]/Pf[+] groups had lower parasitemia, presumably due to 
a more enhanced pro-inflammatory milieu, which may also explain the blunted 
erythropoietic response in the children with worsening anemia. 
 The primary finding of the first study in Aim 1 resulted from the hierarchical 
multiple regression model, which demonstrated that PCM, age, and HIV-1 status were 
the three significant predictors of Hb, in that order.  Pearson correlation indicated that 
Hb increased with age, while advancing HIV-1 status and increasing PfHz burdens were 
associated with lower Hb values.  When G6PD and sickle cell status were added to the 
model, which each showed interesting but non-significant trends across the three HIV-1 
categories, neither of these genetic traits were significant predictors of Hb.  In addition 
to the effect PfHz has on pro-inflammatory cytokine production (Sherry, Alava et al. 
1995; Jaramillo, Gowda et al. 2003; Keller, Davenport et al. 2006; Ong'echa, Remo et 
al. 2008), and hence, erythropoiesis (Mayani, Little et al. 1995; Tarumi, Sawada et al. 
1995; Cashman, Clark-Lewis et al. 1999; Dufour, Corcione et al. 2003), a recent report 
found a direct effect on erythropoietic precursors in the bone marrow (Lamikanra, 
Theron et al. 2009).  In addition to finding that PfHz directly induced caspases, and 
therefore apoptosis, in erythroid precursors without any inflammatory mediator input, 
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they also reported that macrophage phagocytosis of PfHz actually protected erythroid 
precursor cells from the harmful effect of PfHz (Lamikanra, Theron et al. 2009). 
 We followed up this initial determination of severe anemia predictors in malaria 
and HIV-1 co-infected children by analyzing the circulating inflammatory mediators in 
the same groups.  As we observed in the first aim, both the HIV-1[exp]/Pf[+] and HIV-
1[+]/Pf[+] co-infected groups had more profound anemia than the HIV-1[-]/Pf[+] 
children.  The across-group comparisons of the inflammatory mediators revealed that 
IL-12 and IFN-γ were increased in the HIV-1[exp]/Pf[+] and HIV-1[+]/Pf[+] groups.  
This finding was unexpected since IL-12 has been found to support erythropoiesis 
(Bellone, Ostlie et al. 1993; Jacobsen, Veiby et al. 1996) and low levels of this important 
cytokine has been implicated in children suffering from severe anemia (Aste-Amezaga, 
Ma et al. 1998; Luty, Perkins et al. 2000; Perkins, Weinberg et al. 2000; Casals-Pascual, 
Kai et al. 2006; Keller, Yamo et al. 2006).  Given that HIV-1 infection is known to cause 
immune activation resulting in a pro-inflamamtory environment [reviewed in (Ford, 
Puronen et al. 2009)], it is not surprising that this type 1 cytokine is elevated.  Similarly, 
elevation of IFN-γ, as we observed here, would be expected in an immune activation 
scenario, but unlike IL-12, has been directly implicated in causing impaired 
erythropoiesis through an IL-15 mechanism (Mullarky, Szaba et al. 2007).  GM-CSF was 
also substantially increased in the the HIV-1[exp]/Pf[+] and HIV-1[+]/Pf[+] co-infected 
groups, which, like IL-12, should support erythropoiesis (Liehl, Hildebrandt et al. 1994) 
as well as parasite clearance in concert with TNF-α (Kumaratilake, Ferrante et al. 1996).  
Interestingly, IL-12 was also identified as the most influential molecule in component 4, 
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which was the only component significantly and positively associated with Hb.  Given 
the elevated levels of IFN-γ, IL-12 may be driving production of this erythropoiesis-
inhibiting cytokine, and may be an exacerbation of the immune activation syndrome 
known to be elicited by HIV-1 (Martinez-Maza, Crabb et al. 1987; Ascher and Sheppard 
1988; Ascher and Sheppard 1990; Sheppard, Ascher et al. 1991; Hazenberg, Otto et al. 
2003).  These findings highlight that malaria, and other cytokine-mediated diseases, are 
not necessarily the result of the particular inflammatory mediators produced, but rather 
the timing and concentration of these cytokines.  While IFN-γ, and, more importantly, 
IL-12 and GM-CSF would be expected to be a positive response to these two infections, 
and resulted in lower parasitemia levels in the HIV-1[+]/Pf[+] co-infected children, it 
appears their high concentrations have deleterious effects on the erythropoietic 
response to the degree of anemia.  Moreover, given what is known about these 
significant cytokines and growth factors, one would expect a positive hematologic and 
parasitologic outcome in the HIV-1[+]/Pf[+] children, but the worsening anemia in this 
group indicates that soluble mediators alone, or the mediators measured in this study, 
cannot account for the effect on erythropoiesis or RBC destruction and sequestration. 
 In the final aim, we investigated HIV-1[-] children to determine the effect of 
malaria and bacteremia co-infection on the inflammatory milieu.  Interestingly, and 
unexpectedly, we found that co-infected children did not have more severe anemia, 
even though parasitemia levels and proportion of children with HDP were significantly 
lower.  Beyond these two striking findings, the three groups of children were nearly 
identical from a clinical and hematologic standpoint, including their erythropoietic 
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indices and numbers of pigment-containing leukocytes.  From an immunologic 
perspective, the malaria and bacteremia co-infected children had higher levels of IMs 
compared to children with malaria-alone and healthy controls.  Specifically, there were 
higher levels of the pro-inflammatory cytokines IL-12, IL-15, IL-17, IFN-γ, and IFN-α in 
the bacteremic children.  As we noted in the previous study, IL-12 alone is not capable 
of rescuing falling Hb concentrations, perhaps due to increased production of IFN-γ, IL-
15, and IFN-α are known to directly inhibit erythropoiesis (Roodman, Bird et al. 1987; 
Fandrey and Jelkmann 1991; Means, Dessypris et al. 1992; Shami and Weinberg 1996; 
Zhu, Ye et al. 2000; Mullarky, Szaba et al. 2007).  Similar elevations were noted in the 
anti-inflammatory molecules as well, with IL-4, IL-5, and IL-7 showing significantly 
greater concentrations in the bacteremia co-infected children, while IL-10 and TNF-α 
levels were slightly higher in the malaria mono-infected children.  The difference 
between these groups may be what was not elevated, i.e., TNF-α and IL-10, rather than 
those IMs that were.  TNF-α is also a proven inhibitor of erythropoiesis (Roodman, Bird 
et al. 1987; Fandrey and Jelkmann 1991; Shami and Weinberg 1996; Allen, Breen et al. 
1999), and the molecule most often cited as being the precipitator of poor outcomes in 
malaria [reviewed in (Clark and Cowden 2003)] as well as bacteremia [reviewed in 
(Zanotti and Kumar 2002)], and IL-10 has been shown to reduce IL-12 levels with 
negative consequences on recovery from anemia (Keller, Yamo et al. 2006). 
 In the series of studies presented here, we observed two different co-infections 
with malaria having significantly different impacts on anemia.  While the Hb values were 
nearly identical in the malaria infected and bacteremia co-infected children, there was 
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increased RDW, suggesting the presence of younger RBCs and a sign of recent 
erythropoiesis.  This erythropoiesis was taking place in the bacteremia co-infected 
children despite erythrocyte indices suggesting an iron-deficient state was present, 
which is not unexpected in a systemic bacterial illness consuming the available iron.  In 
addition to the iron-deficiency, there was greater production of inflammatory mediators 
in the bacteremia co-infected versus the HIV-1 co-infected children, which should have 
resulted in a more inhibited erythropoiesis and more profound anemia.  This 
observation was supported by the lower parasitemias observed in the bacteremia co-
infected, also suggesting the presence of a more pro-inflammatory environment.   
 The IM commonalities between the two co-infections were increases in IL-4, IL-7, 
IL-12, IFN-α, and IFN-γ.  To some extent, these commonalities rule out these IMs as 
being major influences on erythropoiesis, and hence, the cause of the exacerbated 
anemia observed in the HIV-1/Pf[+] co-infected, but absent in the bacteremia co-
infected.  While IFN-α (Zhou, Chen et al. 1995) and IFN-γ (Musso, Calosso et al. 1999; 
Gysemans, Ladriere et al. 2005; Wenxin, Jinxiang et al. 2005) each elicit molecules 
capable of inhibiting erythropoiesis, i.e., nitric oxide and IL-15, respectively (Mullarky, 
Szaba et al. 2007; Cokic and Schechter 2008), the surprising common finding was 
increased IL-12, which has been shown in a number of studies to be important in 
boosting erythropoietic responses (Mohan and Stevenson 1998; Mohan and Stevenson 
1998; Zhang, Prather et al. 2010).  While seemingly important in supporting the Hb 
levels in the bacteremia co-infected children, this important cytokine was not protective 
in the HIV-1 co-infected group, despite a positive correlation with Hb in the principal 
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component factor analysis.  Furthermore, studies in renal disease patients resistant to 
EPO therapy have found they had higher circulating IL-12 levels,  as well as greater IL-
10, TNF-α, and IFN-γ production by PBMCs (Macdougall and Cooper 2002; Macdougall 
and Cooper 2002), suggesting higher IL-12 levels may not always be beneficial in 
anemia.   
 The cytokines that differed in significance and directionality between the 
bacteremic and HIV co-infected groups were increases in IL-5, IL-15, and IL-17 noted in 
the bacteremia co-infections but not the HIV-1 coinfected group.  Out of those three 
cytokines, only IL-15 (Mullarky, Szaba et al. 2007) has been reported to affect 
erythropoiesis, therefore this explanation would only be plausible if the increase were in 
the HIV-1[+]/Pf[+] group.  However, decreases in two key molecules, IL-10 and TNF-α, 
noted in the bacteremic children but not in the HIV-1[+]/Pf[+] children, may hold the 
key to the differences in anemia severity.  IL-10 has been reported to contribute to 
anemia by reducing IL-12 concentrations (Keller, Yamo et al. 2006; Cambos, Bazinet et 
al. 2010), which does not seem to be a factor in these two co-infections given the 
increased IL-12 levels.  However, as mentioned above, increased secretion of IL-10 from 
the PBMCs of poor EPO responders has been noted (Macdougall and Cooper 2002; 
Macdougall and Cooper 2002).  In addition, TNF-α is a well-known inhibitor of 
erythropoiesis (Roodman, Bird et al. 1987; Johnson, Waddelow et al. 1989; Rusten and 
Jacobsen 1995).  Decreases in these two potent molecules may be the difference  
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between the exacerbated anemia observed in the HIV-1/Pf[+] co-infected children and 
the comparable anemia seen in the malaria mono-infected versus bacteremia co-
infected children. 
 The work presented here helps elucidate the complex cytokine cascade that 
accompanies infection with malaria, HIV-1, and bacteremia in a sub-Saharan African 
population, and the potential effects on parasite clearance and recovery from anemia.  
One caveat to these studies is the cytokine measurements, as well as the parasitologic 
and hematologic values, are from a single point in time, and need to be confirmed using 
a longitudinal approach that will provide an extended picture of an extremely dynamic 
and complex set of infectious diseases and the immune response to those diseases.  
Studies using an in vitro model of erythropoiesis, as we have previously developed with 
CD34+ cells (Awandare et al., 54th Annual Meeting of the American Society of Tropical 
Medicine and Hygiene, 2005, Washington DC, USA), may also help elucidate the role of 
each cytokine, or combinations of cytokines, critical or detrimental to erythrocyte 
production.  
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